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Abstract: 
 
Background 
 
Type 1 diabetes mellitus (T1DM), the third most common chronic disease in children and 
adolescents,  impacts the achievement of normal developmental tasks not only on the 
individual but also on his family and which in turn has a significant effect on the person’s 
health-related quality of life. 
 
Aim 
  
The study aimed at measuring  the quality of life (QOL) and the identification of its 
determinants among T1DM patients registered at the MOH clinics in the northern districts 
of the West Bank. 
 
Method 
 
This descriptive cross-sectional study conducted in the period between April and 
December 2011 among T1DM patients registered in the primary health care centers in the 
northern districts of the West Bank aged 14 years old and above (728 patients).  Of those 
252 (34.5%) patients were randomly selected, stratified by districts, and investigated for 
their QOL. 9 subjects refused to participate, so 245 subjects only were studied. Patient’s 
quality of life was measured by means of SF-36 (version 1) quality of life questionnaire. 
Another questionnaire that included questions on the patients’ socio demographic and 
health status variables and a file review of the patient medical file were also used to 
identify the potential determinants of the QOL. Means and medians of the QOL domains 
were calculated to quantify it’s level. Means of the QOL within the studied variables 
categories were compared using T-test, ANOVA and GLM models in identification of the 
determinates.  
 
Findings 
 
The age of the participants ranged from 14 to 58 years old with a mean of 25.2, 48.6% 
were males and 51.4% females, (45.7%) were at age group 19-29 years. A proportion of 
35.9% finished secondary education, (31%) finished academic degree. About 29% of the 
participants had been diagnosed for diabetes since duration less than 5 years and rest had it 
for longer periods. The mean score for the eight RAND SF-36 domains ranged from 
51.73% to 75.64%, the highest was for bodily pain and the lowest was for general health 
perception. The RF domain was the most significantly influenced one by socio-
demographic, lifestyle and diabetes-related associated factors and this was reflected by the 
high portion of variance in the domain explained by GLM of analysis (R2 0.433), the 
second most explained variability was for the domain GH (R2   0.406) while the physical 
functioning (PF) domain wasn’t influenced by any of the socio-demographic, lifestyle and 
diabetes-related factors (R2 0.023). Compliance with medical dietary recommendations 
and the presence of one or more chronic diabetic complications had the most pronounced 
effect on the domains scores, since these variables affected at least four domains of the 
QOL. Participants level of education; presence of additional family resources; smoking, 
physical activity, BMI, HbA1c levels, number of insulin injections per day, presence of co-
morbidities, and occurrence of hyperglycemic episodes significantly affected one or more 
 XIV 
of the QOL domains. Other factors such as age, gender, marital status, family monthly 
income, current occupation, parental educational level, diabetes duration, and occurrence 
of hypoglycemic episodes had no significant effect on any of the quality of life domains. 
 
Conclusion and recommendations 
 
 The T1DM patients’ QOL was moderate to high and could impair their life at many 
aspects. Factors have been identified that could help in improving the life, its quality and 
care of the patients. Certain public health and medical interventions, educational and 
counseling interventions designed with multidimensional perspective should be performed 
to insure better quality of life. 
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CHAPTER ONE 
 
1.1 Introduction 
 
Health is a privilege for people and they should be responsible in keeping and maintaining 
it in order to remain functional members in the society which will lead to a healthy 
community. 
 
World Health Organization (WHO) in 1948 defined health as “A state of complete 
physical, mental and social well-being and not merely the absence of disease” (WHO 
1997). Health status as a multidimensional construct includes some of the variables that 
are important in measuring health such as premature mortality and life expectancy, various 
symptoms and physiologic states, physical functions, emotional and cognitive functions, 
and perceptions about present and future health (CDC 2000). Saving lives of the 
individuals by providing better treatment for existing disease and delaying mortality isn’t 
less important than improving their lives through improving their quality of life (NIH 
1993, Gill 1994).  
 
1.2 Diabetes mellitus 
 
Diabetes Mellitus (DM) is a group of metabolic disorders characterized by hyperglycemia 
due to defect in insulin secretion, insulin action or both( ADA, 2012). It is classified into 
five categories according to its cause; these categories are: type 1 diabetes that occurs as a 
result of the destruction of beta cells of the pancreas responsible for insulin production due 
to autoimmunity. Type 2 diabetes occurs due to insulin resistance at older age. Impaired 
Glucose Homeostasis which is a metabolic stage intermediate between normal glucose 
homeostasis and diabetes. Gestational diabetes recognized first in pregnancy. Other 
specific types caused by other identifiable etiologies such as drug or chemical use and 
infection (PMOH, 2003).  
 
Diabetes mellitus is a very important public health issue all over the world. Its prevalence 
is increasing worldwide; it was estimated to be 2.8% in the year 2000 with 171 million 
cases, and is expected to reach 366 million cases (4.4%) in the year 2030 (Wild, et al 
2004). In the Arab world the prevalence of diabetes increased from 2-3% prior to 1980 to 
the prevalence of 5-16% (Bloomberg, 2003); among adult males and females in the 
Eastern Mediterranean Region its prevalence ranges from 3.5% - 30%, while the highest 
prevalence is in Countries of the Gulf Cooperation, it is 11.5% - 30% (Wild et al 2004, 
Khatib, et al 2005). The prevalence of diabetes mellitus is expected to be more than double 
in Africa, the Eastern Mediterranean and South-East Asia regions (Diabetes Atlas, 2003). 
This increase is related to many factors such as long life expectancy, increased detection, 
sedentary life style and high fat diet. Adding to its importance is that DM is associated 
 2 
with many other chronic diseases and medical conditions as hypertension, cardiovascular 
diseases, stroke and lower extremities amputation; it is the fourth leading cause of death 
globally, and the first leading cause of blindness and visual impairment, and end-stage 
renal disease in adults in the developed countries (Diabetes Atlas, 2003). These medical 
conditions put an economical burden on the countries, for example, The American 
Diabetes Association (ADA) in 2007 estimated that the United States spends 174 billion in 
direct and indirect costs treating diabetes and its complications; 116 billion is for medical 
expenditures resulting from treatment and hospitalization of people with diabetes-related 
complications and 58 billion is consumed by indirect costs of disease-related productivity 
of both those in labor force and unpaid workers, unemployment from disease-related 
disability and increased absenteeism (CDC, 2008). As well, DM alone or in combination 
with other chronic medical conditions has a significant effect on the person’s health-
related quality of life since these diseases aren’t curable and have long duration which in 
turn have long life impact on the person’s physical, mental, and social functioning (Rubin 
& Peyrot, 1999).  
 
1.3 Quality of Life 
  
Quality of life (QOL) is a broad multidimensional concept that includes subjective 
evaluations of positive and negative aspects of life (WHOQoL Group 1998).It has many 
important domains other than health such as jobs, housing, schools and neighborhood 
which makes its measurement a challenge; despite this fact; researchers managed to 
develop useful techniques that helped in conceptualizing and measuring these domains and 
relate them to each other (CDC 2000).  
 
Quality of life was defined by The World Health Organization (1993) as “An individual 
perception of their position in life in the content of the culture and value system in which 
they live and in relation to their goals, standards, and concerns” (WHO 1993). 
 
Health related quality of life (HRQoL), which is patient based, focuses more on the impact 
of a perceived health state on the ability to live a fulfilling life (Bullinger et al. 1993 as 
cited in Bowling 1999 ). The concept “health related quality of life” and its determinants 
were developed since 1980’s in order to include all aspects of life that affect both physical 
and/or mental health (McHorney1999,Selim et al 2009). HRQoL has both an individual 
and a community levels. On the individual level, it includes physical and mental 
perceptions and what is associated with them such as health risks and conditions, 
functional status, social support and socioeconomic status. On the community level, 
HRQoL includes resources, conditions, policies and practices that affect the population 
health perception and functional support (Kindig et al 2010). 
 
1.4 Impact of Diabetes Mellitus on Health-related Quality of Life 
 
Chronic illness not only has an impact on the achievement of normal developmental tasks 
(Blum, 1992 as cited in Faro 1999 ; Kaplan & Friedman, 1994 as cited in Faro 1999) on 
the individual and family, also it has an impact among the individual, the family, and the 
chronic condition (Blum, 1992 as cited in Faro 1999).  
 
In diabetes mellitus, as one of these chronic illnesses, daily management becomes 
complex and requires major lifestyle modification, personal control and body image are 
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threatened, and the specter of long-term complications poses a threat to future health and 
well being (Faro 1999). 
 
Type1diabetes mellitus (T1DM) is one of the most common endocrine metabolic disorders 
in children and adolescence worldwide with serious acute and chronic complications 
(Efstathiou & Skordis 2011). It is a multifactorial disease that has an early onset, it may 
occur at any age of life and account for 5% to 10% of all diagnosed cases of diabetes 
(Raha et al, 2009). It affects approximately 1 / 400-600 children and adolescents 
worldwide (Roze et al.2005, Wanger and James 2006) resulting in high morbidity and 
premature mortality rates that reaches 0.5% due to either acute or chronic complications. 
The acute complications represented in Diabetic Ketoacidosis (DKA) as a result of 
hyperglycemia or hypoglycemia causes danger signs such as emotional instability, 
seizures or unconsciousness (Wolever et al 1999, Schoenle et al 2002) with episodes 
prevalence ranges from 4-86 episodes/100 patient/year (Diabetes Control and 
Complication Research Group1994, Goldstein D et al 1981).Chronic complications such 
as neuropathy, retinopathy and cardiovascular are rare in children (Glastras et al 2005). 
The prevalence of type 1 diabetes among youth (<19 years) is about 2/1,000, and its 
annual incidence in children 10-19 years old is about 19/100,000, with 3% annual 
increase, but faster, in young children (Schwartz, 2008). American Diabetes Association 
reported in 2009 that there are 23.6 million children and adults in the United States, 7.8% 
of the population, who have diabetes (ADA 2011). In Europe, Middle East, and Australia, 
rates of type 1 diabetes are increasing by 2-5% per year (Votey et al 2009); the annual 
incidence ranges from 1.9 to 7.0/100,000 in Africa, from 0.13 to 10/100,000 in Asia, from 
3.4 to 36/100,000 in Europe, and from 2.62 to 20.18/100,000 in the Middle East and 
approximately 4.4/100,000 in Australasia (CTGA Database), and in India the incidence is 
10.6 cases/100,000/year (Raha et al 2009).  
 
Risk factors for type 1 diabetes may be autoimmune, genetic or environmental, but the real 
cause is still unknown (CDC 2007).  
 
Diabetes mellitus in children cause a lot of imbalances in the lives of the child and as well 
the family. Once diagnosed with diabetes most patients experience long-term social and 
psychological and adaptation issues that influence the determination of the patient’s 
health-related behavior. Diabetics feel they are a burden and keep worrying about the 
future, they suffer from depression more than others in the general population; they have 
little or no interest in life as they are mentally crushed. Depression leads to heart disease 
and multiple anxiety disorders it also causes low glycemic control and this increases the 
risk of retinopathy. Eating disorders such as bulimia are common with young diabetic 
women and the adult diabetics in general (Faro 1999). 
 
In the case of children, diabetes adversely affects the neuro-cognitive and psychosocial 
functioning in a big way. While some of the children adjust to their new routines within a 
year, others don’t and stay at risk of continued psychosocial problems and poor metabolic 
control (Faro 1999).  
 
In adolescence; the transitional period between childhood and adulthood characterized by 
dramatic biologic, physical, cognitive, emotional, and social changes; hormonal changes 
trigger the onset of puberty and, body image is the major concern. During this period of 
time the adolescents try to achieve independence and self identity, therefore, thinking 
transition occurs from thinking only about the present to thinking about the future, and 
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from the referent group from parents and family to peers which puts the adolescents in a 
struggle to cope with these changes, so they often experience mood swings, and may 
engage risk-taking behaviors (Faro 1999). 
 
All the above mentioned becomes more complicated and difficult to achieve when the 
adolescents have diabetes, since they have to follow strict diet recommendations, and 
careful lifestyle choices are only available and this can’t be done among peers so as he/she 
still feels the same as they are which put them in a struggle not only due to their growth 
and development, but also due to their disease and as a result their quality of life is 
affected. 
 
The issue of quality of life and its assessment in chronic diseases in both adults and 
children became of an important interest in order to evaluate interventions, compare 
outcomes in clinical trials, organizing programs of care and assessing the outcomes of new 
treatment (Eiser and Mores 2001). 
 
Health-related quality of life (HRQoL) is associated with chronic diseases such as 
diabetes, hypertension, arthritis and breast cancer as well as with risk factors of these 
diseases (body mass index, smoking status and physical inactivity), therefore, 
improvement of HRQoL become a central goal of public health as it helps in determining 
the burden of preventable disease, injuries, and disabilities, and it provides valuable view 
to the relationships between HRQoL and risk factors (CDC2000). 
 
 Studies on type 1 DM showed that there is a significant impact of DM on HRQoL. 
Subjects with diabetes experienced decreasing in HRQoL when compared with subjects 
without diabetes; and the presence of other medical conditions lead to further lowering of 
HRQoL (Lin et al; 2005). As well the presence of one or more of the diabetic 
complications such as ischemic heart disease, neuropathy, and retinopathy was found to be 
associated with low HRQoL (Solli et al 2010, Al-Khour et al 2010). Relationship was 
detected between high HbA1c (diabetes indicator) and shorter duration of the disease, 
being a female and older adolescents and low HRQoL (Al-Khour et al 2010). 
 
Different studies were conducted on adults, adolescents and children with type 1 diabetes 
mellitus revealed that there are several factors affecting their quality of life and such 
factors are considered to be identified as the determinants of quality of life among those 
patients. These studies showed that socio-demographic factors (such as age, sex, level of 
education, monthly income, and occupation) (ISSA, 2006; AUSSILI, et al 2007, Naughton  
et al 2008), diabetes-related factors (such as diabetic complications, duration of the 
disease, glycemic control, number of insulin injections, and co-morbidities) (Franciiosi; 
2009, Naughton et al 2008, Delamaler, et al; 1999, Kovacs, et al 1985), and life style 
behaviors (such as smoking, physical activity, and diet) (AUSSILI et al, 2007, Glasgow, et 
al 1997) were associated with quality of life. 
 
1.5 Problem Statement 
  
Diabetes mellitus and its complications are major health problems in the Palestinian 
territories. Although the reported visits to PHC diabetic clinics for T1DM in Palestine, 
specifically the West Bank, were 11,106 in 2010 (PMOH, 2010), there is still a lack of 
sufficient information about the QoL those patients experiencing in the society. While 
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some studies were conducted to measure quality of life among diabetic patients in Gaza 
Strip, but not limited to patients with TDM, non was conducted in the West Bank.   
 
So the issue of QoL among patients with T1DM should be considered in order to 
understand how DM affects their daily lives and to help health care professionals to be more 
sensitive to their patients’ needs and concerns to improve the standards of living for this 
group of population. 
 
Therefore, the problem statement of this study can be summarized in the following 
question: what are the determinants of QOL among T1DM patients attending the MOH 
primary health care clinics in the northern districts of West Bank?  
 
1.6 Study Justification 
 
Like the rest of the developing world, the Palestinian population is undergoing changes 
from traditional to western lifestyle. Diet is transforming from natural food to processed 
food, beverages and takes away ones; physical activity also is transforming from walking, 
working in agriculture to public transports and sedentary activities as watching TV’s, 
working on computers and internet. Smoking is another lifestyle habit that affects health 
negatively and practiced without or with limited restrictions. These changes had an effect 
on the disease patterns and burden especially among young age groups (children, 
adolescents and young adults) by shifting from communicable diseases and high infant 
mortality to non communicable diseases. 
  
In Palestine diabetes mellitus, as one of the non-communicable diseases, is considered the 
6th leading cause of death, it causes 5.7% of death in the total population in Palestine, and 
there were 484 deaths due to diabetic complications with a proportion of 15.2/100,000 
(161 cases in males(6.4/100.000) and 222 cases in females(8.8/100.000) (PMOH, 2010). 
 
The increased prevalence of type 1 diabetes makes it a major public health concern due to 
the early onset of the disease, recurrent hospitalization, economical burden, and the early 
occurrence of complications which leads to death at young age. All of these may affect the 
patient’s daily activities, work, social relationships and expose him to great pressure 
physically, psychologically, socially, and financially which eventually affects his quality 
of life. 
 
 Since the researcher work in the diabetic clinic in Tulkarm primary health care center she 
noticed the magnitude of the problem and decided to conduct this study in order to reveal 
the importance of the issue and highlight the quality of life and its determinants among 
type 1 diabetics in the West Bank. The results of this study would help in improving the 
living standards of patients with T1DM by helping them to manage their disease and 
eventually improve their QoL. It would also help to clarify the needs of type 1 diabetics to 
other people who are dealing with such patients including family members, doctors, 
nurses, and decision makers in order to help them in applying certain programs to support 
patients and enable them to get the quality of life they desire.  
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1.7 Study aim and objectives 
 
The aim of this study was to identify quality of life and its determinants among type 1 
Palestinian diabetic patients attending the MOH clinics in the northern districts of the 
West Bank.  
 
1.7.1 General Objectives of the Study: 
 
To fulfill the overall goal of the study, the following objectives should be attained: 
 
1- To measure the level of each of the eight domains (physical functioning, role limitation 
due to physical health problems, role limitation due to emotional problems, energy and 
fatigue, emotional well-being, social functioning, and bodily pain) composing the QoL 
among T1DM patients who are attending the MOH clinics in the northern districts of the 
West Bank. 
 
2- To investigate for the associations between the socio-demographic factors, lifestyle 
factors, and diabetes-related factors and each of the eight domains that composing the QoL 
among T1DM patients who are attending the MOH clinics in the northern districts of the 
West Bank. 
  
1.8 Study Hypotheses  
 
1- H0: There is no association between socio-demographic factors (age, gender, place of 
residence in the district, marital status, participants’ level of education, current occupation, 
family monthly income, additional family resources rather than monthly income, and 
parents’ level of education) of T1DM patients who are attending the MOH clinics in the 
northern districts of the West Bank and their QOL.  
 
2- H0: There is no association between lifestyle behaviors factors (smoking status, physical 
activity status, and compliance with diet recommendations according to medical 
instructions) among T1DM patients who are attending the MOH clinics in the northern 
districts of the West Bank and their QOL. 
 
3- H0: There is no association between the diabetes-related factors (duration of diabetes 
since diagnosis, body mass index (BMI), the value of the last HbA1c test, number of 
insulin injections per day, the presence of  health problems other than diabetes(co-
morbidities), the presence of one or more of the diabetic complications (retinopathy, 
neuropathy, nephropathy, and cardiovascular disease) of T1DM patients who are attending 
the MOH clinics in the northern districts of the West Bank and their QOL. 
 
1.9 Thesis Chapters’ Summary 
 
The thesis consists of six chapters. In chapter one, we discussed the aim, problem 
statement and justification, and the objectives. Chapter two included literature review of 
the previous studies and related to present study. Chapter three discussed the theoretical 
and conceptual framework of the study. While in chapter four included the study 
methodology, data collection methods, sample size, piloting and statistical analysis of the 
data were discussed. Chapter five included study results which were presented in tables. 
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While in chapter six, the study results and findings were discussed and recommendation 
were presented.  
 8 
 
 
 
 
 
 
 
CHAPTER TWO 
 
 Literature Review  
 
This chapter provides an overview of literature and researches on the HRQOL and its 
determinants among type 1 diabetic patients. It includes Quality of life definitions, 
instruments for assessing quality of life for diabetes mellitus, diabetes mellitus and quality 
of life, socio-demographic factors and quality of life, lifestyle factors and quality of life , 
and diabetes-related factors and quality of life. 
 
2.1 Introduction 
     
 There is no certainty as to the origin of the term Quality of Life (Snoek, 2000). As stated 
by the American president Johnson (1964):  
 
“Goals can’t be measured by the size of our bank account; they can only be 
measured in the quality of lives that our people lead.” (Snoek, 2000, p 24). 
 
 These words indicated the importance of quality of lives of the populations which became 
the main interests of social scientists especially in the relationship between social 
indicators of quality of life and the subjective evaluation of these circumstances (Snoek, 
2000). 
 
Quality of life is considered the major goal of health interventions and outcome. It is 
measured as physical and social functioning, and perceived physical and mental well-
being (Rubin and Peyrot, 1999) which is consistent with WHO definition of health in 1948 
as it isn’t only the absence of diseases and infirmity, but also the presence of physical, 
mental and social well-being (WHO,1993). 
 
The concept quality of life became more popular in medicine since the early 70’s and 
several studies were conducted including diabetes in order to: 
 
  Evaluate the psychosocial functioning of patients group and to identify specific 
problems and needs of patients at the different stages of disease process. 
  
  Compare the impact of different treatment regimes on patients’ well-being and 
treatment satisfaction (Haes, 1985 as cited in Snoek, 2000).  
 
Assessment of QOL in chronically ill children and adolescents became important since it 
decreased the mortality rates due to different chronic diseases and increased the survival 
rates (Pantell and Lewis, 1987 as cited in Spieth and Harris, 1996). Pediatric QOL refers 
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to the child’s or adolescents functioning areas that are directly affected by the disease or 
its treatment (Spieth and Harris, 1996). 
 
Diabetic patients had a worse QOL in comparison to people with no chronic diseases 
because they feel challenged by the disease as well as its day to day demands (Rubin and 
Peyrot, 1999). 
 
2.2 Quality of life definition  
 
The term Quality of Life  has no universally accepted definition (Aaronson (1992); Spilker 
(1990) as in Spieth and Harris (1996)). It has usage across different disciplines such as 
geography, literature, philosophy, health economics, advertising, health promotion, 
medical sciences as well as social sciences (Bowling, 1999). 
 
Campbell and colleagues (1976) defined the term QOL as “a multidimensional construct 
compromising the individual’s perception of physical, emotional and social well-being, 
including both a cognitive component such as satisfaction and an emotional component 
such as happiness” (Campbell et al.(1976) as in Rubin and Peyrot (1999)). 
 
 Hörnquist (1982) defined QOL as “a broad spectrum of dimension of human experiences 
ranging from those associated with the necessities of life such as food and shelter; to those 
associated with achieving a sense of fulfillment and personal happiness”( Hörnquist 
(1982) as in Snoek, (2000)). 
 
Walker and Rosser (1988) defined QOL in medical settings as “a concept encompassing a 
broad range of physical and psychological characteristics and limitation, which describe 
an individual’s ability to function and derive satisfaction from doing so” (Walker, and 
Rosser (1988) as in Snoek, 2000)). 
 
 Grand and associates as well defined QOL as “a personal statement of the positivity and 
negativity of attributes that characterize one’s life” (Grand et al.(1990) as in Bowling 
(1999)). 
 
In the year 1993 WHOQOL Group defined the term QOL as: “an individual perception of 
their position in life in the context of the culture and value system in which they live and 
in relation to their goals, expectations, standards and concerns”, this concept is affected by 
physical health, psychological state, level of independence, social relationships and their 
relationships to relevant feature of their environment (WHOQOL Group (1993) as in 
Bowling, (1999)). 
 
Veenhoven distinguished between opportunities for the good life and the good life itself, 
he divided QOL into four categories each with an effect on the other. These categories are 
first; live-ability of the environment (environmental chances / social capital); second, life-
ability of the individual (personal capacities / psychological capital); third, the external 
utility of life (a good life must have an aim other than life itself or higher values), and the 
fourth is the inner perception of life (inner outcome of life / the higher perceived quality of 
life) (Veenhoven, 2000). Since there was no agreement on the definition of QOL concept, 
most researches would agree that QOL is a multidimensional construct, encompassing 
aspects of psychological, social and physical well-being and should reflect the patient’s 
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subjective evaluation of well-being rather than the health care professional’s point of view 
(Snoek, 2000). 
 
In order to narrow the extant of aspects of functioning directly to disease and/or medical 
treatment, the term health-related quality of life was introduced (Patrick, and 
Erickson(1988) as in Snoek (2000)).      
Health-related quality of life (HRQOL) refers to how health influences an individual’s 
ability to function as well as his or her perceived well-being in physical, mental and social 
domain of life. The functioning part of (HRQOL), which includes basic activities such as 
self-care as well as work-related activities and the ability to interact with friends and 
family, is relatively because self-report information can be compared with other sources of 
data such as observations and performance measures (Reuben et al., 1995). The well-being 
part of HRQOL is subjective more than the functioning part because it relies on the 
internal, subjective perception of the respondent. It includes emotional well-being of the 
person such as feeling happy, sad or depressed, it also includes if the person is in severe 
pain or has  pain at all, as well as it includes if the person is energetic or lethargic. 
 
2.3 Instruments for assessing quality of life in diabetes mellitus 
 
According to the Patient Reported Outcomes Measurement Group (PROMs), patients' 
experience of treatment and care is a major indicator of quality and there has been a great 
expansion in the development and application of questionnaires. PROMs provide a means 
of having a view into the way patients perceive their health and the impact that treatments 
or adjustments to lifestyle have on their quality of life. These instruments can be 
completed by a patient or individual about themselves, or by others on their behalf and had 
two kinds of instruments, generic and disease instruments (Fitzpatrick et al., 2006).  
 
2.3.1. Generic instruments: 
 
The following are examples on the generic QOL instruments for measuring QOL : 
  
 SF-36: Medical Outcomes Study 36-item Short Form Health Survey is a self-, 
interview-, or telephone-administered questionnaire that was derived from the work of the 
Rand Corporation during the 1970s. It was published in 1990 for application in a wide 
range of conditions and with the general population and should capture both mental and 
physical aspects of health. It assess health across eight domains: bodily pain (BP: two 
items), general health perceptions (GH: five items), mental health (MH: five items), 
physical functioning (PF: ten items), role limitations due to emotional health problems 
(RE : three items), role limitations due to physical health problems (RP: four items), social 
functioning (SF: two items), and vitality (V: four items), an additional health transition 
item, not included in the final score, assesses change in health. All items use categorical 
response options (range: 2-6 options). Scoring uses a weighted scoring algorithm and a 
computer-based program is recommended. Eight domain scores give a health profile; 
scores are transformed into a scale from 0 to 100, where 100 represent the best health. 
Two component summary scores for physical and mental health (MPS and MCS, 
respectively) can also be calculated (Ware and Sherbourne, 1992; Ware et al., 1994; Ware, 
1997). 
 
WHOQOL-BREF (The WHO Quality of Life Abbreviated Questionnaire) was developed 
to provide a brief version of the WHOQOL-100. It is used in studies needing the 
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practicality of a short questionnaire, in large-scale epidemiological studies, for audit, and 
clinical work and intervention evaluation. The WHOQOL-BREF composed of 24 items 
and provides a profile of scores on four dimensions of quality of life: physical health, 
psychological, social relationships, and environment. Each item is rated on a five-point 
scale. This instrument also provides one global rating on QOL and general health (WHO, 
1996).  
  
EuroQol-EQ-5D (The EuroQol Group, 1990; revised 1993) is a self or interview-
administered and was developed by researchers in five European countries to provide an 
instrument with a core set of generic health status items. Although providing a limited and 
standardized reflection of HRQL, it was intended that use of the EuroQol would be 
supplemented by disease-specific instruments. The developers recommend that EuroQol 
should be used in evaluative studies and policy research; it can also be used for economic 
evaluation (Fitzpatrick et al., 2006).  
 
The 15D is a generic, comprehensive (15-dimensional), self-administered instrument for 
measuring HRQOL among adults (age 16+ years). It combines the advantages of a profile 
and a preference-based, single index measure. A set of utility or preference weights is used 
to generate the 15D score (single index number) on a 0-1 scale (Fitzpatrick et al., 2006).  
 
Health Utilities Index (HUI) was designed as a comprehensive measure of health status 
and health related quality of life. The Health Utilities Index (Mark 3) health status 
classification was developed by Feeny et al., (1995) to assess capacity on eight 
dimensions: vision, hearing, speech, ambulation, dexterity, emotion, cognition and 
pain/discomfort. The utility function reflects community preferences and scores each 
unique health state on a scale ranging from 0 (death) to 1 (perfect health) (Fitzpatrick et 
al., 2006). 
 
3.3.2. Diabetes-specific instruments:  
 
The following are examples on the diabetes-specific instruments for measuring QOL: 
 
Diabetes Health Profile/DHP is a multidimensional self-completion instrument that was 
designed to identify psychosocial dysfunction among adult insulin-dependent and insulin 
requiring patients in an ambulatory care setting .The DHP-1 comprises 32 items covering 
three dimensions: psychological distress (14items), barriers to activity (13 items), and 
disinhibited eating (5 items); and the last may be appropriate as a screening tool for eating 
problems. Each item has a four-point adjectival scale; items are summed within the three 
dimensions and transformed to produce a score from 0-100 where 0 represents no 
dysfunction. The DHP-18 is a modified scale developed for use within type 2 diabetics 
(non-insulin dependent) patients (Meadows et al.,(1996) as cited in Fitzpatrick et al., 
(2006);  Meadows et al.,(2000) as cited in Fitzpatrick, et al., (2006)).   
 
 Diabetes Quality of Life Measure/DQOL: Although the DQOL was originally 
developed for use in a clinical trial comparing the efficacy of two different treatment 
regimens on the appearance and progression of chronic complications of patients with 
IDDM (Jacobson et al.,1988), its structure allows for application to other patients with 
IDDM and NIDDM. And it can be used in clinical settings as a screening measure to 
identify patients with concerns about diabetes. The instrument has 46 core items forming 
four scales: satisfaction with treatment (15items), impact of treatment (20 items), worries 
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about future effects of diabetes (four items), and worries about social and vocational issues 
(seven items). It also includes a generic health item that does not contribute to the scales. 
Adolescent and youth versions of the DQOL have been developed (Ingersoll and Marrero, 
1991). The dimensions and DQOL total scores (average score across the four dimensions) 
are scored 0-100 where 0 represents the lowest possible quality of life and 100 the highest 
(Fitzpatrick et al., 2006). 
 
3.3.3. Pediatric diabetic-specific instruments: 
 
The following are examples on pediatric generic and diabetes specific instruments: 
 
Child Health Questionnaire-Child form 87 (CHQ-CF87) is a generic quality of life 
instruments that have been designed for children 5-to-18 years of age. The CHQ measures 
14 physical and psychosocial concepts. The parent form is available in 2 lengths - 50 or 28 
items. Scores can be analyzed separately, the CHQ Profile Scores, or combined to derive 
an overall physical and psychosocial score, the CHQ Summary Scores (Health Act CHQ, 
2008). 
 
 Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0) measures physical, emotional, 
social, and school functioning of health-related quality of life (HRQOL) in healthy 
children and adolescents and those with acute and chronic health conditions. It consists of 
23 items for use with community, school, and clinical pediatric populations. It is 
appropriate for ages 2-18; child self-report ages 5-7, 8-12, 13-18; and parent proxy-report 
for ages 2-4, 5-7, 8-12, and 13-18).The PedsQL  Measurement Model integrates both 
generic core scales and disease-specific modules into one measurement system (Varni, 
1998).  
 
Diabetes Quality of Life for Youth scale (DQOLY) is a diabetes-specific and self-
administered instrument developed by Ingersoll Gary M. to assess the psychosocial impact 
of treatment regimens for diabetes in youth population (pediatrics and adolescents) with 
type 1 diabetes mellitus. It is present in long form that consists of 52 item and short form 
that consists of 22 item (PROQOLID, 2011). 
 
2.4 Diabetes mellitus and quality of life 
 
The relationship between diabetes mellitus and quality of life has been a subject of study 
for many decades (Rubin & Peyrot, 1999). In addition to the burden of the disease itself, 
diabetes has some special characteristics in relation to quality of life. Its treatment requires 
self-managed regimens such as changes in lifestyles (diet and exercise), self-testing of 
blood sugar, and strict insulin therapies. Glycemic control puts extra burden to social, 
emotional, and physical aspects of daily life. Therefore, these factors may have a 
significant impact in the perception of quality of life in individuals with diabetes. A great 
number of studies published in the literature addressed this issue (Hanestad, 1993; 
Jacobson et al., 1994; Aalto et al., 1997; Rubin & Peyrot, 1999; Trief et al., 2003).  
Although assessing QOL is methodologically complex, valid and reliable tools are 
available and could be used with diabetes patients and several studies differ regarding the 
purpose, design, target population, and especially the methodology to assess quality of 
life. Some studies included both type 1 and type 2 diabetes (Glasgow et al., 1997; 
Jacobson et al., 1997; Rubin & Peyrot, 1999). 
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Type of diabetes seemed to affect quality of life in some of these studies (Jacobson et al., 
1994; Trief et al., 2003) but not in others (Aalto et al., 1996). It has been unclear if these 
differences result from the type of diabetes or factors associated with diabetes type such as 
disease duration and treatment regimen (Jacobson et al, 1994; Rubin & Peyrot, 1999). 
Sarac et al.(2007) and Jacobson et al. (1994) detected that individuals with type 2 diabetes 
who started treatment with insulin reported poorer quality of life than those with type 1 
diabetes. Naughton et al. (2008) as well showed that HRQOL was significantly higher for 
youths with T1DM compared with T2DM. The same was reported by Glasgow et al. 
(1997) in a study of a large national sample of adults with diabetes in the United States. 
 
Individuals with type 2 diabetes taking insulin reported lower quality of life scores than 
individuals with T2DM on diet or pills or those with type 1 diabetes. The authors reported 
that people with T2DM starting on insulin had probably failed previous treatment 
regimens such as diet and oral medication or developed complications of the disease 
increasing the amount of stress in their daily routine with a negative impact on their 
quality of life (Glasgow et al., 1997). 
  
It has been shown that individuals with T1DM have poorer quality of life when compared 
to the general population (Wandell et al., 1998; Hahl et al., 2002) although some 
researchers did not find differences between these populations (Wikblad et al., 1996; Hart 
et al., 2003 a). These differences seemed to be dependent on some factors such as duration 
of diabetes and whether comparisons were made between populations with similar age 
distributions. In newly diagnosed individuals with type 1 diabetes, Huang et al found that 
people who are younger at diagnosis rate their health more highly than do people who are 
older at diagnosis (Huang et al., 2004). Hart et al. did not find any differences in the 
physical and mental component scores of quality of life compared to the general 
population (Hart et al., 2003b). The same research group also reported similar quality of 
life scores of type 1 diabetes individuals to the general population of comparable age (Hart 
et al., 2003a).  
 
Results from meta-analyses have shown that depression increases the risk of disease 
progression in either type 1 or 2 diabetes (Saydah et al., 2002). Studies have also been 
consistent in showing that the prevalence of depression is higher among those with 
diabetes compared to the general population (Diabetes UK. 2007; Anderson et al., 2001). 
Anxiety has been estimated to occur in approximately 20% of those with diabetes (Li et 
al., 2008). 
 
2.5 Socio-demographic factors and quality of life 
 
Socio-demographic factors such as age, gender, and level of education were studied by 
several researches to investigate their associations with quality of life as possible 
determinants. 
 
 Older age has been associated with worse quality of life among people with type 1 
diabetes. The greater impact of age has been observed on physical components of quality 
of life especially those related to daily functioning (Kalyva et al., 2011; Imayama 2011, 
Al-Akour et al., 2010; Sarac et al., 2007; Huang et al.,2004; Hart et al., 2003a; Trief et al., 
2003; Hahl et al., 2002; Aalto et al., 1997). Ismail showed in her study that there were no 
differences in self-rating health among better or poorer group regarding to age and so age 
didn’t affect quality of life (Ismail, 2011).  
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Among studies that reported differences in gender, men with type 1 diabetes have shown 
higher quality of life scores than women (Kalyva et al., 2011; Al-Akour et al., 2010; 
Tabaei et al., 2004; Huang et al.,2004, Aalto et al., 1997; Glasgow et al., 1997). These 
findings have been supported by other studies that showed that girls in older age groups 
had than boys the same groups as well, men reported higher satisfaction with their 
treatment and lower burden of diabetes on their physical and emotional functioning than 
women (Naughton et al., 2008; Peyrot & Rubin, 1997). Some studies found that being 
female was associated with depression in individuals with type 1 diabetes (Anderson et al., 
2001; Li et al., 2008). 
   
Some studies have found associations between socioeconomic status measured by level of 
education, marital status or income and quality of life. (Issa & Baiyewu, 2006; Huang et 
al.,2004; Egede & Zheng, 2003; Wikblad et al., 1996; Glasgow et al., 1997), while others 
didn’t (Al-Akour et al., 2010). Issa & Baiyewu showed that low monthly income, 
elementary occupation such as trading was associated with poor score on overall QOL, 
health satisfaction, Physical and Psychological health as well as social relationship 
domains (Issa & Baiyewu, 2006). Huang et al found that people with higher maternal level 
of education and higher socioeconomic level reported better health (Huang et al., 2004). 
Egede & Zheng found that lower level of education and being unmarried were associated 
with depression in T1DM (Egede & Zheng, 2003). Wikblad et al showed that, although 
there were no differences regarding metabolic control among groups, those with less 
education and low income reported lower quality of life scores than those with higher 
education and income, respectively (Wikblad et al., 1996). In a clinic-based study in 
Finland, Aalto et al observed that lower education was associated with lower scores in 
health perception, mental health, social and role functioning. However, these associations 
were not statistically significant when controlled for diabetes-specific psychosocial factors 
such as social support and self-efficacy (Aalto et al., 1997). 
Regarding place of residence Al-Akhuor et al reported that it wasn’t associated with 
quality of life (Al-Akhour et al., 2010) 
 
2.6 Lifestyle factors and quality of life 
 
Lifestyle factors including physical activity, diet regimen and smoking status were 
investigated for their association with quality of life in several studies (Ismail 2011, 
Imayama, 2011; Sarac et al., 2007). Ismail in her study found that regular exercise was 
associated with better health ( Ismail, 2011). Imayama reported the same findings 
regarding to physical activity levels, diet regimen as well as non smoking status which 
found to be positively associated to better health (Imayama 2011). 
 
Similarly, Sarac et al in their study reported that reduced physical activity, not following 
diet regimen and being smokers reduced the levels of six domains of SF-36 that are role 
physical, physical functioning, role emotional, bodily pain, social functioning and general 
health among patients with T1DM (Sarac et al., 2007). 
 
 
2.7 Diabetes-related factors and quality of life  
 
Different studies were conducted to assess the association between quality of life and 
diabetes-related factors such as chronic diabetic complication, the presence of co-
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morbidities, presence of hyperglycemic and hypoglycemic episodes,HbA1c levels and 
BMI in patients with T1DM. Some researchers found associations between quality of life, 
diabetes-related distress and glycemic control (Kalyva et al., 2011; Wit et al., 2007; 
Weinger & Jacobson, 2001; Wikblad et al., 1996; Hanestad & Albrektsen, 1993). In a 
group of 117 children and adolescents with T1DM and 128 matched healthy children and 
adolescents Kalyva et al. found that HbA1c as well as number of hyperglycemic episodes 
were significantly associated with poor quality of life (Kalyva et al., 2011). Another study 
by Wit et al. indicated  that higher HbA1c values were associated with more depressive 
symptoms and lower psychosocial well-being and adolescents with good glycemic control 
(≤7.5%) reported less family conflicts than the others (Wit et al., 2007). Weinger and 
Jacobson showed that improvement of glycemic control was related to improvement of 
diabetes-related emotional distress and depression in people with type 1 diabetes (Weinger 
& Jacobson, 2001).   
 
In a group of 185 patients with T1DM, Wikblad et al found that individuals with poor 
glycemic control rated their quality of life scores significantly lower than those with good 
or acceptable metabolic control (Wikblad et al., 1996). 
 
Other characteristics related to diabetes also had significant associations. Higher frequency 
of hypoglycemic reactions was significantly associated with lower scores for physical role 
and higher levels of glycosylated hemoglobin were also independently related to lower 
scores on the general health scale (Klein et al., 1998). In addition, individuals with 
hypoglycemic episodes rated their general health as being poorer than those without 
hypoglycemia (Lustman et al., 2000; Wikblad et al., 1996). Lustman et al published a 
meta-analysis for investigating the relationship between poor glycemic control and 
depression (Lustman et al., 2000). This study revealed a significant association of 
depression with hyperglycemia in patients with either type 1 or type 2diabetes. While 
Kalyva et al found that number of hypoglycemic episodes had no effect on quality of life 
(Kalyva et al., 2011). 
 
The association between chronic diabetic complications; macro vascular (cardio- and 
cerebrovascular diseases) and micro vascular (neuropathy, nephropathy, and retinopathy) 
diseases; with poor quality of life has been consistent across studies (Tabaei et al., 2004; 
Hart et al., 2003a; Hahl et al., 2002; De Groot et al., 2001; Lustman et al., 2000; Aalto et 
al., 1997; Wikblad et al., 1996; Jacobson et al., 1994). Type1 diabetes has an early onset 
and, as a consequence, patients need to deal with the burdens of diabetes-related 
complications during a significant period of their lives. Hahl et al showed that the presence 
of macro vascular complications had the most pronounced negative influence on quality of 
life in a population with type 1 diabetes in the Netherlands. Micro vascular complications 
did not have significant impact on quality of life in their study. This finding could be 
explained by the fact that most of the individuals had micro vascular complications at their 
initial stages with minor symptoms (Hahl et al., 2002). Overall, the impact of these 
complications has been   most commonly seen on quality of life domains related to 
physical role and functioning (Hahl et al., 2002; Wikblad et al., 1996). 
 
In a meta-analysis, De Groot et al showed that the relationships between depressive 
symptoms and long-term complications of diabetes were statistically significant when 
studies were all combined irrespective of type of complications or when analyzed 
according to type (i.e. nephropathy, neuropathy, and retinopathy). In addition, no 
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differences were observed between types 1 and 2 and most of the studies were clinic based 
(De Groot et al., 2001). 
Assessments of self-rated health using the MOS SF-36 have already been performed at the 
14-year follow-up examination of the Wisconsin Epidemiologic Study of Diabetic 
Retinopathy (WESDR 4, 1995-96) (Klein et al., 1998). A cross-sectional analysis 
demonstrated that long-term complications including neuropathy were independently 
associated with poorer scores in general health, physical functioning, and physical role 
domains. Diabetic retinopathy was associated with poorer physical functioning and 
nephropathy was associated with lower scores of general health. The physical functioning 
scale includes questions about limitations of specific activities and the physical role scale 
concentrated more on whether physical problems cause limitations in daily activities.  
 
The relationship between the number of complications and quality of life was studied by 
some researchers (Aalto et al., 1997; Jacobson et al., 1994). In a study in Finland, Aalto et 
al observed that those with higher number of complications reported poorer mental health, 
role functioning, and perceived health even after controlling for confounding factors 
(Aalto et al., 1997). Jacobson et al showed a cumulative effect of increasing number of 
complications in their study with greater number of complications associated with lower 
quality of life scores (Jacobson et al., 1994). 
  
Few studies have shown longitudinal, long-term changes of these associations but most of 
them supported the findings from cross-sectional studies previously discussed (Hart et al., 
2005a; Hart et al., 2005b; Huang et al., 2004; Wandell et al., 1999; The Diabetes Control 
and Complications Trial Research Group, 1996). Hart et al. (Hart et al., 2005a; Hart et al., 
2005b) followed 234 adults with type 1 diabetes during 6 years in the Netherlands and 
used two generic instruments: the RAND-36 Health Survey and the EuroQol. In this study, 
yearly decreases in quality of life scores were found for the majority of scales from both 
instruments, especially the measurements of physical components (physical subscales and 
the physical component score). In addition, when compared to a population without 
diabetes, individuals with type 1 diabetes had poor quality of life scales, possibly due to a 
higher proportion of micro- and macro vascular complications among them. 
 
The Wisconsin Diabetes Registry (Huang et al., 2004) investigated factors associated with 
self rated health in a population of T1DM. Males reported better health than females as did 
those with higher compared to lower socioeconomic status. The researchers also indicated 
that individuals who were young at the time of diagnosis and those with better glycemic 
control reported better health status. Wandell et al followed 48 patients with both types of 
diabetes in Sweden during a 3-year period. They observed that the overall health condition 
of this group worsened during this period and this change was associated with lower 
scores of physical functioning at the follow-up visit. (Wandell et al., 1999). 
 
A longitudinal analysis of quality of life was also carried out in the DCCT study (The 
Diabetes Control and Complications Trial Research Group, 1996). This randomized 
controlled clinical trial in patients withT1DM indicated that quality of life for patients who 
were under strict treatment regimen to achieve glycemic control that also resulted in 
higher frequencies of hypoglycemic episodes was similar for those in the conventional 
treatment group.  
 
Duration of diabetes was studied by several researchers (Ismail 2011; Al-Akhour et al., 
2010; Naughton et al., 2008; Huang et al., 2004) to assess its association with quality of 
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life. Some researchers found that longer duration of diabetes was found to be associated 
with better health (Al-Akhour et al., 2010; Naughton et al., 2008), while others found that 
longer duration was associated with decreased self-rated health (Ismail 2011; Huang et al., 
2004). 
 
Number of insulin injections per day was also investigated (Al-Akhour et al., 2010; 
Naughton et al., 2008; Huang et al., 2004). Huang et al in their study found that there was 
an inverse association between number of insulin injections and self-rated health (Huang 
et al., 2004). Naughton et al in a study to examine the associations between demographic 
and diabetes management variables and the health-related quality of life (HRQOL) of 
youths with type 1 or type 2 diabetes mellitus found that youth with T2DM with at least 
three times insulin injections reported better health (Naughton et al., 2008). This 
association wasn’t found in Al- Ahkour et al study (Al-Akhour et al., 2010). 
 
Body mass index (BMI) was found to have an association in patients T1DM (Imayama, 
2011; Naughton et al., 2008; Issa and Baiyewu, 2008). Imayama reported that higher BMI 
was associated negatively with quality of life (Imayama, 2011) and mainly with social 
functioning (Naughton et al., 2008) as well as with poor physical heath (Issa and Baiyewu, 
2008); the last in the same study found that weight loss (low BMI) was associated with 
poor health satisfaction. 
 
Naughton et al. as well as Imayama in their studies indicated that the presence of co-
morbidities was found to be associated negatively with quality of life (Imayama, 2011; 
Naughton et al., 2008). 
 
In Summary, many factors directly or indirectly related to diabetes have shown to be 
associated with quality of life among individuals withT1DM. Most studies were cross-
sectional and those that investigated changes longitudinally used short follow up periods. 
In addition, many studies relied on clinic or convenience samples to describe their 
associations. There are several determinants of QOL in T1DM’ patients among different 
countries throughout the world. The review of literature showed that QOL can be 
measured using various instruments, each of them had its own domains and scoring 
methods. 
 
Despite the differences in these instruments and scoring methods, these instruments gave a 
view on possible determinants of QOL among T1DM’patints. 
Although some studies revealed socio-demographic determinants such as age, gender, 
level of education, occupation and monthly income) were associated with better QOL, 
others didn’t find this association, the same was found in respect to lifestyle determinants 
such as smoking and exercise, and diabetes-related determinants such as duration of 
diabetes, HbA1c values, BMI, co-morbidities and diabetes complications. 
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CHAPTER THREE 
 
Conceptual Framework 
 
3.1 Introduction 
 
Conceptual framework is consider a basic element in the scientific research, it represents 
the infrastructure of any study. 
 
3.2 Quality of life and Diabetes Mellitus  
 
 Quality of life refers to  how good or bad a person feels their life to be and this 
emphasizes to capture the individual’s subjective evaluation of their QOL and not what 
others imagine it to be (Singh & Bradley,2006). Health related quality of life (HRQOL) 
refers to those aspects of quality of life which are related to a person's health status. It is 
primarily concerned with that aspect of quality of life which may be affected by health and 
disease (Polonsky, 2000). The issues of HRQOL related to the physical, mental, and social 
domains of person’s health, become increasingly important in health care and clinical 
practice (Testa and Simonson,1996). 
 
Diabetes mellitus is a long life disease that has a great burden on individuals. The 
demands of self-care can be burdensome; frustrating and the impact of long-term 
complications can be severe, leading to major changes in a patient's ability to function in 
daily life which makes the patient feel worried and depressed. Also the social relationships 
may be greatly affected (Polonsky, 2000).  
 
In the case of T1DM, Polonsky defined HRQOL as “The patient's perception of the way 
diabetes affects his/her physical, psychological, and social functioning”. It reflects the 
perceived burden of living with T1DM (Polonsky, 2000). 
  
Diabetes mellitus and physical functioning: Physical well-being of patients is negatively 
affected by the development of diabetic long-term complications (such as vision loss, 
kidney damage, peripheral neuropathy, and heart diseases) as well as short-term 
complication (such as hyperglycemia and hypoglycemia) in addition to lifestyle changes 
due to diabetes regimen which results in impaired functioning, increased fatigue and sleep 
problems, additional insulin injections, as well as the undesirable weight gain and 
limitation in daily activities which in turn leads to a significant drop in perceived QOL 
(Polonsky, 2000).  
 
Diabetes mellitus and psychological functioning: Presence of short-term complication 
and long-term ones, and the demands of diabetic care make the patient chronically 
frustrated and discouraged, helpless and always in depressed mood due to persistent 
 19 
fatigue, and the sense of mortality always confirmed and his disease isn’t responding to 
treatment (Polonsky, 2000).  
 
Diabetes mellitus and social functioning: Quantity and quality of diabetic patient’s 
relationships are also affected by the disease. As diabetes started, lifestyle changes begin, 
friends and family members begin to share in self-care of the patient over his/her willing 
which makes patients feel different from other people, feel alone and unsupported  
(Polonsky 2000). 
 
 In the current study the RAND-36 was used to assesses HRQOL multidimensionality, 
containing subscales focusing primarily on physical, social, and emotional functioning and 
general health perceptions such as the subscales general health, vitality (Hays and 
Morales, 2001). The physical functioning domain measures the individual limitations in 
physical activities because of health; role limitations due to physical health problems 
measure the extent to which physical health interferes with doing work or other regular 
daily activities; role limitations due to emotional problems measure the extent to which 
emotional problems interfere with doing work or other regular daily activities; emotional 
well-being measures the general mood or effect including depression, anxiety and positive 
well-being; energy and fatigue measures energetic versus tired and worn out; social 
functioning measures the extent to health interferes with social activities with family, 
friends, neighbors or group; bodily pain measures pain frequency and the extent of role 
interference due to pain; while general health perception measures the individual’s 
perceptions of health in general such as feeling well or ill ( Hays,1998).  
 
3.3 Factors that affect QOL 
 
the association of several patient characteristics, life style factors and diabetes specific 
factors with physical, mental, and social domains of a person's health related quality of life 
(HRQOL) were investigated though different studies. 
3.3.1. Socio-demographic determinants: 
The socio-demographic factors included age, gender, place of residence, level of 
education, marital status, occupation, in addition to information about the participants’ 
(family  monthly income, presence of additional resources other than the patients’ or his 
family work as well as parent’s level of education).  These factors were studied by 
(Ingersoll et al., 1991; Rubin &Peyrot, 1999; Faulkner, 2003; Huang et al., 2004; Issa & 
Beiyewu, 2006; Gonen et al., 2007; de Wit et al., 2007; and Imayama 2011). 
3.3.2. Lifestyle determinants: 
The lifestyle factors included smoking status, following special diet for diabetes, and 
physical activity such as playing sports, walking and running. These factors were studied 
by 9Gonen et al.,2007; and Imayama,2011). 
3.3.3. Diabetes-related determinants: 
These included the body mass index (BMI) which was calculated from the formula weight 
in kg/ height in merter2, the duration of diabetes mellitus which was calculating 
subtracting age at diagnosis from the current age of the participant, the value of HbA1C, 
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the number of insulin injections per day, presence of diseases other than diabetes, the 
presence of chronic diabetic complications (retinopathy, neuropathy, cardiovascular 
diseases, and nephropathy), the presence of acute diabetic complications (hypoglycemia 
and hyperglycemic episodes in the last four weeks), the need for hospitalization because of 
DM or its complications, and the compliance of regular visits to diabetic clinic. The effect 
of these factors on QOL was studied by (Eiser et al., 1992; Guttmann et al., 1998; Rubin & 
Peyrot, 1999; Huang et al., 2004; Issa & Beiyewu, 2006; de Wit 2007; Gonen et al., 2007; 
Naughton et al., 2008; Solli et al., 2010; and Imayama 2011). 
3.4 Conceptual framework of the study 
 
The following conceptual frame work was developed after reviewing the literature for 
QOL definition, measurements and the factors that may affect it and considered as 
possible determinants of QOL (Figure 3.1): 
 
 
                             
                                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (3.1): Factors affecting the QOL in patients with T1DM based on the literature 
review. 
Diabetes-related factors includes: 
•  Duration of the disease  
•  BMI 
•  HbA1c 
•  Number of insulin injections/ day 
•  Presence of co-morbidities  
•  Presence of diabetic chronic 
complications 
•  Occurrence of hypoglycemic 
episodes  
•  Occurrence of hyperglycemic 
episodes  
 
Lifestyle factors include:  
•  Smoking 
•  Compliance with dietary       
recommendations 
•  Physical activity 
 
Socio-demographic factors 
include:  
• Age 
• Gender 
•  Education 
•  Marital status  
• Occupation  
• Family monthly income  
• Additional resources to the 
monthly income  
 
Quality of life domains 
• Physical Functioning (PF) 
• Role Limitation due to physical health problems (RF) 
• Role limitation due to emotional problems (RE) 
• Energy/ Fatigue (EF) 
• Emotional Wellbeing (EWB) 
• Social Functioning (SF) 
• Bodily Pain (BP) 
• General Health (GH)  
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3. 5 Operational Definitions 
 
Physical Functioning 
(PF) domain 
Items that measures the individual limitations in physical 
activities because of health. It is measured by calculating the 
average of 10items (3,4,5,6,7,8,9,10,11, and12) of the RAND 
SF-36 (Hays, 1998). 
Role Limitation 
physical (RF) domain 
Items that measure the extent to which physical health interfere 
with doing work or other regular daily activities. It is measured 
by calculating the average of 4 items (13, 14, 15, and 16) of the 
RAND SF-36 (Hays, 1998). 
Role Limitation 
emotional (RE) 
domain 
Items that measure the extent to which emotional problems 
interfere with doing work or other regular daily activities. It is 
measured by calculating the average of 3 items (17, 18, and 19) 
of the RAND SF-36 (Hays, 1998). 
Bodily Pain (BP) 
domain 
Items that measure pain frequency and the extent of role 
interference due to pain. It is measured by calculating the 
average of 2 items (21, and 22) of the RAND SF-36 (Hays, 
1998).  
Social functioning 
(SF) domain  
Items that measure pain frequency and the extent to which health 
interfere with social activities and family, friends, neighbors, or 
groups. It is measured by calculating the average of 2 items (20, 
and 32) of the RAND SF-36 (Hays, 1998). 
Emotional well-being 
(EWB) domain 
Items that measure general mood or affect, including depression, 
anxiety, and positive well-being. It is measured by calculating 
the average of 5 items (24, 25, 26, 28 and 30) of the RAND SF-
36 (Hays, 1998). 
Energy/ fatigue (E/F) 
domain 
Items that measure feeling energetic versus tired and worn out. It 
is measured by calculating the average of 4 items (23, 24, 29, 
and 31) of the RAND SF-36 (Hays, 1998). 
General Health (GH) 
domain 
Items that measure the individual’s perception of health in 
general, such as feeling well or ill. It is measured by calculating 
the average of 5 items (1, 33, 34, 35,and 36) of the RAND SF-36 
(Hays, 1998). 
Age  Age of the participants at the time of data collection. 
Education  number of years of school completed at the time data collection. 
Physical activity Regular moderate intensity physical activity – such as walking, 
cycling, or participating in sports 
Body-mass index 
(BMI)  
 
Body-mass index was calculated as the weight in kilograms 
divided by the height in meters squared 
(weight(kg)/[height(m)]2). 
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Chronic diabetic 
complications 
Neuropathy, Retinopathy, Nephropathy, and Cardiovascular 
disease. 
Other health problems 
than diabetes 
Diseases such as musculoskeletal (arthritis, low back pain), 
and/or respiratory diseases   
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CHAPTER FOUR 
 
Study Methodology 
 
4.1 Introduction 
 
This study focused on the quality of life and its determinants among type 1 diabetic 
patients attending at the diabetic clinics in the governmental primary health care centers of 
the northern districts of West Bank. In this chapter the methodology is presented. The 
study design, study setting, study population, sampling, study tool, as well as data analysis 
are discussed. 
 
4.2 Study design 
 
A descriptive cross sectional study design was used to conduct this study in its focus on 
the QOL including its different domains among T1DM in the study settings. 
 
4.3 Study setting 
 
This study was carried out through the governmental primary health care clinics (PHC) 
that provide care and follow up for T1DM in the northern districts of the WB which 
includes Jenin, Nablus, Tulkarm, Qalqelia, Salfit, and Tubas. In these districts a total of 
six clinics were identified, one for each district, and all were selected for the study 
purpose. 
 
4.4 Study population 
 
All patients diagnosed with T1DM and whose age 14 years and above and currently 
registered and receiving treatment at the governmental primary health care clinics in the 
northern districts of the West Bank. The number of those patients was 728 cases.  
 
4.4.1 Inclusion criteria: 
 
From the total number of T1DM patients who had files opened for receiving care and 
treatment at the clinics, people were selected for the sampling frame to compare the target 
population based on the following criteria: 
1- The patients were Type 1 diabetic patients who aged 14 years and above. 
2- T1DM patients with the disease since at least one year. 
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3- T1DM patients who had regular visits to the diabetic clinic for check up and treatment. 
Regular visits were considered according to the appointments given to the diabetic patients 
by the nurse according to the amount of insulin decided by the diabetic doctor. 
4- Subjects can communicate verbally with the researcher.  
4.4.2 Exclusion criteria: 
 
At the beginning of the study, a total number of 911 patients from all ages were registered 
at the primary health care clinics in the six districts of the West Bank. After reviewing the 
medical files, 787 subjects aged 14 years and above were selected. 57 subjects were 
excluded from the study because:  
1- They had history of other chronic diseases (thalacemia and sickle cell anemia)before 
being diagnosed as T1DM’ patient. 
2- They were diagnosed with T1DM for less than one year.  
3- They weren’t being able to response due to mental illness. 
4- They didn’t come to follow up and receiving treatment because they did so in the 
UNRWA clinics.  
 
4.5  Study Sampling 
 
The study sample was determined as follows: 
 
4.5.1 Sample size determination: 
 
The study population met inclusion criteria included 728 eligible type1 diabetic patients 
attending the governmental primary health care centers diabetic clinics in the northern 
districts of West Bank. From those eligible subjects a systematic random sample of 252 
subjects was selected. The sample size was determined based on the formula described by 
the WHO :   
  
Sample size (ss) = (Z 2 * (p) * (1-p)) / C 2 
 
 
Where: Z = Z value (e.g. 1.96 for 95% confidence level), p = percentage picking a choice, 
expressed as decimal (.5 used for sample size needed), c = confidence interval, expressed 
as decimal (0.05). 
The correction of the final calculation as follows: 
New sample size (ss) =  ss / 1+( ( ss-1) / population )) 
 
4.5.2 Sampling procedure: 
 
For the sample to be representative to the districts, the proportion (34.5%) of eligible 
number of patients in the district diabetic clinics relative to the total eligible patients in the 
sample frame were calculated. Then the district was allocated the same proportion from 
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the total sample size. A total of 252 subjects distributed as follows, Jenin 95, Nablus 66, 
Tulkarm 54, Qalqilya 10, Salfit 13 and Tubas 13 were chosen. 
By using the method of systematic random sampling, each subject of the sample frame 
was given a serial number and then the sample interval (fraction) was determined by 
dividing the total population size (N) on the sample size of the study (n) which yielded a 
sampling interval of 2.7 for this study, this was rounded to 2 as described by Trochim 
(2006). 9 subject refused to participate in the study, so they were excluded from the study 
(table 4.1).  
 
Table (4.1): Distribution of the study sample in the area of study  
 
District Study Population (T1DM patients ≥ 14 
years) 
Study 
sample 
required  
No. of 
remained 
subjects 
Jenin 275 95 92 
Nablus 191 66 68 
Tulkarm 157 54 54 
Qalqelia 29 10 8 
Salfit 38 13 12 
Tubas 38 13 11 
Total 728 252 245 
 
4.6 Ethical considerations 
 
Formal approval was obtained from the concerned authorities at the Palestinian Ministry 
of Health (PMOH) to conduct the study. Subjects were asked to sign the consent form 
(Appendix A) after explaining the study details and procedures to them. The participants 
and their families were assured that their names and responses would be confidential. All 
participants have been informed that, their participation is entirely voluntary, and that even 
after the researcher-administrator questionnaire begins they can refuse to answer any 
specific question and that they have the right to terminate filling the questionnaire at any 
time. They have also been informed that, neither their participation nor their refusal to 
answer any question will have any effect on their right for receiving health care services 
from the MOH. 
 
4.7 Study tools or instruments  
 
Based on the study design used, the researcher used the medical files of T1DM patients 
attending the study settings, as well, mean of questionnaire was used as instruments to 
collect the required data for this study. Questionnaire were submitted to the patients and 
were filled in with the help of the researcher to collect the data from the participants 
themselves. This procedure of questionnaire filling helps the respondent to respond more 
easily as well as it helps the researcher to gather and summarize responses more efficiently 
(Trochim, 2006). 
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4.7.1. Medical files: 
 
All sampled subjects’ medical files were systematically reviewed to obtain basic 
identification information. These information include: HbA1c values based on the criteria 
followed by the PMOH, number of injections per day, onset of the disease, duration of the 
disease, presence of diabetes co-morbidities (hypertension, high cholesterol levels, joints 
pain, and sleeping problems), as well as the presence of chronic diabetic complications 
(CVDS , nephropathy, retinopathy and neuropathy) and the last visit the participant 
attended to the diabetic clinic was also noticed. The required information were fully 
recorded except the variable duration of the disease, so it was calculated by the researcher.  
 
4.7.2. Patient information sheet: 
 
Information on the possible socio-demographic determinants of QOL was obtained for 
each patient by mean of questionnaire that was developed by the researcher himself to 
collect personal data from the participants. This sheet was developed after extensive 
review of the available literature on T1DM and QOL. The sheet (Appendix B) has covered 
the following areas of interest: 
 
1- Demographic data including, age, gender, marital status, level of education 
accomplished. 
 
2- Socioeconomic status including, current occupation, monthly income, other resources 
of income.  
 
3- Lifestyle status including, smoking, diet and physical activity. 
 
 4- Diabetes-related information including, height, weight, episodes of hyperglycemia and 
hypoglycemia.  
 
4.7.3. Quality of life questionnaire: 
 
A comprehensive measure of HRQOL would include items assessing physical, mental, 
and social domain of life (Hays and Morales, 2001).The HRQOL is measured either by 
Disease-targeted HRQOL measures that are applied to a particular disease such as diabetes 
or cancer, or by Generic HRQOL measures that are applied to anyone, the later had two 
basic forms: preference-based and profile based. In the preference-based measures such as 
the EQ-5D, Assessment of Quality of Life (AQOL), and Health Utility Index (HUI),  a 
single summary score that cuts across the multiple domains of HRQOL is produced, while 
in profile measures multiple scores are produced on the multiple domains of HRQOL such 
as the RAND-36 (Hays and Morales, 2001) which was used in this study. 
 
The RAND 36-Item Health Survey 1.0 (RAND-36) is comprised of 36 items selected from 
large number of items used in the RAND Medical Outcome Study (MOS) that assess eight 
domains of health; Physical Functioning (10 items) which considers limitation in 
performing daily activities as walking stairs, bathing, or dressing one’s self, or carrying 
groceries as a result of a health problem, Role Limitation (physical problems; 4 items) that 
measures problems with work or other daily activities as a result of physical health during 
the last 4 weeks, Role Limitation (emotional problems; 3 items) which considers role 
limitation due to emotional problems, Energy / Fatigue (4 items) considers feelings of 
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energy and tiredness, Mental Health (5 items) that contains questions about feelings of 
depression and nervousness, Social Functioning (2 items) that considers limitations in 
social activities such as visiting friends or relatives, Pain (2 items) considers the amount of 
pain and limitations due to bodily pain , and the General Health Perceptions (5 items) 
which measures the subjective evaluation of their own general health status, and finally, an 
additional item, that isn’t included in any of the eight domains, was added considering 
health change, referring to general health compared to 1 year ago. The eight domains are 
then summarized into three summary domains; physical, mental and global health 
summary scores (Hays, 1998). The RAND website and manual explains in details the 
questions measuring each dimension, scoring and calculating of QOL. Briefly, raw 
RAND-36 scores on the eight domains are linearly converted to 0– 100 scales with higher 
scores indicating better quality of life. Aggregate scores are compiled as a percentage of 
the total points possible, using the RAND scoring table. The scores from those questions 
that address each specific area of functional health status are then averaged together, for a 
final score within each of the eight domains measured such as pain, physical functioning 
(Hays, 1998).  
 
A translated Arabic version of RAND-36 Health Survey is available for free use on the 
RAND Website. This Arabic form, which was used in this study (Appendix C),was 
validated by both Sabbah et al., (2003) and Alabdulmohsin et al., (1998) and found to be 
valid for use for Arabic speakers (Sabbah et al., 2003. Alabdulmohsin et al., 1998).  
 
Rational for using the Rand-36 questionnaire: The RAND SF-36 is a brief 
questionnaire that has been well validated in the social science and medical literature, and 
is being used extensively around the world as a tool for assessing clinically relevant 
patient outcomes which is available for free use by the RAND website. This questionnaire 
is widely used in many countries and has been translated into many languages and proved 
to be valid and reliable. 
 
Although the RAND-36 questionnaire consists of more items and takes longer to complete 
than other instruments, it is very sensitive to changes in HRQOL in a cohort of patients 
with T1DM and provides information about diabetes-specific associations with HRQOL. 
The RAND mental summary score (MCS) was associated with a change in a diabetes-
specific characteristic and the onset of micro-vascular complications was associated with a 
decrease in MCS, while the PCS will be influenced negatively later. The generic and 
diabetes-specific instruments show low correlations and identify for the most part different 
patients with the lowest HRQOL (Hart et al., 2007). 
 
4.8 Data collection 
 
After the necessary permission was obtained from the concerned authorities to conduct the 
study, the researcher met with the physicians and the nurses in charge of the diabetic 
clinics in the six governmental primary health care centers in the northern districts of the 
West Bank, and the purpose of the study was explained to them and their assistance was 
requested in recruiting the subjects. The subjects who met the inclusion criteria were 
selected as potential participants for the sampling frame of the study. The selected subjects 
were informed via phone; by the their diabetic nurse; and the study objectives were 
discussed to them to attain their agreement. Subjects were willing to participate in the 
study, so they were asked to  come to the diabetic clinic to fulfill the questionnaire. 
 28 
 
4.9 Pilot testing 
 
The data collection instruments; the demographic sheet and the QOL questionnaire; were 
both field tested on 25 subjects from the six diabetic clinics in the governmental primary 
health care centers in the northern districts of the West Bank, for any considerations or 
modifications needed before carrying out the study. All those who were pilot tested were 
excluded from the study. The goals of the pilot study were to assess the adequacy of the 
data collection plan, to identify any part of the instrument that might need revision and 
refinements or might be objectionable or culturally incongruent in order to minimize the 
problems which may be raised during data collection. 
 
4.10 Data analysis 
 
The collected data was coded then entered, cleaned and analyzed using the statistical 
package for social science (SPSS version 15.0). Descriptive statistics such as frequencies, 
percentages, means and standard deviations, summary scores for each participant were 
calculated then inferential tools within the program were used to make comparisons and 
inferences on association; t-test, and ANOVA were used to describe the variables of the 
study and their association with the QOL scores to find out if they could be considered as 
determinants for these scores. General Linear Model (univariate analysis) was used for 
confirmation of the results. These inferential methods were used based on the large sample 
size that fit the requirements of the central limit theorem (Witt & Witt, 1997) and the 
findings of Torrance et al., (2009).  
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CHAPTER FIVE 
 
Study Results 
 
5.1 Introduction 
 
In this chapter the results of the data analysis are presented. The sample characteristics 
were first described followed by bivariate and univariate analysis testing for the variables 
associated with the QOL domains. 
  
5.2 Response rate 
 
The study sample composed of 252 subjects diagnosed with T1DM attending at the six 
governmental primary health care centers located in the northern districts of the West 
Bank, in which the data was collected. 245 subjects were studied (9 subjects refused to 
participate in the study). Therefore, the response rate was 97.2%. 
  
5.3 Characteristics of the sample 
 
The general characteristics of the sample and variables studied are presented in this 
section; they included socio-demographic variables; Lifestyle variables and diabetes-
related variables. 
 
5.3.1. Socio-demographic characteristics: 
  
Socio-demographic variables included participant’s age, gender, marital status, 
participants’ level of education, current occupation, family monthly income, additional 
family resources rather than monthly income. 
  
Age  
At the time of data collection the age of the participants ranged between 14 and 58 years 
old with a mean of 25.2 years and standard deviation of 8.37. The results showed that 
25.3% were at the age group (14 – 18), 45.7% were at the age group (19 – 29), 21.4% 
were at the age group (30 – 39), and 7.3% were above 40 years old (Table 5.1).  
 
Gender 
 
Both genders were represented in the sample, males were 119 (48.6%), while 126 (51.4%) 
were females (Table 5.1).  
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Participants’ education 
 
Participants who were illiterate composed 1.6% (n=4), while 6.5% had primary level of 
education composed 24.9% finished preparatory level of education, 35.9% of the 
participants finished secondary education, and 31% finished academic degree (first 
university degree and above) (Table 5.1). 
 
Marital status 
 
The main proportion (65.5%) of the participants were currently not married (single 62%, 
divorced 1.2%, widowed 1.2%) at the time of the study, while married participants 
composed only 35.5% (Table 5.1).  
 
Current occupation 
 
The distribution of participants by their current occupation showed that 9.8% were 
governmental employees, 2.9% worked in private sectors establishments, 10.2% were 
independent freelancers, 2.4% were farmers, 18.8% were housewives, 13.1% were 
unemployed, 34.4% of the participants were students, and 8.6% were unskilled workers 
(Table 5.1).  
  
Family monthly income  
 
Concerning family income, participants whose family monthly income was less than 1000 
NIS represented 18%, participants whose family monthly income ranged from 1000 to 
2000 NIS represented 44.5%, families with income of 2001-3000 NIS represented 21.6% 
and only 15.9% had a monthly income more than (3000NIS) (Table 5.1.b), in addition to 
that, a proportion of 11.4% of the participants reported to have additional resources of 
income other than their family monthly income, (Table 5.1).  
  
5.3.2. Lifestyle characteristics: 
  
The lifestyle variables studied in this study were smoking status, physical activity status, 
and compliance with dietary instructions of the participants. 
  
Smoking status 
 
The results on the current smoking status showed that 18.8% of the participants were 
smokes, while 81.2% non-smokers (Table 5.1). 
 
Compliance with dietary instructions 
 
Related to their diet, a proportion of 52.7% of the participants said that they currently 
followed a special diet for diabetes mellitus according to the medical instructions, while 
47.3% said that they didn’t follow the instructions (Table 5.1). 
 
Physical activity 
 
Participants who responded positively to the question about practicing walking, running 
and  swimming accounted only for 61.2% of the sample (Table 5.1). 
 
 31 
5.3.3. Diabetes-related characteristics:  
 
Participants’ diabetes-related variables that were studied and collected from the patients’ 
files included duration of diabetes since diagnosis, body mass index (BMI) of the 
participant, the value of the last HbA1c test, number of insulin injections per day, the 
presence of  health problems other than diabetes(co-morbidities), the presence of one or 
more of the chronic diabetic complications (retinopathy, neuropathy, nephropathy, and 
cardiovascular disease), and occurrence of hyperglycemic and hypoglycemic episodes four 
weeks prior data collection that were self reported. 
 
Duration of the disease 
 
The results showed that 29% of the participants had been diagnosed for diabetes for less 
than 5 years, 28.2% had diabetes for 6 to 10 years, 17.6% had diabetes for 11 to 15 years, 
and 25.3% had diabetes for more than 15 years (Table 5.1). 
 
Body mass index (BMI) 
 
Following the Palestinian guidelines for diagnosis and management of diabetes mellitus 
(2003), a proportion of 5.7 % of the participants were diagnosed as very underweight with 
BMI less than 18, 10.6% were underweight with BMI ranged from 18.8 to 19.9, about 
40.4% of the participants had healthy weight with BMI ranged from 20 to 25, 26.9% were 
overweight with BMI ranged from 25.1 to 29.9 %, while a proportion of 11% were 
diagnosed as obese with BMI ranged from 30 to 40, and the remained proportion 5.3% 
were very obese; their BMI was more than 40. Since the proportion of the participants 
who were very underweight was small, it was aggregated to those who were underweight 
to form a proportion of 16.3%, and those who were obese and very obese were aggregated 
to overweight participants to have a proportion of 43.2% (Table 5.1). 
 
Metabolic control 
 
With relation to metabolic control of diabetes measured by glycosylated hemoglobin 
(HbA1c) level according to PMOH (2003), the files of the participants review of the last 
HbA1c showed that 25.7% of the participants had an HbA1C value of  less than 8 (which is 
an acceptable control), while74.3% had a value of HbA1c 8 or more (which is a poor 
control) (Table 5.1). 
 
Number of insulin injections per day 
 
The files of the participants review showed that a proportion of 8.6% of the participants 
inject themselves with insulin once daily to control their blood sugar level, 41.6% inject 
themselves twice daily, 37.6% inject themselves with insulin three times daily, while 
12.2% inject themselves with insulin more than three times per day (Table 5.1). 
 
Presence of health problems other than diabetes mellitus (co-morbidities) 
 
The files of the participants review showed that presence of one or more of health 
problems other than DM (hypertension, high cholesterol levels, respiratory diseases or 
infections, joints pain and sleeping problems) were present in 26.5% of the participants, 
while the remaining proportion 72.5% had no co-morbidities (Table 5.1). 
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Chronic diabetic complications 
 
Concerning chronic diabetic complications, the files of the participants review showed that 
a proportion of 20.4% of the study sample had one or more of the investigated diabetic 
complications; these were distributed as 9.4% with retinopathy, 11.4% with neuropathy, 
1.6% with cardiovascular diseases (CVD’s) and 6.5% with nephropathy. The remaining 
79.6% of the participants didn’t have any of these complications (Table 5.1). 
 
Acute diabetic complications 
 
Regarding the reporting of occurrence of  acute diabetic complications a proportion of 
43.7% of the study sample reported being exposed to hypoglycemic episodes during the 
four weeks prior to data collection (such as having symptoms of sweating, anxiety, 
hunger, and sleepiness), while hyperglycemic episodes during the four weeks prior to data 
collection (such as having symptoms of more urine output than usual, increased thirst, dry 
skin and mouth, fatigue, drowsiness, or no energy) was reported by 45.3% of the 
participants (Table 5.1). 
 
Table 5.1: Distribution of the study sample according to the socio-demographic, lifestyle 
and diabetes-related characteristics of its subjects 
 
Characteristics of the study sample N (%) 
14 - 18 62 (25) 
19 - 29 112 (45.7) 
30 - 39 53 (21.6) 
Age group of the participants (years) 
≥ 40 18 (7.3) 
Male 119 (48.6) Gender 
Female 126 (51.4) 
Illiterate 4 (1.6) 
Primary 16 (6.5) 
Preparatory 61 (24.9) 
Secondary 88 (35.9) 
Level of education 
Academic  76 (31.0) 
Governmental Employee 24 (9.8) 
Private establishment Sector 
Employee 
7 (2.9) 
Self-employed 25 (10.2) 
Farmer 6 (2.4) 
Housewife 46 (18.8) 
Unemployed 32 (13.1) 
Student 84 (34.3) 
Current occupation 
Unskilled worker 21 (8.6) 
Married  87 (35.5) 
So
ci
o-
de
m
og
ra
ph
ic
 c
ha
ra
ct
er
is
tic
s 
  
Marital status 
Not currently married  158 (64.5) 
Continue……………. 
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< 1000 44 (18.0) 
1000 – 2000 109 (44.5) 
2001 – 3000  53 (21.6) 
Family monthly income 
> 3000 39 (15.9) 
Yes 28 (11.4) 
 
Family additional resources of 
income No 217 (88.6) 
Yes 46 (18.8) Smoking status 
No 199 (81.2) 
Yes 129 (52.7) Compliance with dietary 
recommendations No 116 (47.3) 
Yes 150 (61.2) 
L
if
es
ty
le
 
ch
ar
ac
te
ri
st
ic
s 
Physical activity (walking ,running, 
swimming) No 95 (38.8) 
< 5 71 (29.0) 
5 – 10  69 (28.2) 
11 – 15  43 (17.6) 
Diabetes duration in years 
> 15 62 (25.3) 
< 19.9 40 (16.3) 
20 – 25  99 (40.4) BMI 
> 25  106 (43.2) 
Acceptable control ( < 8 ) 63 (25.7) HbA1 c 
Poor control ( > 8 ) 182 (74.3) 
Once  21 (8.6) 
Twice  102 (41.6) 
Three times 92 (37.6) 
Number of insulin injections / day 
> Three times 30 (12.2) 
Yes  65 (26.5) Presence of health problems other 
than diabetes mellitus No 180 (73.5) 
Yes  50 (20.4) Presence of one or more of chronic 
diabetic complications No 195 (79.6) 
Yes  107 (43.7) Occurrence of hypoglycemic 
episodes within the four weeks prior 
data collection 
No 138 (56.3) 
Yes  111 (45.3) 
D
ia
be
te
s-
re
la
te
d 
ch
ar
ac
te
ri
st
ic
s 
Occurrence of hypoglycemic 
episodes within the four weeks prior 
data collection 
No 134 (54.7) 
 Total  245 (100%) 
 
5.4 Description of quality of life domain measures 
 
The items that described and assessed the level of QOL for the participants over the past 4 
weeks included 36 items (the RAND-36 version 0.1). The RAND-36 covers the following 
eight sub domains: The mean score and the median for the QOL domains were calculated 
and the results showed that the bodily pain domain (BP) had the highest mean of 75.64% 
and the GH domain had the lowest mean score (51.73%). 
 
The physical functioning (PF) mean was 74.57%, social functioning (SF) mean was 71.88, 
role limitation due to physical health problems (RF) domain mean was 66.42%, role 
limitation due to emotional problems (RE) mean was 63.26%, emotional well-being 
(EWB) domain mean was 58.82%, energy/ fatigue (E/F) domain mean was 58.69%, and 
the additional item that assessed changes in perceived health had a mean score of 62.85% 
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(Table 5.2). Regarding the median, the PF domain had the highest median value (90), and 
the GH domain had the lowest value (55). the median for the bodily pain domain (BP) was 
80, social functioning (SF) median was 75, role limitation due to physical health problems 
(RF) domain median was 75, role limitation due to emotional problems (RE) median was 
66, emotional well-being (EWB) domain median was 56, energy/ fatigue (E/F) domain 
median was 60. 
 
Table (5.2): Description of means, median and standard deviation of the RAND-36 QOL 
sub-domains 
 
QOL domains 
Mean 
score Median Std. Dev. 
physical functioning (PF) 
 
74.57 90 26.43 
role limitation due to physical health problems (RF) 
 
66.42 75 34.44 
role limitation due to emotional problems (RE) 
 
63.26 66 40.84 
energy/ fatigue (E/F) 
 
58.69 60 19.38 
emotional well-being domain (EWB) 
 
58.82 56 19.77 
social functioning(SF) 
 
71.88 75 22.77 
Pain (BP) 
 
75.64 80 24.65 
general health (GH) 
 
51.73 55 19.66 
General Health change 62.85 75 24.75 
 
 
5.5 Quality of life determinants 
 
Possible determinants of health related quality of life were divided in the analysis into 
socio-demographic factors, lifestyle factors and diabetes-related factors. The sections 5.5.1 
through 5.5.3.7 show the results for the analysis to detect possible relationship of the 
factors with QOL. Only factors associated with at least one of the eight domains are 
represented in this section. Factors none significantly associated with any of the domains 
are presented in Appendix (D). For the significant associations only mean, standard 
deviation, test statistic and p-value are presented in Appendix (E). 
 
5.5.1. Socio-demographic factors and QOL:  
 
The socio-demographic factors of the study sample were analyzed with regard to their 
potential relationship with the Quality of life eight domains. 
  
While performing T-test or One-Way ANOVA to assess the relationship with age of the 
participants, gender, marital status, current occupation, family monthly income, and 
duration of diabetes mellitus, no significant association was found between these above 
mentioned variables and any of the eight domains of QOL. Tables and results of this 
analysis are shown in Appendix (D). The below description is only for the factors that 
were found significantly associated with at least one domain which are participants’ level 
of education, presence of additional resources than family monthly income, smoking 
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status, compliance with special diet for diabetics according to medical instructions, 
physical activity and exercise, BMI of the participants, HbA1c levels, number of insulin 
injections per day, presence of health problems other than DM, occurrence of 
hypoglycemic episodes, occurrence of hyperglycemic episodes, presence of one or more 
of diabetic complications. Table (5.3) showed the associated variables with each domain 
and its p- value. 
 
5.5.1.2 Participants’ level of education: 
 
Participants’ level of education was found to be significant associated with only the EWB 
domain (p 0.005) (table 5.3).One-Way ANOVA test detected a significant negative 
association was detected between the level of education and EWB domain(Appendix E). 
For the association of participants’ level of education with EWB, LSD test was performed 
to test for the differences between participants’ levels of education categories in relation to 
EWB of QOL domain(Appendix E). LSD test showed that participants who were illiterate 
had a higher mean score of EWB of QOL (84, p 0.013) than those who had primary, 
preparatory, secondary and university level of education. Participants with  preparatory 
level of education had a high mean score on emotional well-being of QOL domain 62.09 
than those with secondary level of education (p 0.012); and participants with academic 
level of education had a high mean score of 60.94 than those with secondary education (p 
0.021)  
 
5.5.1.3 Additional resources rather than monthly income:  
 
Additional resources rather than monthly income had a significant relationship with the 
domain of role limitation due to physical health problems (RF) (p 0.007), role limitation 
due to emotional problems (RE) (p < 0.0001), and bodily pain domain (BP) (p 0.037) 
(table 5.3). The results of two independent samples T- test (Appendix E) showed that there 
was a significant negative association between the presence of additional resources rather 
than the monthly income and those three domains of QOL. 
 
The mean sore of RF domain for those with additional resource was lower 37.88 than the 
mean score for those without these resources 33.48 (p 0.007) (Appendix E). 
 
For role limitation due to emotional problems (RE), participants with additional resource 
had a slightly lower mean score 38.85 than those without these resources 39.93 (p 0.001) 
(Appendix E). 
 
Similar trend of lower score for those without additional income was found in BP domain, 
since the mean score of this domain was lower for participants who had additional 
resources (66.60) than participants without the additional resources (76.80),  
p 0.039 (Appendix E).  
 
5.5.2 Lifestyle factors and QOL: 
 
Quality of life eight domains were analyzed with regard to their potential relationship with 
the different socio-demographic factors of the study sample. This section shows the results 
of the significant associations.  
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5.5.2.1 Smoking status: 
 
A significant association was found between smoking status of the participant and the role 
limitation due to physical health problems (p< 0.0001) and SF domains (p 0.005) (table 
5.3). The results of the t-test analysis (Appendix E) showed that there was significant 
negative association between. The mean score of RF was as low as 49.4% among smokers 
compared to a mean of 70.3 for non smokers (p<0.0001). A significant positive 
association was detected between social functioning (SF) and smoking status , the SF 
mean score was 80.4 among smokers  in comparison to 69.9 for non-smokers (p-value 
0.005). No association was detected with the other domains(Appendix E). 
 
5.5.2.2 Compliance with special diet for diabetics:  
 
Following the diabetic diet requirements seems to have a positive impact on four of the 
domains of QOL, as well as the general health domain(table 5.3). T-test was used to assess 
significance of the association(Appendix E). Role limitation due to physical health 
problems (RF) was positively affected by following the dietary advices; mean score for the 
followers was 76.5 vs. 55.1 for non followers (p-value < 0.0001), following the special 
diet as well increased the score of role limitation due to emotional problems (RE) from 
47.4 for non followers to 77.5 for the followers ( p < 0.0001). Social functioning as well 
was affected positively by dietary requirement advices as following the diet requirements 
increased score from 64 for non followers to 78.9 for followers (p < 0.0001). 
 
The same trend was observed for the mean scores of pain which increased from 68.9 to 
81.6 (p < 0.0001), and for the general health domain, the mean score increased from 45.6 
to 57.2 (p-value < 0.0001) (Appendix E). 
 
5.5.2.3. Physical activity and exercise: 
  
Physical activity and exercising seems to positively affect some QOL domains, a 
relationship was detected in T-test analysis between this variable and two QOL domains 
(table 5.3). 
 
Participants who were physically active had a higher score in physical functioning domain 
(mean 77.2 for active vs. 70.3 for non active participants, p-value=0.045 and as well in 
energy/fatigue domain (mean of 63 for active vs. 51.8 for the non active, p < 0.0001) 
(Appendix E). 
 
5.5.3. Diabetes-related factors: 
 
Quality of life domains were analyzed with regard to their potential relationship with the 
diabetes-related factors of the study sample the significant results were as following: 
 
5.5.3.1. Body mass index (BMI): 
 
ANOVA test used to test for relationship between BMI of the participants and their QOL 
domains detected significant positive associations between this variable and five of the 
QOL domains. A significant positive association was detected with the  role limitation due 
to physical health problems (p 0.009), role limitation due to emotional problems (p 0.001), 
EF domain (p 0.001), EWB domain (p 0.004), and BP domain (p 0.020) (table 5.3). 
 37 
 
For the association of participants’ BMI with the above mentioned QOL domains, LSD 
test was performed (Appendix E) to test for the differences between BMI categories in 
relation to these domains. LSD test showed that participants with healthy weight had a 
higher means score (73.73) on RF of QOL domain than the mean score for those who were 
very underweight or underweight (55), and the mean score for those who were overweight 
or obese (63.91). Participants with healthy weight had a higher mean score on RE of QOL 
74.41 than the mean score for those who were very underweight or underweight (61.66) 
and those who were overweight or obese 53.45.  
 
Participants with healthy weight had a higher means score (63.93) on EF of QOL domain 
than the mean score for those who were very underweight or underweight (51), and the 
mean score for those who were overweight or obese (56.59). 
 
BMI was negatively associated emotional well-being, since overweight or obese 
participants achieved high mean score of (63.13) compared with those who were very 
under weight or underweight (51.90) and the participants with healthy weight (57.01). 
Bodily pain wasn’t less important, that is BMI was positively associated with this domain, 
participants who were very under weight or underweight (BMI 25 or less) and participants 
who were with healthy weight achieved a mean score of 79.56, 79.44, respectively, in 
comparison to the mean score for those overweight or obese 70.61 
 (p 0.002) (Appendix E). 
 
5.5.3.2. HbA1c value:  
 
The relationship of HbA1c with the QOL domains was assessed by t- test. The results 
showed a significant positive relation with the pain domain and GH domain (table 5.3).  
 
The mean score for the BP domain among those who had acceptable control (HbA1c value 
>8) was 83.73 compared to 72.84 for those who had poor control (HbA1c value ≥8) (p-
value=0.001). Similar trend applied to the opposite with the general health domain as its 
mean score of 59.04 for participants with acceptable control compared to a lower mean 
score of  49.20 for those with poor control (p 0.001) (Appendix E). 
  
5.5.3.3. Number of insulin injections per day: 
 
ANOVA test showed the presence of significant association between number of insulin 
injections/day and role limitation due to physical health problems (RF) p <0.0001, role 
limitation due to emotional problems (p <0.0001), energy and fatigue of QOL domain (p 
<0.0001), emotional well-being (p <0.0001), SF (p 0.003), and GH domain of QOL (p 
0.006) (table 5.3).  
 
As shown in (Appendix E): for RF quality of life domain, The mean score for participants 
who inject themselves with insulin once daily was higher (75) compared to the mean score 
for those who inject themselves twice daily (57.82) and those who inject themselves more 
than 3 times daily (51.66) suggesting an inverse association. As for RF domain, and 
participants who inject  3 times daily had a high mean score (78.80) in comparison to the 
mean score for those who inject themselves less than twice (57.84) and more than three 
times per day (51.66).  
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Similar trends were observed for the domains RE, EF, EWB, SF and GH. The only 
domains that weren’t associated with number of insulin injections per day were the PF and 
the BP domains. Details were as following; the mean score of RE quality of life domain 
for participants who inject themselves with insulin once daily was 90.47 compared to the 
mean score for those who inject themselves twice daily (51.96) and those who inject 
themselves more than 3 times daily (54.44), and participants who had 3 insulin injections 
daily had a high mean score of RE domain 72.46 in comparison to the mean score for 
those who inject themselves twice daily (51.96) and more than three times per day (54.44).  
 
For EF quality of life domain, the mean score for participants who inject themselves with 
insulin once daily was 68.80 compared to the mean score of 56.27 for those who inject 
themselves twice daily and the mean score of 45.50 for those who inject themselves more 
than 3 times per day; as well, participants who had 3 insulin injections daily had a high 
mean score of EF domain (63.36) in comparison to the mean scores of 56.27% for those 
who inject themselves twice  and 45.50 for those who inject themselves more than three 
times per day. 
 
The mean score of EWB quality of life domain was higher for participants who inject 
themselves with insulin once daily (75.80) compared to the mean score for those who 
inject themselves twice daily 56.54, three times daily(64.34) and more than three times 
daily (37.73), and participants who injected themselves with insulin twice daily had a high 
mean score of EWB domain (56.54) in comparison to the mean score for those who inject 
themselves more than three times per day (37.73), in addition, participants with three 
insulin injections per day had a high mean score on EWB of QOL domain (64.34) than 
those who injected themselves twice daily (56.54) and more than three times daily (37.73). 
 
Participants who injected themselves with insulin once daily reported a high mean score 
on SF of QOL domain (83.33) than the mean score for those who injected themselves with 
insulin twice daily (66.42); three times daily (75.81) and more than three times daily 
(70.41), also, participants who injected themselves with insulin three times daily reported 
a high mean score (75.81) compared to the mean score for those who inject themselves 
with insulin twice daily (66.42). For GH, participants who had one insulin injection daily 
reported a high mean score (65.23) than those who inject themselves with insulin twice 
daily (49.21), three times daily (50.76)and more than three times daily (53.83) (Appendix 
E). 
 
5.5.3.4. Presence of health problems other than diabetes mellitus:  
 
A T- test was used to assess whether there were significant relationships between chronic 
diabetic complications and QOL domains. The results showed that there was significant 
negative associations between presence of health problems other than diabetes mellitus 
(co-morbidities) and the energy/fatigue (EF) domain (p < 0.0001), bodily pain (BP) 
domain (p < 0.0001) and the general health domain(GH) ( p < 0.0001) (table 5.3).  
 
For EF, participants with co-morbidities had mean score of 48.46 in comparison to the 
higher mean score of 60.38 for those without co-morbidities. The same was found for BP, 
that is, the mean score for this domain was lower for participants with co-morbidities 
(65.34) compared to the mean score for those without co-morbidities (79.36). Regarding 
the mean score of GH for participants with co-morbidities, it was lower than for those 
without co-morbidities 39 vs.56.33(Appendix E).  
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5.5.3.5. Presence of chronic diabetic complications: 
 
A T- test was used to assess whether there were significant relationships between chronic 
diabetic complications and QOL domains. The results showed that there was significant 
negative association between presence of chronic complications and QOL domains except 
for the domain physical functioning which wasn’t significant (table 5.3). 
  
Participants who had chronic diabetic complications had low mean score of RF than those 
without chronic diabetic complications 31.50 vs. 74.17 (p< 0.0001). 
 
The mean score of RE for participants who had chronic diabetic complications was lower 
than the mean score for those who didn’t have chronic diabetic complications 28 vs.72.30 
( p < 0.0001). For EF, the mean score for this domain decreased for participants with 
chronic diabetic complications to 42, while it was 62.97 for participants without chronic 
diabetic complications (p < 0.000). Regarding EWB, the same was detected, as the mean 
score of this domain was low for participants with chronic diabetic complications 49.44 
compared to those without chronic diabetic complications 61.23 
 (p 0.001), SF domain wasn’t less important, since participants who had chronic diabetic 
complications had a mean score of 49, while those participants who didn’t have these 
complications had a mean score of 77.65 (p < 0.0001). The mean score of bodily pain 
(BP) was low for participants who had chronic diabetic complications 58.55, while those 
participants who didn’t have these complications had a mean score of had a mean score of 
80.02 (p < 0.0001).  
 
The same trend was detected for the mean score of GH, such that, participants with 
chronic diabetic complications had a mean score of 33.20, and participants without these 
complications had a mean score of 56.48 (p < 0.0001) (Appendix E). 
 
5.5.3.6. Hypoglycemic episodes:  
 
A T- test was used to detect whether there were significant relationships between presence 
of hypoglycemic episodes during the four weeks prior to data collection and the QOL 
domains. The results showed that there were significant negative associations between 
presence of hypoglycemic episodes during the four weeks and the physical functioning 
domain (PF) (p 0.036) as well as the general health domain (GH) (p 0.012) (table 5.3). 
 
Participants who were exposed to such episodes during the four weeks prior to data 
collection had mean score of 70.56 on PF of QOL domain in comparison to mean score of 
77.86 for those who weren’t exposed to such episodes. For the GH, the mean score for 
participants who were exposed to hypoglycemic episodes was lower than that for those 
who weren’t exposed to hypoglycemic episodes 48.17 vs.54.49 consecutively(Appendix 
E). 
 
5.5.3.7. Hyperglycemic episodes: 
 
A significant negative association was detected between presence of hyperglycemic 
episodes during the four weeks prior to data collection and all QOL domains except for the 
PF domain (table 5.3). These results were as following: Participants who were exposed to 
hyperglycemic episodes during the above mentioned period had low mean score of RF 
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compared to those who weren’t exposed 56.98 vs.74.25 (p< 0.0001). The mean score of 
RE for participants exposed to hyperglycemic episodes was lower than the mean score for 
those who weren’t exposed 49.54% vs.74.62 ( p < 0.0001).  For EF, the mean score for 
this domain decreased for participants exposed to hyperglycemic episodes from 63.88 for 
not exposed to 52.43 for exposed (p < 0.000). Regarding EWB, the same was detected, as 
the mean score of this domain was low for participants who were exposed to 
hyperglycemic episodes (54.30) compared to those who weren’t exposed to these episodes 
(62.56), p 0.001. 
 
Social functioning (SF) domain was also affected, since participants who were exposed to 
hyperglycemic episodes had a mean score of 66.42, while those participants who weren’t 
exposed had a mean score of 76.49 (p < 0.0001). The mean score of bodily pain (BP) was 
low for participants who were exposed to hyperglycemic episodes 66.86, while those 
participants who weren’t exposed had a mean score of 82.91 (p < 0.0001). The same trend 
was detected for the mean score of GH, such that, participants who were exposed to 
hyperglycemic episodes had a mean score of 44.36, and participants who weren’t exposed 
had a mean score of 57.83 (p < 0.0001) (Appendix E). 
 
Table 5.3: Associations with QOL domains in the Bivariate Analysis 
 
Independent  variables /  
QOL domains 
PF 
(P value) 
RF 
(P value) 
RE 
(P value) 
E / F 
(P value) 
EWB 
(P value) 
SF 
(P value) 
BP 
(P value) 
GH 
(P value) 
Level of 
education 
NS NS NS NS 0.005 NS NS NS 
So
ci
o-
de
m
og
ra
ph
ic
 
va
ri
ab
le
s 
Additional 
resources 
NS 0.007 < 0.0001 NS NS NS 0.037 NS 
Smoking NS < 0.0001 NS NS NS 0.005 NS NS 
Diet NS < 0.0001 < 0.0001 NS NS < 0.0001 < 0.0001 < 0.0001 
L
if
es
ty
le
 
va
ri
ab
le
s 
Physical 
activity 
0.045 NS NS < 0.0001 NS NS NS NS 
BMI NS 0.009 0.001 0.001 0.004 NS 0.020  
HbA1C NS NS NS NS NS NS 0.001 0.001 
No. of  insulin 
injections/day 
NS < 0.0001 0.021 < 0.0001 < 0.0001 NS NS NS 
Co-morbidities NS NS NS < 0.0001 NS NS < 0.0001 < 0.0001 
Chronic 
complications 
NS < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 
Hypoglycemia 0.036 NS NS NS NS NS NS 0.012 D
ia
be
te
s-
 r
el
at
ed
 v
ar
ia
bl
es
 
hyperglycemia NS < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 
NS: Not significant at ∞ 0.05 
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5.6 Univariate analysis for determinant of QOL 
 
A univariate analysis (GLM) was used to assess for the associations detected in bivariate 
analysis between QOL domains and the variables of socio-demographic factors, lifestyle 
factors and diabetes-related factors. The model includes only variables associated with the 
domain in the bivariate analysis, the results were as follows: 
 
5.6.1. Physical functioning domain (PF):  
 
In the bivariate analysis the variables physical activity and occurrence of hypoglycemic 
episodes during the four weeks prior to data collection were found associated with PF 
domain, however, the results in table (5.4) showed that those associations lost their 
significance and became marginal when entered in the univariate analysis (GLM), and so 
none of the studied variables appeared as a determinant of the PF domain (Appendix F). 
 
5.6.2. Role limitation due to physical health problem (RF): 
  
Univariate analysis in table (5.4) showed that both BMI and hyperglycemic episodes lost 
the significant association with the role limitation due to physical health domain they 
presented in the bivariate analysis, while the presence of additional resources smoking 
status, following special diet for diabetics, being physically active, presence of 
hyperglycemic episodes, presence of chronic complications and number of insulin 
injections per day remained significantly associated with this particular domain. 
  
Presence of resources additional to the monthly income remained negatively associated 
with RF(Appendix F). Participants who had additional resources to the monthly income 
had low mean score for RF domain of 36.39  (F 4.45 and P value 0.036), while those who 
didn’t had additional resources had a higher mean score of 47.60. This variable could have 
explained about 2% of the variability in this domain score as it partial eta square showed.  
   
Smoking remained negatively associated with the mean score of role limitation due to 
physical health (F28.83, P<0.0001) (Appendix F). The mean score for RF was (28.61) for 
smokers versus 55.37 for nonsmokers. This variable appeared as the second strongest 
predictor and could have explained about 11% of the variability in the domain. 
 
The mean score of RF remained positively associated with following special diet for 
diabetics, since the followers had a mean score of (50.33) while the non follower had a 
mean score of 33.66 (F 19.96, P< 0.0001) (Appendix F). This variable could have 
explained about 8% of the variability in the domain. 
 
Number of insulin injections per day remained negatively associated with RF of QOL 
(F7.52; P <0.0001) (Appendix F), this is because participants who inject themselves with 
insulin once daily had a mean score more of (58.80) which is higher than the mean score 
for those who injected themselves twice daily (43.56), three times daily (44.53)  or more 
than three times daily (21.08). This variable could have explained 9% of the variability in 
this domain.  
  
Another negative association was confirmed, that is the relation of presence of chronic 
complications with role limitation due to physical health domain (F 60.44, P<0.0001) 
(Appendix F), participants with one or more of diabetic chronic complications had a very 
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low mean score (24) of RF versus (59.99) for those who didn't have chronic 
complications. This variable appeared as the strongest predictor of RF score among all 
associated variable as it could have explained about 21% of the variability in the domain. 
In total, the model could have explained about 43% of the variability in the score. 
 
5.6.3.  Role limitation due to emotional problems (RE): 
  
The associations detected in the bivariate analysis between the presence of additional 
resources other than monthly income, following special diet for diabetics, BMI of the 
participants, number of insulin injections per day, occurrence of hyperglycemic episodes, 
and presence of diabetic complication with RE domain were investigated using GLM 
(univariate). As shown in table (5.4) all tested variables remained significantly associated 
with the role limitation due to emotional problems except for occurrence of hyperglycemic 
episodes. 
  
There was a significant negative association between RE domain and the presence of 
additional resources other than monthly income (F 13.43, P <0.0001). Participants who 
had additional resources had lower mean score of RE domain versus those who didn't have 
additional resources (34.32 vs. 58.26). This variable could have explained 5% of the 
variability in this domain(Appendix F). 
 
Participant who follow special diet for diabetics had significant positive association with 
the RE domain (F 28.03, P <0.0001). The mean score of RE domain for the followers was 
(58.49 vs. 34) for the non followers. This variable could have explained 11% of the 
variability in this domain(Appendix F). 
   
The results of this analysis also showed that BMI remained to be associated with the RE 
domain (F 7.64, P 0.001). Participants who were underweight or very underweight and 
those who had healthy weight had higher mean score of 55.55; 49.28 respectively for RE 
domain compared to the mean score for those who were overweight or obese 34. This 
variable could have explained about 6% of the variability in this domain(Appendix F).  
 
 Number of insulin injections per day persisted negatively associated with RE (F 7.82; P 
<0.0001), since the mean score of 68.52 for RE for participants who inject themselves 
once daily was higher than the mean score for those who inject themselves twice daily 
(47), three times daily (48.69) or more than three times daily (20.8).This variable could 
have explained 9% of the variability in this domain(Appendix F).  
 
Presence of diabetes chronic complications also had a significant negative association with 
RE domain (F30.10, P<0.0001). This association was the strongest among the associated 
variables as it had partial squared eta of 0.119. Participants with chronic diabetic 
complication had mean score of 23.18 vs. 55.40 mean score of those without chronic 
complication(Appendix F). 
  
In total, the model could have explained 38% of the variability in domain score (adjusted 
R2 0.381). 
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5.6.4.  Energy / Fatigue Domain: 
 
Univariate analysis was used to confirm for the relationships between the Energy Fatigue 
domain and physical activity, presence of co-morbidities, hyperglycemia, presence of 
chronic diabetic complications and BMI. The results in table (5.4) showed that BMI of the 
participants and occurrence of hyperglycemic episodes lost the significance of their 
association with EF of QOL domain, while the significant positive association detected in 
the univariate analysis between EF domain and physical activity remained consistent (F 
18.26, P <0.0001). Appendix (F) showed  that being physically active raised the mean 
score of EF to 56.66 compared with non- physically active who had a mean score of 45.68. 
This variable could have explained about 7% of the variability in this domain.   
  
The negative significant association between number of insulin injections per day and EF 
domain was also confirmed (F 7.27, P <0.0001) (Appendix F). The mean score of (59.88) 
for participants who inject themselves once daily was higher than the mean score for those 
who had been injected with insulin twice (46.5) or more than three times daily (43.76), in 
addition, those who inject themselves with insulin three times daily had a higher mean 
score of (54.53) on RF of QOL domain compared to the mean score for those who had 
been injected with insulin twice or  more than three times daily but not for those injecting 
once daily. This variable is the strongest predictor in the model, since it could have 
explained 9% of the variability in this domain.  
 
Another negative relationship found between EF domain and presence of health problems 
rather than DM (co-morbidities) was confirmed (F 20.44, P < 0.0001) (Appendix F); such 
that the participant who had co-morbidities had a low score of EF domain 45.27 in 
comparison to the mean score for those without co-morbidities (57). This variable could 
have explained about 8% of the variability in this domain. 
 
The negative association was also confirmed between chronic diabetic complications and 
EF (F 2021, P < 0.0001). Participants who suffered from chronic diabetic complications 
marked a low mean score of EF domain 44.83; while absence of chronic diabetic 
complications resulted in a higher mean score of 57.5. This variable could have explained 
about 8% of the variability in this domain. The model, with all associated variables, could 
have explained 37% of the variability in the domain score (adjusted R2 = 0.373) (Appendix 
F). 
 
5.6.5. Emotional well–being domain (EWB): 
 
Univariate analysis tested for the relationships between EWB domain and participant level 
of education, presence of hyperglycemic episodes, presence of chronic diabetic 
complications and BMI of the participants. The results table (5.4). showed that no 
significant associations persisted between EWB domain and BMI as well as the 
occurrence of hyperglycemic episodes. However, the significant positive association 
between participants’ level of education and EWB (F 2.53, P 0.041) detected in the 
bivariate analysis remained,such that participants who were illiterate had a higher mean 
score on EWB of QOL 73.93 than the mean score for those with secondary and university 
levels of educations (51.7%, 55.47) respectively. 
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In addition, participants with preparatory education had a higher mean score of 58.31 than 
the mean score for those with secondary education 51.7. This variable could have 
explained about 4% of the variability in this domain(Appendix F). 
 
The negative significant association between number of insulin injections per day and 
EWB domain of QOL was confirmed (F 15.73, P <0.0001) (Appendix F), since 
participants who inject themselves once daily had a higher mean score (71.69) than those 
who inject themselves with insulin twice daily (59.95) or more than three times daily (40), 
as well, participants who inject three times daily reported a mean score of 64.32. This 
variable was the strongest predictor for the domain score among all as its partial eta 
squared showed. 
 
.A significant negative relationship between EWB domain and diabetic complications was 
detected (F 8.85, P 0.003). Participants who suffered from chronic diabetic complications 
had a low mean score of EF domain (54.53); while those who didn’t had chronic diabetic 
complications had a higher mean score (63.48). This variable could have explained about 
4% of the variability in this domain (Appendix F). This model was able to account for 
about 28% of variability in the mean score (adjusted R2 = 0.280). 
 
5.6.6. Social Functioning Domain (SF): 
 
The relationships between the social functioning domain and smoking status, following 
special diet for diabetics, number of insulin injections per day, occurrence of 
hyperglycemic episodes and presence of chronic diabetic complications detected in the 
bivariate analysis were tested by using the univariate analysis. The result shown in table 
(5.4) revealed that the number of insulin injections per day, and presence of 
hyperglycemic episodes lost the significance of their association with SF of QOL domain. 
The results also revealed that there was a significant positive association between smoking 
status and SF domain (F 8.11, P 0.005), such that the mean score of SF for smokers was 
(68.53) versus nonsmokers (58.83). This variable could have explained about 3% of the 
variability in this domain(Appendix F). 
   
Participants who followed special diet for diabetics had a mean score of 70.18 for the SF 
domain, while the followers had a mean score of 57.17, this association was significantly 
positive (F 25.11, P < 0.001). This variable could have explained about 10% of the 
variability in this domain(Appendix F). 
   
A significant negative association was found between Presence of chronic diabetic 
complications and SF domain (F 53.42, P < 0.001), since the participants who had one or 
more of the chronic diabetic complications had a low mean score (51.65), while those who 
had no chronic diabetic complications had a higher mean score of 75.70.  This variable 
was the strongest predictor for the domain score among all (explained 19%) as its partial 
eta squared showed (Appendix F).  
 
This model was able to account for about 35% of variability in the mean score (adjusted 
R2 = 0.352). 
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5.6.7. Bodily Pain Domain (BP): 
  
The univariate analysis test was used to assess the associations between bodily pain and 
the presence of additional resources other than monthly income, diet regimen, presence of 
co-morbidities, presence of hyperglycemic episodes, presence of one or more of chronic 
diabetic complications, HbA1c  and BMI of the participants. As shown in table (5.4), the 
significant association has been lost between BP and presence of additional resources. The 
association between following special diet for diabetics and BP in QOL domains remained 
significantly positive (F 12.96, P < 0.001). Participants who followed special diet for 
diabetics had a mean score of 75.55 for the BP domain, while the non followers had a 
mean score of 63.08. This variable could have explained about 5% of the variability in this 
domain(Appendix F).  
  
The significant negative association consisted between BMI of the participants and BP of 
QOL domain (F 3.46, P 0.033), since participants who were very underweight or 
underweight (BMI less than 19.9) achieved high mean score of 75.28 in comparison to 
those who were overweight or obese who achieved a mean score for BP of 65.32. This 
variable could have explained about 3% of the variability in this domain (Appendix F).  
 
Another  significant negative association was found between HbA1c and BP (F 8.38, P 
0.004), such that participants with acceptable control (HbA1c levels less than 8%) had 
higher mean scores of BP 74.94 than those with Poor control (HbA1c levels 8% or more) 
the mean score was 65.69. This variable could have explained about 4% of the variability 
in this domain(Appendix F). 
 
A significant negative association was found between health problems other than DM (co-
morbidities) and BP (F 8.95, P 0.003), such that participants had co-morbidities had a low 
mean scores of BP 65.36 than those without co-morbidities; the mean score was 75.27. 
This variable could have explained about 4% of the variability in this domain(Appendix 
F). 
 
The same trend of negative association remained between occurrence of hyperglycemic 
episodes and BP (F 4.41, P 0.037). Such that, participants who were exposed to 
hyperglycemic episodes had a low mean score of 67.05 for BP while those who weren’t 
exposed to such episodes had high mean score of 73.58. This variable could have 
explained only about 2% of the variability in this domain(Appendix F). 
  
 As well, another significant negative association was found between chronic diabetic 
complications and BP (F 6.69, P 0.010), such that participants had one or more of diabetic 
complications had a low mean scores of BP 65.43 than those without any of those 
complications the mean score was 75.20. This variable could have explained about 3% of 
the variability in this domain (Appendix F). 
 
This model was able to account for about 28% of variability in the mean score (adjusted 
R2 = 0.282). 
  
5.6.8 General Health Perceptions (GH): 
 
The relationship between diet regimen, number of insulin injections per day, presence of 
co-morbidities, occurrence of hypoglycemic episodes; occurrence of hyperglycemic 
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episodes, presence of chronic diabetic complication and HbA1c level detected in the 
bivariate analysis were tested by using univariate analysis in GLM to confirm if these 
variables remained significantly associated with the general health perceptions (GH). As 
in table (5.4), the results showed that number of insulin injections per day, occurrence of 
hypoglycemic and occurrence of hyperglycemic episodes lost the significance of their 
association with GH of QOL domain, while the other variables remained significantly 
associated with this domain.  
  
Following diet regimen had a significant positive association with GH (F 26.83 P < 
0.001). Participants who follow diet regimen had high mean score on GH (52.95) than non 
followers (41.51). This variable could have explained about 10% of the variability in this 
domain(Appendix F). 
 
A significant negative association was found between presence of health problems other 
than DM (co-morbidities) and GH (F 25.47, P < 0.0001) since participants with health 
problems other than DM had a mean score of GH (40.61) than those without co-
morbidities (53.84). This variable could have explained about 10% of the variability in this 
domain. The same trend detected between chronic diabetic complication and GH (F 27.17, 
P < 0.0001) such that, participants with one or more chronic diabetic complications had a 
mean score (39.79) on GH while those without chronic diabetic complications had a mean 
score of 54.67.  This variable could have explained about 10% of the variability in this 
domain(Appendix F). 
 
Another significant negative association was found between HbA1c levels and the GH (F 
13.58, P <0.0001). Participants with acceptable control of HbA1c had higher mean score 
of GH (51.84) than the mean score for those with poor control of HbA1c (42.61). This 
variable could have explained about 6% of the variability in this domain (Appendix F). 
This model was able to account for about 41% of variability in the mean score (adjusted 
R2 = 0.406). 
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Table 5.4: Associations with QOL domains in the Univariate analysis 
 
Independent  variables /  
QOL domains 
PF 
(P, ETA) 
RF 
(P, ETA) 
RE 
(P, ETA) 
F /F 
(P, ETA) 
EWB 
(P, ETA) 
SF 
(P, ETA) 
BP 
(P, ETA) 
GH 
(P, 
ETA) 
Level of 
education 
NS NS NS NS 
0.005 
(4%) 
NS NS NS 
So
ci
o-
de
m
og
ra
ph
ic
 
va
ri
ab
le
s 
Additional 
resources 
NS 
0.024 
(2%) 
<0.0001 
(5%) 
NS NS NS NS NS 
Smoking NS 
<0.0001 
(11%) 
NS NS NS 
0.002 
(3%) 
NS NS 
Diet NS 
<0.0001 
(8%) 
<0.0001 
(11%) 
NS NS 
<0.0001 
(10%) 
<0.0001 
(5%) 
<0.0001 
(11%) 
L
if
es
ty
le
 v
ar
ia
bl
es
 
Physical 
activity 
NS NS NS 
0.001 
(7%) 
NS NS NS NS 
BMI NS NS 
0.002 
(6%) 
NS NS NS 
0.033 
(3%) 
NS 
HbA1C NS NS NS NS NS NS 
0.004 
(4%) 
0.001 
(6%) 
No. of  insulin 
injections/day 
NS 
<0.0001 
(9%) 
<0.0001 
(9%) 
0.005 
(9%) 
<0.0001 
(17%) 
NS NS NS 
Co-morbidities NS NS NS 
<0.0001 
(8%) 
NS NS 
0.003 
(4%) 
<0.0001 
(10%) 
Chronic 
complications 
NS 
<0.0001 
(21%) 
<0.0001 
(11%) 
<0.0001 
(8%) 
0.002 
(4%) 
<0.0001 
(19%) 
0.010 
(3%) 
<0.0001 
(11%) 
Hypoglycemia NS NS NS NS NS NS NS NS 
D
ia
be
te
s-
re
la
te
d 
va
ri
ab
le
s 
hyperglycemia NS NS NS NS NS 
0.037 
(2%) 
NS NS 
Adjusted  R² 0.023 0.433 0.381 0.373 0.280 0.352 0.282 0.406 
NS: Not significant at ∞ 0.05 
 
5.7  Summary of the results 
 
In summary: The bivariate analysis results using T-test and ANOVA (see table 6.1) 
revealed that level of education, presence of additional resources to the monthly income, 
smoking status, compliance to dietary recommendations, physical activity, BMI, HbA1c 
levels, presence of other health problems in addition to DM (co-morbidities), presence of 
acute and chronic diabetic complications, occurrence of hypoglycemic episodes and 
occurrence of hyperglycemic episodes were associated with at least one of the QOL 
domain.  
 
In the final univariate analysis, all the above variables remained significantly associated 
with at least one domain of QOL except for the occurrence of hypoglycemic episodes that 
didn’t show association with any of the QOL domains (see table 5.5).  
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Table (5.5): Summary of the associations of independent variables with QOL domains 
 
QOL  domains 
PF RF RE EF EWB SF BP GH Independent 
variables 
Bivariate 
Univariate 
Bivariate 
Univariate 
Bivariate 
Univariate 
Bivariate 
Univariate 
Bivariate 
Univariate 
Bivariate 
Univariate 
Bivariate 
Univariate 
Bivariate 
Univariate 
Socio-demographic variables 
Participants’ 
level of 
education 
NS NS NS NS 
0.005** 
 
0.005*** 
NS NS NS 
Additional 
resources of 
monthly income 
NS 
0.007** 
 
0.024*** 
<0.0001** 
 
<0.0001*** 
NS NS NS 
0.039** 
 
NS 
NS 
Lifestyle variables 
Smoking NS 
<0.0001** 
 
<0.0001*** 
NS NS NS 
0.005** 
 
0.002*** 
NS NS 
Compliance with 
dietary 
recommendations 
NS 
<0.0001** 
 
<0.0001*** 
<0.0001** 
 
<0.0001*** 
NS NS 
<0.0001** 
 
<0.0001*** 
<0.0001** 
 
<0.0001*** 
<0.0001** 
 
<0.0001*** 
Physical activity 0.045
** 
NS 
NS NS 
<0.0001** 
 
0.001*** 
NS NS NS NS 
Diabetes-related variables 
BMI NS 0.009
** 
NS 
0.001** 
 
0.002*** 
0.001** 
 
NS 
0.004** 
 
NS 
NS 
0.020** 
 
0.033*** 
NS 
HbA1C NS NS NS NS NS NS 
0.001** 
 
0.004*** 
0.001** 
 
0.001*** 
Number of 
insulin 
injections/day 
NS 
<0.0001** 
 
<0.0001*** 
0.021** 
 
<0.0001*** 
<0.0001** 
 
0.005*** 
<0.0001** 
 
<0.0001*** 
NS NS NS 
Health problems 
other than DM 
NS NS NS 
<0.0001** 
 
<0.0001*** 
NS NS 
<0.0001** 
 
0.003*** 
<0.0001** 
 
<0.0001*** 
Chronic diabetic 
complications 
NS 
<0.0001** 
 
<0.0001*** 
<0.0001** 
 
<0.0001*** 
<0.0001** 
 
<0.0001*** 
<0.0001** 
 
0.002*** 
<0.0001** 
 
<0.0001*** 
<0.0001** 
 
0.010*** 
<0.0001** 
 
<0.0001*** 
Hypoglycemia  
0.036** 
 
NS 
NS NS NS NS NS NS 
0.012** 
 
NS 
Hyperglycemia  NS 
<0.0001** 
 
NS 
<0.0001** 
 
NS 
<0.0001** 
 
NS 
0.001** 
 
NS 
<0.0001** 
 
0.037*** 
<0.0001** 
 
NS 
<0.0001** 
 
NS 
Adjusted R2 
(GLM ) 
0.023 0.433 0.381 0.373 0.280 0.352 0.282 0.406 
* NS: not significant  ** level of significance of (p ≤ 0.05) in bivariate analysis     
*** level of significance of (p ≤ 0.05) in univariate analysis   
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CHAPTER SIX 
 
Discussion and Recommendations 
 
Diabetes mellitus is a chronic metabolic disease that requires careful dietary and physical 
activity habits, frequent monitoring of blood glucose and compliance with prescribed 
medications to reduce the risk of acute and chronic complications. Persons with diabetes 
often feel exhausted by the burden the disease places on them and their families. The 
demands of diabetes care can affect health-related quality of life (QOL) of patients at any 
age but may present a special challenge in the adolescent and young adult stage (de 
Beaufort, 2006 cited in Tulloch-Reid and Walker, 2009). Type 1 diabetes, the most 
common form of diabetes at this age, does not result from poor lifestyle choices and may 
be perceived as an unfair diagnosis by many youth (Sawyer et al., 2007 cited in Tulloch-
Reid and Walker, 2009). As the prevalence and incidence of youth onset diabetes 
continues to increase due to improved survival, there is a need to assess not only the acute 
and chronic complications of the disease but also the impact it has on QOL (Daneman, 
2007; Dabelea, 2007  cited in Tulloch-Reid and Walker, 2009).  
 
Several studies were conducted to identify the factors that affect the QOL of patients with 
T1DM in the world using different approaches. This study represents the first study aimed 
to assess the QOL and its determinants in patients with T1DM in Palestine. Patients’ QOL 
was assessed using the RAND-36 questionnaire. The target subjects for this study were 
participants diagnosed with T1DM and treated at the Palestinian Ministry of Health 
(PMOH) primary health care clinics in the northern districts of the West Bank between 
April and December, 2011. 
  
The present study examined the socio-demographic factors, lifestyle factors and diabetes-
related factors as determinants of QOL for patients with T1DM in the northern districts of 
WB in Palestine.  
 
Quality of life was assessed using the RAND SF-36 which evaluated the different 
dimensions and domains that composed it. The mean score for the eight QOL composing 
domains ranged from 51.73% to 75.64%, with the highest for bodily pain domain and the 
lowest for general health and the median of the domains mean score; which was calculated 
in addition to the mean scores due to the lack of reference population in Palestine; range 
from 55 for general health perceptions domain to 90 for the physical functioning. These 
calculated values indicate that the QOL for those patients can be considered to be 
moderate to high, but lower than QOL measured among T1DM subjects in other different 
populations, that is, Mostafa and Almkhtar, (2012) using WHOQOL-BREF reported that 
47% of patients with T2DM in Al-Mousel have fair overall quality of life and 41% have a 
good overall quality of life. In a Turkish SF-36 study conducted by Sarac et al., (2007) 
among T1DM and T2DM, the mean scores were considerably higher for  the domains  of  
RE , EWB, EF, and GH in diabetic patients as compared to our sample, but only slightly 
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higher for the domains of PF, RF, BP and SF. In a Dutch study; using the RAND-36 
conducted by Hart et al., (2003) among subjects with T1DM, the mean score for all 
domains was higher compared to our sample QOL domains mean score. Such lower 
values recorded in the current study could be due to differences in economic status, health 
care provided for these patients, health care access in these countries or due to differences 
in targeted population and QOL measurement tool used such as the case in Mostafa and 
Almkhtar study. 
       
It appears in the our study that the RF domain of the RAND SF-36 is the most 
significantly influenced by the associated studied socio-demographic, lifestyle, and 
diabetes-related factors. This is shown through the high percentage of variability in the 
domain explained by General Linear Model used (R2 0.433) for RF, followed by GH (R2 
0.406). For the other domains, the models used explained percentage of variability ranging 
from R2 = 0.381 to such a low R2 = 0.023 ; the R2=0.023 was for the PF domain with 
which the associated factors in the bivariate analysis lost their associations in the 
univariate (GLM) analysis suggesting that the domain is independently affected by 
diabetes and that, to confirm, needs further research and a standard comparison population 
which is beyond the current research scope.    
   
Socio-demographic factors and QOL: The univariate analysis for QOL domains showed 
that the level of education, and the presence of additional resources to the family monthly 
income affected one or more of QOL domains. 
 
The level of education completed by the participants at the time of data collection was 
negatively associated with low score of EWB domain(p 0.005), and this could explained 
only 4% of the variability in the domain which is consistent with the related studies 
conducted by Egede & Zheng, (2003); Wikblad et al., (1996); Aalto et al., (1997); 
Glasgow et al., (1997); Jacobson et al., (1994). A possible explanation for such association 
is that high level of education could be an opportunity for employment, marriage and 
social relationships. In case of being a diabetic patient, although having high level of 
education,  these opportunities decreased due to the presence of one or more of the acute 
which may have an obvious effect on health status and affect the emotional wellbeing of 
patients as well as their quality of life. So, it may be effective to take into account the level 
of education of the patient while education programs and interventions about diabetes is 
performed.  
 
The Presence of additional resources to family monthly income was negatively 
associated with RF and RE domains (p 0.007, p < 0.0001) respectively and this effect 
could have explained only 2% and 5%  of the variability in the domains, respectively. A 
possible explanation is that the presence of additional resources to the family monthly 
income indicates higher income to the family, but also earning such additional income 
could put a demand on them in securing these additional resources; participants who had 
additional resources to the family monthly income either have to work more if they are 
independent income generators and so they would have to suffer more due to work 
demands and have less time for themselves and their emotional well-being; or if they are 
dependent on their family in their income, then the family income generators might have 
less time to spend with them and looking for their needs. This variable wasn’t studied 
previously, so further investigation may be needed at this level.  
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Lifestyle factors and QOL: The univariate analysis for QOL domains showed that a 
number of lifestyle factors affect one or more of the QOL domains. Smoking is one of the 
lifestyle variable that had a pronounced effect on QOL. In the current study, smoking was 
associated negatively with RF; it explained 11% of the variability in the domain. This is 
consistent with the findings of Vogl et al., (2012) study who reported that a heavy-smoker 
is associated with 86% more likelihood of reporting some/severe problems in 
anxiety/depression compared with 42% in usual activity. The negative association between 
smoking and poor QOL was also reported by Imayama, (2011) and Sarac et al., (2007). 
Smoking was  also associated, but positively, with SF, and could explain 10% of the 
variability in the domain,  A possible explanation for this association is that smoking 
among some of the T1DM is a way of social engagement in and interaction with external 
world and so feeling of better self that could reflect positively on this domain of QOL. 
Lynes and Lynes, (2012) explained that smoking comprises physical developments 
associated with puberty as well as psychological development including that of an adult 
identity. Snow and Bruce found that some adolescents used cigarette smoking as a way of 
achieving status among their peers (Snow and Bruce as cited in Lynes and Lynes,2012).  
 
The compliance with dietary recommendations according to medical advice had the 
most pronounced effect on QOL, such that, it was positively associated with five domains 
of QOL (RE, GH, RF, BP and SF). It could explain 11%, 10, 8%, 5% and 3% of the 
variability in these domains respectively. Good compliance with dietary recommendations 
was associated with a higher QOL which is in agreement with the findings of Imayama, 
(2011); Chaveepojnkamjorn et al., (2008); and Gönen et al., (2007). A possible 
explanation is that compliance with dietary recommendations reduce bodyweight and 
HbA1c (Asplund et al., 2010) of the patients and so reduce the chances of complications 
occurrences, which in turn could reflect positively on his quality of life.  
 
Physical activity in the univariate analysis was found to be associated positively only with 
EF domain. It could explain only 7% of the variability in the domain. The positive effect 
of physical activity on QOL was reported by Ismail, (2011); Imayama, (2011), Sarac et al., 
(2007); and Gönen et al., (2007). Fatigue in patients with diabetes may be associated with 
physiological phenomena, such as hypoglycemia and /or hyperglycemia, psychological 
factors, such as depression or emotional distress related to the diagnosis or to the intensity 
of diabetes self-management regimens (Fritschi and Quinn, 2012). Physical activity, which 
is an important part of diabetes management plan makes the muscles use glucose for 
energy, improves the body's response to insulin which leads to lower blood sugar level 
which may increase participants feelings of energy and decreased feeling of fatigue.  
 
Diabetes-related factors and QOL: The univariate analysis for QOL domains showed 
that the following diabetes-related factors affect one or more of QOL domains: 
 
 Body mass index (BMI) was negatively associated with QOL which is in agreement with 
the findings of  Imayama, (2011) and Naughton et al., (2008). The negative associations in 
the current study were found mainly in the domains RE and BP; and it could explained 6% 
and 3% of the variability in these domains respectively. The negative association between 
BMI and RE domain that was reported in this study may be a result of other factors such 
as  fear of hypoglycemia. Russell-Jones and Khan in their review article (2007) reported 
that weight gain has to be viewed as an undesirable side effect of insulin therapy such that 
patients increase their carbohydrate intake and so, total calorie intake in response to the 
perceived threat or experience of hypoglycemia which may result from their more frequent 
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injection regimen (Russell-Jones and Khan, 2007). Fear of hypoglycemia  may result in 
increased anxiety about diabetes management, obsessive self-monitoring, deliberately 
keeping blood glucose levels too high, dependence on others, feelings of guilt and 
frustration, a sense of loss of control, embarrassment, relationship stress and avoidant 
behavior (Frier, 2007 as cited in Gonder-Frederick et al.,  2011). The negative association 
between BMI and BP domain may be due to the mechanical consequences of carrying 
excess weight (Burns et al., 2001) and associated symptoms such as symptoms of chronic 
low back pain and respiratory symptoms (Han et al., 1999 as cited in Burns et al., 2001) 
that may be associated problems in functioning and daily activities.  
 
 Patients with high HbA1c levels (poor control); reported low scores on QOL scales, 
specifically, BP and GH domains which could explain only 4% and 6% of the variability 
in the domains respectively. The association between HbA1c and QOL is consistent with 
the findings of Kalyva et al., (2011); Wit et al., (2007); Huang et al., (2004); Weinger & 
Jacobson, (2001). Wikblad et al. in their study reported that patients with poor control 
rated their HRQOL to be  lower than those with good or acceptable control which they 
explained that, if the treatment is non-adequate, the patient’s quality of life is affected by 
physical symptoms and by the presence of late complications that follow the poor control. 
On the other hand, if the treatment regime is too tight, the patient’s quality of life might 
also deteriorate. Patients with a tight control and who had experienced hypoglycemic 
episodes that they could not manage on their own rated their general health as being 
poorer than those without severe hypoglycemia (Wikblad et al., 1996). Sinnott et al., 
(2005) in their study found that patients who had elevated HbA1c levels reported more 
bodily pain, poor physical functioning, and poor self-assessment of their overall health. 
Krein et al., (2005) reported that chronic pain limited the ability of patients with diabetes 
to self-manage their disease.  
 
Our data showed that increased number of insulin injections per day negatively affect 
QOL. Such an association was confirmed by Huang et al., (2004) who reported an inverse 
association between number of insulin injection per day and quality of life. The effect of 
number of insulin injections per day was found  mainly on the RF, RE, EWB and EF 
domains since it could explain 9%, 6%, 9% and 16% of the variability in these domains 
respectively. Increased number of insulin injections per day interfere with  performing 
regular daily activities either due to fear of injection-related pain (Rubin et al., 2009) 
which makes patients unhappy, anxious and depressed or due to increased number of 
episodes of hypoglycemia due to greater amount of insulin used which could negatively 
affect the quality of life in people with diabetes (Rubin & Peyrot, 1999). Such interference 
is associated either in the time, amount, effort, and degree of carefulness needed in 
performing their work and activities or the type of work performed.  
 
In relation to the Presence of health problems other than DM, a proportion of 26.5% of 
this study population reported having other health problems in addition to DM such as 
hypertension, high cholesterol levels, respiratory diseases or infections, joints pain and 
sleeping problems. The presence of health problems other than DM was negatively 
associated with QOL. Such association was noted by Imayama, (2011) and Naughton et 
al., (2008). The presence of health problems other than DM associated negatively with the 
EF, BP and GH domains and could have explained 8%, 4% and 10% of the variability of 
these domains respectively. A possible explanation could be that due to the presence of  
health problems other than DM may intense need for recurrent visits to diabetic clinic or 
the need for recurrent hospitalization or extra health care and management according  to 
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the type of this health problem. Struijs et al., (2006) found that non diabetes-related co-
morbidity increases the health care demand as much as diabetes-related co-morbidity do.  
 
A proportion of 20.4% of the study subjects was found to suffer from one or more chronic 
diabetic complications; including neuropathy, retinopathy and nephropathy 
complications (11.4%, 9.4%, and 6.5% respectively), while the frequency of CVDs  was 
relatively low (1.6%). Chronic diabetic complications had the most pronounced negative 
effect on quality of life; it affected the domains of RF,RE, EF, EWB, SF, BP, and GH, and 
could explain 21%, 11%, 8%, 4%, 19%, 3% and 10% of the variability in these domains, 
respectively. Coyne et al., (2004); De los Ríos et al., (2005); and Lewko et al., (2007) 
reported that patients with diabetic retinopathy, neuropathy and diabetic nephropathy 
could have an  impaired QOL due to their physical, psychosocial and leisure activities that 
were reduced as a result of these complications. Visual impairment due to diabetic 
retinopathy resulted in deterioration in daily activities such as reading, hobbies, diabetes 
care activities, cooking, housekeeping and getting dressed, as well, it interferes with 
exercise, diet, insulin injections and blood testing. In addition to the financial burden of 
these complications that lead to emotional distress, anxiety, depression, fears as well as 
lose of one’s independence, self-concept and some of social integration. Patients with 
diabetic peripheral neuropathy may consider themselves to be greater burden on their 
families and friends and make them always anxious as a result of their illness. 
 
 In the current study, limitations due to physical and emotional health as well as social 
functioning were higher in the group with diabetic complications who also rated their 
general health as worse than the patients without complications. Wikblad et al., (1996) 
reported that, regarding the emotional factor, patients without complications scored higher 
on positive feelings than patients with diabetic complications. Such association was also 
found by  Huang et al., (2004); Hahl et al., (2002) and De Groot et al., (2001) study who 
indicated a significant positive relationships between depressive symptoms and long-term 
complications of diabetes. Moreover, Wandell et al., (1999) and  Klein et al., (1998) 
studies demonstrated that long-term complications including neuropathy, retinopathy and 
nephropathy were associated with poorer scores in general health, physical functioning, 
and physical role domains.  
 
Occurrence of hyperglycemic episodes was associated negatively only with BP domain 
and could explain 2% of the variability in this domain. A proportion of 45.3% of the study 
subjects reported that they experienced episodes of hyperglycemia and this was negatively 
associated with their QOL, mainly the BP domain, and that could have explained only 2% 
of the variability in the BP domain. This result could be due to either an early or prolonged 
signs that patients suffer when they have elevated blood sugar levels (hyperglycemia) such 
as tiredness, loss of weight, blurred vision, infections e.g. thrush (International Diabetes 
Institute, 2003); or due to the presence of other illness such as cold or flu that may raise 
blood sugar levels (International Diabetes Institute, 2004) which may increase bodily pain 
and interfere with their daily activities.  
 
 
Strengths and limitations of the study 
The main strength of this study its fairly large sample size, relative to the targeted 
population, that was recruited for the purpose of this study and of its being; not only; the 
first of its kind of T1DM patients in the West Bank, but also its ability to detect many of 
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the variables that are associated with QOL and so could establish for improvements in care 
and future researches. Another strength of this study is the high response rate.  
The limitations of this study are as follows: (i) in some diabetic clinics, the files didn’t 
have the exact data of the onset and severity of complications which made it difficult to 
study the effect of such information on QOL of patients with T1DM; (ii) the study was 
carried out in the northern districts of the West Bank, so the findings might not be easily 
generalized to patients with T1DM who live in other places in the other districts of the 
West Bank or Gaza strip; (iii) the lack of age-matched  healthy subjects as a control group 
to compare our results on the determinants of quality of life in T1DM; (iv) the lack of 
normative data for the Palestinian population that measures QOL using the RAND SF-36 
to help us to have  a cut off  value in order to compare our results with on the determinants 
of quality of life in T1DM.     
 
In conclusion, the results of the present study support the following findings:  
 
1. The quality of life assessment provides valuable information regarding how the 
effect of diabetes mellitus on the living standards of patients’ life. 
 
2. Diabetes mostly puts limitations on Palestinians T1DM patients in performing their 
daily activities. This is evident from the result that role limitation due to physical 
health is the main domain significantly affected by socio-demographic, lifestyle 
and diabetes-related factors since it has a high portion of variability in the score 
explained by GLM (R2  0.433).  
 
3. Palestinian T1DM patients with chronic complications and co-morbidities perceive 
their general health negatively. This is evident from the second high portion of 
variability explained by GLM (R2  0.406). 
 
4. Although Palestinians with T1DM with poor glycemic control represents a 
proportion of 74.3%,  it negatively affects only BP and GH domains of quality of 
life.  
  
5. Prevention and adequate treatment of complications and control of DM appears to 
be an important strategy in improving life quality in diabetic patients. 
 
6. More attention must be paid for factors that increases the risk of developing 
chronic diabetic complications such as smoking, low activity, and diet in order to 
improve QOL of Palestinians with T1DM. 
 
7. Although participants who have one or more chronic diabetic complications 
represents only 20% of the study sample, the presence of these complications is the 
most pronounced determinant of their quality of life among all variables studied. 
 
8. Although a small proportion of the study subjects have other health problems in 
addition to DM (26.5%), these health problem are determinants of quality of life. 
 
9. Years of diabetes duration, and occurrence on hypoglycemic episodes aren’t 
determinants of  quality of life among Palestinians with T1DM. 
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The results of our study provided strong support that quality of life assessment is a very 
important outcome that should be considered when dealing with patients with T1DM. The 
followings are some recommendations that evidently enhance the quality of life among 
those patients: 
 
1. Intensive educational programs for diabetics are encouraged to be held at the 
individual and community levels about the importance of smoking cessation and its 
relation with reducing the co-morbid conditions and complications associated with 
diabetes mellitus or the quality of life. 
 
2. Educational programs for diabetics are encouraged to be held at the individual and 
community levels on the importance of healthy lifestyle behaviors and its relation 
with reducing the co-morbid conditions and complications associated with diabetes 
mellitus and as well as on the quality of life.  
 
3.  Group discussions and regular meetings among T1DM should be encouraged to be 
held in order to allow them to share ideas and express their feelings, anxiety about 
their future as people with long-life disease to ensure better QOL outcome. 
  
4. Interventions targeting psychosocial adjustment should be considered as an 
important part of diabetes management and should be offered along with 
interventions designed to improve QOL. 
 
5. Mental-health screening should be part of routine care for young people with 
diabetes in order to detect mental health problems such as diabetes-related 
depression and anxiety and solve these problems to attain better mental health and 
better quality of life. 
 
6. Health care providers, strategic planners and policy makers should focus on 
prevention rather than treatment in order to reduce diabetic complications in 
patients with T1DM as well as on social and financial burden in both patient, 
family and the financial burden on the health authorities. 
 
Recommendations for future research studies: The results of our study provide a 
significant incentive for future investigations in the subject that include: 
 
1. Community based studies are recommended for measuring quality of life in 
diabetes mellitus and setting norms for the Palestinians.  
   
2. Study the quality of life and its determinants among T1DM patients attending the 
governmental primary health care clinics in the southern districts of the West Bank 
to have a comprehensive picture, especially that people have different lifestyle and 
community structure in these districts. 
 
3. Investigate the quality of life and its determinants among T1DM patients attending 
the UNRWA and private sector diabetic clinics. Since the health services and care 
provided for those patients in both sectors may differ from those provided in 
governmental primary health care clinics.   
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4. Study on the impact of the various diabetic complications such as nephropathy and 
cardiovascular diseases and their severity in relation with the quality of life among 
T1DM patients in Palestine.  
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  ﻑ ﺘﻘﻴﻡ ﺤﺎﻟﺘﻙ ﺍﻟﺼﺤﻴﺔ ﺍﻵﻥ ﺒﺼﻭﺭﺓ ﻋﺎﻤﺔﻜﻴ،  ﻤﻘﺎﺭﻨﺔ ﺒﻌﺎﻡ ﻤﻀﻲ-2 
  
  (ﺃﻤﺎﻡ ﺍﻹﺠﺎﺒﺔ ﺍﻟﻤﻨﺎﺴﺒﺔ   ( √)   ﺍﺨﺘﺭ ﺇﺠﺎﺒﺔ ﻭﻀﻊ ﻋﻼﻤﺔ )
    ﺃﻓﻀل ﺒﻜﺜﻴﺭ ﻤﻤﺎ ﻜﺎﻨﺕ ﻋﻠﻴﻪ ﻗﺒل ﻋﺎﻡ○                 
    ﺃﻓﻀل ﻨﻭﻋﺎ ﻤﺎ ﻤﻥ ﺍﻟﻌﺎﻡ ﺍﻟﻤﺎﻀﻲ○                 
    ﺘﻘﺭﻴﺒﺎ ﻋﻠﻰ ﻤﺎ ﻫﻲ ﻋﻠﻴﻪ○                 
  ﺃﺴﻭﺀ ﻨﻭﻋﺎ ﻤﺎ ﻤﻥ ﺍﻟﻌﺎﻡ ﺍﻟﻤﺎﻀﻲ  ○                 
    ﺃﺴﻭﺀ ﺒﻜﺜﻴﺭ ﻤﻤﺎ ﻜﺎﻨﺕ ﻋﻠﻴﻪ ﺍﻟﻌﺎﻡ ﺍﻟﻤﺎﻀﻲ○                 
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  .ﺘﺘﻌﻠﻕ ﺍﻟﺒﻨﻭﺩ ﺍﻟﺘﺎﻟﻴﺔ ﺒﺄﻨﺸﻁﺔ ﻴﻤﻜﻥ ﺃﻥ ﺘﻘﻭﻡ ﺒﻬﺎ ﺨﻼل ﻴﻭﻤﻙ ﺍﻟﻌﺎﺩﻱ
  :ﺇﻟﻰ ﺃﻱ ﻤﺩﻯ ﺘﻘﻴﺩﻙ ﺤﺎﻟﺘﻙ ﺍﻟﺼﺤﻴﺔ، ﻓﻲ ﺍﻟﻭﻗﺕ ﺍﻟﺤﺎﻟﻲ
  (  ﺃﻤﺎﻡ ﺍﻹﺠﺎﺒﺔ ﺍﻟﻤﻨﺎﺴﺒﺔ   ( √)   ﻊ ﻋﻼﻤﺔ ﺍﺨﺘﺭ ﺇﺠﺎﺒﺔ ﻭﻀ                                      )
ﻨﻌ ــﻡ   
ﺘﻘﻴﺩﻨﻲ 
  ﻜﺜﻴﺭﺍ
ﻨﻌ ــﻡ 
ﺘﻘﻴﺩﻨﻲ 
  ﻗﻠﻴﻼ
ﻻ 
ﺘﻘﻴﺩﻨﻲ 
ﺤﻤل ﺍﻷﺸﻴﺎﺀ ﺍﻟﺜﻘﻴﻠﺔ ﺃﻭ ﻤﺯﺍﻭﻟـﺔ ،ﺍﻟﺠﺭﻱ:ﻤﻥ ﻤﻤﺎﺭﺴﺔ ﺍﻷﻨﺸﻁﺔ ﺍﻟﺸﺎﻗﺔ ﻤﺜل   -3  ﺇﻁﻼﻗﺎ
  ﺍﻟﻨﺸﻁﺔ ﺍﻟﺭﻴﺎﻀﻴﺔ ﺍﻟﻤﺠﻬﺩﺓ ﺠﺩﺍ  
  ○  ○  ○
ﻟﺘﻨﻅﻴـﻑ ﻜﺘﺤﺭﻴـﻙ ﺍﻟﻁﺎﻭﻟـﺔ ﺃﻭ ﺍ ، ﻤﻥ ﻤﻤﺎﺭﺴﺔ ﺍﻷﻨﺸﻁﺔ ﻤﺘﻭﺴﻁﺔ ﺍﻟﺠﻬـﺩ   -4
  ﺒﺎﺴﺘﺨﺩﺍﻡ ﺍﻟﻤﻜﻨﺴﺔ ﺍﻟﻜﻬﺭﺒﺎﺌﻴﺔ ﺃﻭ ﺘﻨﻅﻴﻑ ﺤﺩﻴﻘﺔ ﺍﻟﻤﻨﺯل ﻭﺍﻟﻌﻨﺎﻴﺔ ﺒﻬﺎ؟
  ○  ○  ○
  ○  ○  ○  ؟(ﺍﻟﺴﻭﺒﺭ ﻤﺎﺭﻜﺕ)ﻤﻥ ﺤﻤل ﺍﻟﻤﺸﺘﺭﻴﺎﺕ ﻤﻥ ﺍﻟﺒﻘﺎﻟﺔ ﺃﻭ ﺍﻟﺴﻭﻕ ﺍﻟﻤﺭﻜﺯﻱ   -5
  ○  ○  ○  ﻤﻥ ﺼﻌﻭﺩ ﺍﻟﺩﺭﺝ ﻟﻌﺩﺓ ﺃﺩﻭﺍﺭ؟  -6
  ○  ○  ○  ﻤﻥ ﺼﻌﻭﺩ ﺍﻟﺩﺭﺝ ﻟﺩﻭﺭ ﻭﺍﺤﺩ ﻓﻘﻁ؟  -7
  ○  ○  ○  ﻭﺩ؟ﻤﻥ ﺍﻻﻨﺤﻨﺎﺀ ﺃﻭ ﺍﻟﺭﻜﻭﻉ ﺃﻭ ﺍﻟﺴﺠ  -8
  ○  ○  ○  ﻤﻥ ﺍﻟﻤﺸﻲ ﻷﻜﺜﺭ ﻤﻥ ﻜﻴﻠﻭ ﻭﻨﺼﻑ ﻤﺘﺭ؟  -9
  ○  ○  ○  ﻤﻥ ﺍﻟﻤﺸﻲ ﻟﻤﺴﺎﻓﺔ ﻨﺼﻑ ﻜﻴﻠﻭ؟  -01
  ○  ○  ○  ﻤﻥ ﺍﻟﻤﺸﻲ ﻟﻤﺴﺎﻓﺔ ﻤﺌﺔ ﻤﺘﺭ؟  -11
  ○  ○  ○  ﻤﻥ ﺍﻻﺴﺘﺤﻤﺎﻡ ﺃﻭ ﺍﺭﺘﺩﺍﺀ ﺍﻟﻤﻼﺒﺱ ﺒﻨﻔﺴﻙ؟  -21
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 ﺍﻟﺼﺤﺔ ﺍﻟﺠﺴﻤﻴﺔ
  
ﻬﻙ ﺨﻼل ﺘﺄﺩﻴﺘﻙ ﻟﻌﻤﻠﻙ ﺃﻭ ﻟﻸﻨﺸﻁﺔ ﺍﻟﻴﻭﻤﻴﺔ ﺍﻟﻤﻌﺘﺎﺩﺓ ﺒﺎﻟﻤﺸﺎﻜل ﺍﻟﺘﻲ ﻴﻤﻜﻥ ﺃﻥ ﺘﻭﺍﺠ( ﺩ،ﺝ،ﺏ،ﺃ)ﺘﺘﻌﻠﻕ ﺍﻟﺒﻨﻭﺩ ﺍﻟﺘﺎﻟﻴﺔ 
  .ﻨﺘﻴﺠﺔ ﻟﺤﺎﻟﺘﻙ ﺍﻟﺼﺤﻴﺔ ﺍﻟﺠﺴﻤﻴﺔ
  : ﻫل ﺘﺴﺒﺒﺕ ﺤﺎﻟﺘﻙ ﺍﻟﺼﺤﻴﺔ ﺍﻟﺠﺴﻤﻴﺔ ﻓﻲ،ﺨﻼل ﺍﻷﺴﺎﺒﻴﻊ ﺍﻷﺭﺒﻌﺔ ﺍﻟﻤﺎﻀﻴﺔ
  (ﺃﻤﺎﻡ ﺍﻹﺠﺎﺒﺔ ﺍﻟﻤﻨﺎﺴﺒﺔ    ( √)  ﺍﺨﺘﺭ ﺇﺠﺎﺒﺔ ﻭﻀﻊ ﻋﻼﻤﺔ  )                                  
  ﻻ  ﻨﻌﻡ  
  ○  ○  ل ﻤﻥ ﺍﻟﻭﻗﺕ ﺍﻟﺫﻱ ﺘﻘﻀﻴﻪ ﻓﻲ ﺍﻟﻌﻤل ﺃﻭ ﺃﻱ ﺃﻨﺸﻁﺔ ﺃﺨﺭﻯ؟ ﺍﻟﺘﻘﻠﻴ-ﺃ  -31
  ○  ○   ﺍﻟﺘﻘﻠﻴل ﻤﻤﺎ ﺘﻭﺩ ﺍﻨﺠﺎﺯﻩ ﻤﻥ ﺍﻟﻌﻤل ﺃﻭ ﺃﻱ ﺃﻨﺸﻁﺔ ﺃﺨﺭﻯ؟-ﺏ  -41
  ○  ○   ﺘﻘﻴﻴﺩﻙ ﻓﻲ ﺃﺩﺍﺀ ﻨﻭﻉ ﻤﻌﻴﻥ ﻤﻥ ﺍﻷﻋﻤﺎل ﺃﻭ ﺃﻱ ﺃﻨﺸﻁﺔ ﺃﺨﺭﻯ؟-ﺝ  -51
  ﺃﻥ ﺘﺠﺩ ﺼﻌﻭﺒﺔ ﻓﻲ ﺘﺄﺩﻴﺔ ﺍﻟﻌﻤل ﺃﻭ ﺃﻱ ﺃﻨﺸﻁﺔ ﺃﺨﺭﻯ؟  -61
  (ﺠﺕ ﺇﻟﻰ ﺠﻬﺩ ﺇﻀﺎﻓﻲ ﻟﺘﺄﺩﻴﺘﻬﺎﺍﺤﺘ، ﻋﻠﻰ ﺴﺒﻴل ﺍﻟﻤﺜﺎل)
  ○  ○
  
 ﺍﻟﺼﺤﺔ ﺍﻟﻨﻔﺴﻴﺔ
ﺒﺎﻟﻤﺸﺎﻜل ﺍﻟﺘﻲ ﻴﻤﻜﻥ ﺃﻥ ﺘﻭﺍﺠﻬﻙ ﺨﻼل ﺘﺄﺩﻴﺘﻙ ﻟﻌﻤﻠﻙ ﺃﻭ ﻟﻸﻨﺸﻁﺔ ﺍﻟﻴﻭﻤﻴﺔ ﺍﻟﻤﻌﺘﺎﺩﺓ ( ﺩ،ﺝ،ﺏ،ﺃ)ﺘﺘﻌﻠﻕ ﺍﻟﺒﻨﻭﺩ ﺍﻟﺘﺎﻟﻴﺔ 
  (ﻤﺜﻼ ﺍﻟﻌﻭﺭ ﺒﺎﻻﻜﺘﺌﺎﺏ ﺃﻭ ﺍﻟﻘﻠﻕ.)ﻨﺘﻴﺠﺔ ﻟﺤﺎﻟﺘﻙ ﺍﻟﺼﺤﻴﺔ ﺍﻟﻨﻔﺴﻴﺔ
  :ﻙ ﺍﻟﺼﺤﻴﺔ ﺍﻟﺠﺴﻤﻴﺔ ﻓﻲﻫل ﺘﺴﺒﺒﺕ ﺤﺎﻟﺘ،ﺨﻼل ﺍﻷﺴﺎﺒﻴﻊ ﺍﻷﺭﺒﻌﺔ ﺍﻟﻤﺎﻀﻴﺔ
  (    ﺃﻤﺎﻡ ﺍﻹﺠﺎﺒﺔ ﺍﻟﻤﻨﺎﺴﺒﺔ   ( √)   ﺍﺨﺘﺭ ﺇﺠﺎﺒﺔ ﻭﻀﻊ ﻋﻼﻤﺔ )                                      
  ﻻ  ﻨﻌﻡ  
  ○  ○   ﺍﻟﺘﻘﻠﻴل ﻤﻥ ﺍﻟﻭﻗﺕ ﺍﻟﺫﻱ ﺘﻘﻀﻴﻪ ﻓﻲ ﺍﻟﻌﻤل ﺃﻭ ﺃﻱ ﺃﻨﺸﻁﺔ ﺃﺨﺭﻯ؟-ﺃ  -71
  ○  ○   ﺍﻟﺘﻘﻠﻴل ﻤﻤﺎ ﺘﻭﺩ ﺍﻨﺠﺎﺯﻩ ﻤﻥ ﺍﻟﻌﻤل ﺃﻭ ﺃﻱ ﺃﻨﺸﻁﺔ ﺃﺨﺭﻯ؟-ﺏ  -81
  ○  ○  ﻋﺩﻡ ﺍﻨﺠﺎﺯ ﺍﻟﻌﻤل ﺃﻭ ﺃﻱ ﺃﻨﺸﻁﺔ ﺃﺨﺭﻯ؟  -91
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 ﺍﻟﺼﺤﺔ ﺍﻟﺠﺴﻤﻴﺔ ﻭﺍﻟﻨﻔﺴﻴﺔ
ﺇﻟﻰ ﺃﻱ ﻤﺩﻯ ﺘﻌﺎﺭﻀﺕ ﺼﺤﺘﻙ ﺍﻟﺠـﺴﻤﻴﺔ ﺃﻭ ﺍﻟﻨﻔـﺴﻴﺔ ﻤـﻊ ﺘﺄﺩﻴﺘـﻙ ، ﺨﻼل ﺍﻷﺴﺎﺒﻴﻊ ﺍﻷﺭﺒﻌﺔ ﺍﻟﻤﺎﻀﻴﺔ   -02
ﻟﻨﺸﺎﻁﺎﺘﻙ ﺍﻻﺠﺘﻤﺎﻋﻴﺔ ﺍﻟﻤﻌﺘﺎﺩﺓ ﻤﻊ ﻋﺎﺌﻠﺘﻙ ﺃﻭ ﺃﺼﺩﻗﺎﺅﻙ ﺃﻭ ﺠﻴﺭﺍﻨﻙ ﺃﻭ ﺃﻱ ﻤﻥ ﺍﻟﻤﻨﺎﺴـﺒﺎﺕ ﺍﻻﺠﺘﻤﺎﻋﻴـﺔ 
  ؟ﺍﻷﺨﺭﻯ
    ﻟﻡ ﻴﻜﻥ ﻫﻨﺎﻙ ﺃﻱ ﺘﻌﺎﺭﺽ ﺇﻁﻼﻗﺎ○                       (     ﺃﻤﺎﻡ ﺍﻹﺠﺎﺒﺔ ﺍﻟﻤﻨﺎﺴﺒﺔ   ( √)   ﺍﺨﺘﺭ ﺇﺠﺎﺒﺔ ﻭﻀﻊ ﻋﻼﻤﺔ )                             
    ﻜﺎﻥ ﻫﻨﺎﻙ ﺘﻌﺎﺭﺽ ﻗﻠﻴل○                     
    ﻜﺎﻥ ﻫﻨﺎﻙ ﺘﻌﺎﺭﺽ ﻤﺘﻭﺴﻁ○                     
  ﻜﺎﻥ ﻫﻨﺎﻙ ﺘﻌﺎﺭﺽ ﻜﺒﻴﺭ  ○                     
    ﻜﺎﻥ ﻫﻨﺎﻙ ﺘﻌﺎﺭﺽ ﻜﺒﻴﺭ ﺠﺩﺍ○                     
 
 ﺸﺩﺓ ﺍﻷﻟﻡ
  ﻤﺎ ﺸﺩﺓ ﺍﻷﻟﻡ ﺍﻟﺠﺴﻤﻲ ﺍﻟﺫﻱ ﻋﺎﻨﻴﺕ ﻤﻨﻪ ﺨﻼل ﺍﻷﺴﺎﺒﻴﻊ ﺍﻷﺭﺒﻌﺔ ﺍﻟﻤﺎﻀﻴﺔ؟  -12
  (     ﺃﻤﺎﻡ ﺍﻹﺠﺎﺒﺔ ﺍﻟﻤﻨﺎﺴﺒﺔ   ( √)   ﺍﺨﺘﺭ ﺇﺠﺎﺒﺔ ﻭﻀﻊ ﻋﻼﻤﺔ   )                          
  
    ﻟﻡ ﻴﻜﻥ ﻫﻨﺎﻙ ﺃﻱ ﺃﻟﻡ○                  
    ﻜﺎﻥ ﻫﻨﺎﻙ ﺃﻟﻡ ﺨﻔﻴﻑ ﺠﺩﺍ○                  
    ﻜﺎﻥ ﻫﻨﺎﻙ ﺃﻟﻡ ﺨﻔﻴﻑ○                  
    ﻜﺎﻥ ﻫﻨﺎﻙ ﺃﻟﻡ ﻤﺘﻭﺴﻁ○                  
    ﻜﺎﻥ ﻫﻨﺎﻙ ﺃﻟﻡ ﺸﺩﻴﺩ○                  
   ﻜﺎﻥ ﻫﻨﺎﻙ ﺃﻟﻡ ﺸﺩﻴﺩ ﺠﺩﺍ○                  
 
ﺇﻟﻰ ﺃﻱ ﻤﺩﻯ ﺃﺩﻯ ﺍﻷﻟﻡ ﺍﻟﺠﺴﺩﻱ ﺇﻟﻰ ﺍﻟﺘﻌﺎﺭﺽ ﻤﻊ ﺘﺄﺩﻴﺘﻙ ﻷﻋﻤﺎﻟﻙ ،  ﺍﻟﻤﺎﻀﻴﺔﺨﻼل ﺍﻷﺴﺎﺒﻴﻊ ﺍﻷﺭﺒﻌﺔ  -22
  ( :ﺴﻭﺍﺀ ﺩﺍﺨل ﺍﻟﻤﻨﺯل ﺃﻭ ﺨﺎﺭﺠﻪ)ﺍﻟﻤﻌﺘﺎﺩﺓ 
  (ﺃﻤﺎﻡ ﺍﻹﺠﺎﺒﺔ ﺍﻟﻤﻨﺎﺴﺒﺔ    ( √)  ﺍﺨﺘﺭ ﺇﺠﺎﺒﺔ ﻭﻀﻊ ﻋﻼﻤﺔ )                               
    ﻟﻡ ﻴﻜﻥ ﻫﻨﺎﻙ ﺃﻱ ﺘﻌﺎﺭﺽ ﺇﻁﻼﻗﺎ○                     
    ﻜﺎﻥ ﻫﻨﺎﻙ ﺘﻌﺎﺭﺽ ﻗﻠﻴل○                     
    ﻜﺎﻥ ﻫﻨﺎﻙ ﺘﻌﺎﺭﺽ ﻤﺘﻭﺴﻁ○                     
    ﻜﺎﻥ ﻫﻨﺎﻙ ﺘﻌﺎﺭﺽ ﻜﺒﻴﺭ○                     
    ﻜﺎﻥ ﻫﻨﺎﻙ ﺘﻌﺎﺭﺽ ﻜﺒﻴﺭ ﺠﺩﺍ○                     
 57 
 
  ،ﻴﺔﺍﻷﺴﺌﻠﺔ ﺍﻟﺘﺎﻟﻴﺔ ﺘﺘﻌﻠﻕ ﺒﻜﻴﻔﻴﺔ ﺸﻌﻭﺭﻙ ﻭﻁﺒﻴﻌﺔ ﺴﻴﺭ ﺍﻷﻤﻭﺭ ﻤﻌﻙ ﺨﻼل ﺍﻷﺴﺎﺒﻴﻊ ﺍﻷﺭﺒﻌﺔ ﺍﻟﻤﺎﻀ
  . ﺍﻟﺭﺠﺎﺀ ﺇﻋﻁﺎﺀ ﻭﺍﺤﺩﺓ ﻟﻜل ﺴﺅﺍل ﺒﺤﻴﺙ ﺘﻜﻭﻥ ﻫﺫﻩ ﺍﻹﺠﺎﺒﺔ ﻫﻲ ﺍﻷﻗﺭﺏ ﺇﻟﻰ ﺍﻟﺤﺎﻟﺔ ﺍﻟﺘﻲ ﻜﻨﺕ ﺘﺸﻌﺭ ﺒﻬﺎ
  :ﻜﻡ ﻤﻥ ﺍﻟﻭﻗﺕ، ﺨﻼل ﺍﻷﺴﺎﺒﻴﻊ ﺍﻷﺭﺒﻌﺔ ﺍﻟﻤﺎﻀﻴﺔ
  ( ﺃﻤﺎﻡ ﺍﻹﺠﺎﺒﺔ ﺍﻟﻤﻨﺎﺴﺒﺔ    ( √)  ﺍﺨﺘﺭ ﺇﺠﺎﺒﺔ ﻭﻀﻊ ﻋﻼﻤﺔ                         )                             
ﻓﻲ ﻜل   
  ﺍﻷﻭﻗﺎﺕ
ﻓﻲ 
ﻤﻌﻅﻡ 
  ﺍﻷﻭﻗﺎﺕ
ﻓﻲ 
ﻜﺜﻴﺭ 
ﻤﻥ 
  ﺍﻷﻭﻗﺎﺕ
ﻓﻲ 
ﺒﻌﺽ 
  ﺍﻷﻭﻗﺎﺕ
ﻓﻲ 
ﻗﻠﻴل 
ﻤﻥ 
  ﺍﻷﻭﻗﺎﺕ
ﻟﻡ 
ﺘﺸﻌﺭ 
ﻓﻲ ﺃﻱ 
ﻭﻗﺕ 
  ○  ○  ○  ○  ○  ○  ﺸﻌﺭﺕ ﺒﺄﻨﻙ ﻤﻠﺊ ﺒﺎﻟﺤﻴﻭﻴﺔ ﻭﺍﻟﻨﺸﺎﻁ؟  -32
  ○  ○  ○  ○  ○  ○  ﻜﻨﺕ ﺸﺨﺼﺎ ﻋﺼﺒﻴﺎ ﺠﺩﺍ؟  -42
ﺸﻌﺭﺕ ﺒﺄﻨﻙ ﻓﻲ ﺤﺎﻟﺔ ﺍﻜﺘﺌﺎﺏ ﺇﻟﻰ ﺩﺭﺠﺔ ﻟـﻡ   -52
   ﺇﻟﻴﻙ  ﻴﻤﻜﻥ ﻤﻌﻬﺎ ﺇﺩﺨﺎل ﺍﻟﺴﺭﻭﺭ
  ○  ○  ○  ○  ○  ○
  ○  ○  ○  ○  ○  ○  ﺸﻌﺭﺕ ﺒﺎﻟﻬﺩﻭﺀ ﻭﺍﻟﻁﻤﺄﻨﻴﻨﺔ؟  -62
  ○  ○  ○  ○  ○  ○  ﻜﺎﻨﺕ ﻟﺩﻴﻙ ﻁﺎﻗﺔ ﻜﺒﻴﺭﺓ ﺠﺩﺍ؟  -72
  ○  ○  ○  ○  ○  ○  ﺸﻌﺭﺕ ﺒﺎﻹﺤﺒﺎﻁ ﻭﺍﻟﻴﺄﺱ؟  -82
  ○  ○  ○  ○  ○  ○  ؟(ﺍﺴﺘﻨﻔﺫﺕ ﻗﻭﺍﻙ)ﺸﻌﺭﺕ ﺒﺄﻨﻙ ﻤﻨﻬﻙ   -92
  ○  ○  ○  ○  ○  ○  ﺸﻌﺭﺕ ﺒﺄﻨﻙ ﺸﺨﺹ ﺴﻌﻴﺩ؟  -03
  ○  ○  ○  ○  ○  ○  ﺸﻌﺭﺕ ﺒﺄﻨﻙ ﺘﻌﺒﺎﻥ؟  -13
 
ﻤﺎ ﻤﻘﺩﺍﺭ ﺍﻟﻭﻗﺕ ﺍﻟﺫﻱ ﺘﻌﺎﺭﻀﺕ ﻓﻴﻪ ﺼﺤﺘﻙ ﺍﻟﺠﺴﻤﻴﺔ ﺃﻭ ﻤﺸﺎﻜﻠﻙ ، ﺨﻼل ﺍﻷﺴﺎﺒﻴﻊ ﺍﻷﺭﺒﻌﺔ ﺍﻟﻤﺎﻀﻴﺔ  -23
  ؟(ﻤﺜل ﺯﻴﺎﺭﺓ ﺍﻷﺼﺩﻗﺎﺀ ﻭﺍﻷﻗﺎﺭﺏ ﻭﻏﻴﺭ ﺫﻟﻙ)ﺍﻟﻨﻔﺴﻴﺔ ﻤﻊ ﻨﺸﺎﻁﺎﺘﻙ ﺍﻻﺠﺘﻤﺎﻋﻴﺔ 
  ( ﺍﻟﻤﻨﺎﺴﺒﺔﺃﻤﺎﻡ ﺍﻹﺠﺎﺒﺔ   ( √)                  ﺍﺨﺘﺭ ﺇﺠﺎﺒﺔ ﻭﻀﻊ ﻋﻼﻤﺔ                               
    ﻜﺎﻥ ﺍﻟﺘﻌﺎﺭﺽ ﻓﻲ ﻜل ﺍﻷﻭﻗﺎﺕ○                     
    ﻜﺎﻥ ﺍﻟﺘﻌﺎﺭﺽ ﻓﻲ ﻤﻌﻅﻡ ﺍﻷﻭﻗﺎﺕ○                     
    ﻜﺎﻥ ﺍﻟﺘﻌﺎﺭﺽ ﻓﻲ ﺒﻌﺽ ﺍﻷﻭﻗﺎﺕ○                     
    ﻜﺎﻥ ﺍﻟﺘﻌﺎﺭﺽ ﻓﻲ ﻗﻠﻴل ﻤﻥ ﺍﻷﻭﻗﺎﺕ○                     
  ﻌﺎﺭﺽ ﻓﻲ ﺃﻱ ﻭﻗﺕ ﻤﻥ ﺍﻷﻭﻗﺎﺕ  ﻟﻡ ﻴﻜﻥ ﻫﻨﺎﻙ ﺘ○                     
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  ﺒﺎﻟﻨﺴﺒﺔ ﺇﻟﻰ ﺤﺎﻟﺘﻙ ﺍﻟﺼﺤﻴﺔ؟( ﺩ، ﺝ، ﺏ، ﺃ)ﻤﺎ ﻤﺩﻯ ﺼﺤﺔ ﺃﻭ ﺨﻁﺄ ﻜل ﻤﻥ ﺍﻟﻌﺒﺎﺭﺍﺕ ﺍﻟﺘﺎﻟﻴﺔ 
  (ﺃﻤﺎﻡ ﺍﻹﺠﺎﺒﺔ ﺍﻟﻤﻨﺎﺴﺒﺔ  ( √)     ﺍﺨﺘﺭ ﺇﺠﺎﺒﺔ ﻭﻀﻊ ﻋﻼﻤﺔ                                                      
ﺼﺤﻴﺤﺔ   
  ﺒﻼ ﺸﻙ
ﺼﺤﻴﺤﺔ 
  ﻏﺎﻟﺒﺎ
ﻻ 
  ﺃﻋﻠﻡ
ﺄ ﺨﻁ ـ
  ﻏﺎﻟﺒﺎ
ﺨﻁ ـﺄ 
ﻼ ﺒــ
  ﺸﻙ
  ○  ○  ○  ○  ○   ﻴﺒﺩﻭ ﺃﻨﻨﻲ ﺃﺼﺎﺏ ﺒﺎﻟﻤﺭﺽ ﺃﺴﻬل ﻤﻥ ﺍﻵﺨﺭﻴﻥ-ﺃ  -33
  ○  ○  ○  ○  ○   ﺤﺎﻟﺘﻲ ﺍﻟﺼﺤﻴﺔ ﻤﺴﺎﻭﻴﺔ ﻷﻱ ﺸﺨﺹ ﺃﻋﺭﻓﻪ-ﺏ  -43
  ○  ○  ○  ○  ○   ﺃﺘﻭﻗﻊ ﺃﻥ ﺘﺴﻭﺀ ﺤﺎﻟﺘﻲ ﺍﻟﺼﺤﻴﺔ-ﺝ  -53
  ○  ○  ○  ○  ○   ﺤﺎﻟﺘﻲ ﺍﻟﺼﺤﻴﺔ ﻤﻤﺘﺎﺯﺓ-ﺩ  -63
  
  ..............ﺷﻜﺮا ﻟﺘﻌﺎوﻧﻜﻢ.............
 
 0.1 yevruS htlaeH metI-63 dnaR lanigiro eht fo noitalsnart a si noisrev cibarA sihT
  .ydutS emoctuO lacideM eht fo trap sa noitaroproC DNAR eht yb depoleveD     
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Scoring the RAND SF-36-item Health Survey 1.0 
  
NOTE:   This information is derived from the article:  
Goertz, C.M. (1994): Measuring Functional Health Status in the Chiropractic Office 
Using Self-Report Questionnaires. Top in Clin Chiro, 1 (1): 51-59.  
  
Scoring the RAND involves 3 steps 
 
STEP 1:   Scoring questions: 
 
Item numbers Original response  Recorded value 
1 100 
2 75 
3 50 
4 25 
1, 2, 20, 22, 34, 36 
 
 
5 0 
1 0 
2 50 
3, 4, 5, 6, 7, 8, 9, 10, 11, 12 
 3 100 
1 0 13, 14, 15, 16, 17, 18, 19 
 
2 100 
1 100 
2 80 
3 60 
4 40 
5 20 
21, 23, 26, 27, 30 
 
 
 6 0 
1 0 
2 20 
3 40 
4 60 
5 80 
24, 25, 28, 29, 31 
 
 
 6 100 
1 0 
2 25 
3 50 
4 75 
32, 33, 35 
 
 
 
5 100  
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STEP 2: Averaging items to form 8 scales: 
 
Scale 
Number 
of items 
After recording scores per Table (1), 
Average the following items 
Physical functioning 10 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 
Role limitations due to physical 
health 
4 13, 14, 15, 16 
Role limitations due to 
emotional problems 
3 17, 18, 19 
Energy/ fatigue 4 23, 27, 29, 31 
Emotional well being 5 24, 25, 26, 28, 30 
Social functioning 2 20, 32 
Pain 2 21, 22 
General health 5 1, 33, 34, 35, 36 
  
STEP 3:   Figuring scores: 
RAND recommends the following straightforward approach to scoring the RAND 36-
Item Health Survey. 
All questions are scored on a scale from 0 to 100, with 100 representing the highest 
level of functioning possible. Aggregate scores are compiled as a percentage of the 
total points possible, using the RAND scoring table (STEP I chart).  
The scores from those questions that address each specific area of functional health 
status (STEP II chart) are then averaged together, for a final score within each of the 8 
dimensions measured. (e.g. pain, physical functioning etc.)  
For example, to measure the patient's energy/fatigue level, add the scores from 
questions 23, 27, 29, and 31. If a patient circled 4 on 23, 3 on 27, 3 on 29 and left 31 
blank, use table 1 to score them.  
An answer of 4 to Q23 is scored as 40, 3 to Q27 is scored as 60, and 3 to Q29 is scored 
as 40. Q31 is omitted. The score for this block is 40+60+40 =140. Now we divide by 
the 3 answered questions to get a total of 46.7. Since a score of 100 represents high 
energy with no fatigue, the lower score of 46.7% suggests the patient is experiencing a 
loss of energy and is experiencing some fatigue. 
All 8 categories are scored in the same way.  
 
 79 
Appendix D 
Variables with no significant Associations with QOL domains In the bivariate 
analysis 
Age:  
One-Way ANOVA comparing the effect of age of the participant on QOL 
QOL Domain age of the participant 
Sum of 
Squares df Mean Square F P value 
Between Groups 3323.193 3 1107.731 
 Within Groups 167206.807 241 693.804 PF 
Total 170530.000 244  
1.597 
 
 
.191 
 
 
Between Groups 3767.145 3 1255.715 
Within Groups 285732.855 241 1185.614 RF 
Total 289500.000 244  
1.059 
 
 
.367 
 
 
Between Groups 1929.871 3 643.290 
 Within Groups 405235.662 241 1681.476 RE 
Total 407165.533 244  
.383 
 
 
.766 
 
 
Between Groups 1104.381 3 368.127 
 Within Groups 90627.660 241 376.048 
 
EF 
Total 91732.041 244  
 
.979 
 
 
.403 
 
 
Between Groups 413.784 3 137.928 
 Within Groups 94991.669 241 394.156 
 
EWB 
Total 95405.453 244  
 
.350 
 
 
.789 
 
 
Between Groups 1009.551 3 336.517 
 Within Groups 125523.613 241 520.845 SF 
Total 126533.163 244  
.646 
 
 
.586 
 
 
Between Groups 3009.101 3 1003.034 
 Within Groups 145258.399 241 602.732 PAIN 
Total 148267.500 244  
1.664 
 
 
.175 
 
 
Between Groups 2708.288 3 902.763 
 Within Groups 91629.467 241 380.205 
 
GH 
Total 94337.755 244  
 
2.374 
 
 
.071 
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Gender: 
Independent T-test comparing relation between gender and QOL 
QOL Domain Gender N Mean Std. Deviation t P value 
male 119 75.4202 26.05063  PF 
 female 126 73.7698 26.87517  
.488 
 
.626 
 
male 119 68.2773 34.55183  RF 
 female 126 64.6825 34.39038  
.816 
 
.415 
 
male 119 64.1457 41.20585  RE 
 female 126 62.4339 40.65773  
.327 
 
.744 
 
male 119 58.3613 20.24332  EF 
 female 126 59.0079 18.62278  
-.260 
 
.795 
 
male 119 59.3950 20.47331  EWB 
 female 126 58.2857 19.15614  
.438 
 
.662 
 
male 119 72.1639 23.32509  SF 
 female 126 71.6270 22.32782  
.184 
 
.854 
 
male 119 75.1891 24.94307  PAIN 
 female 126 76.0714 24.46309  
-.279 
 
.780 
 
male 119 50.7563 21.06928  GH 
 female 126 52.6587 18.27224  
-.756 
 
.450 
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Current occupation:  
 
One-Way ANOVA comparing relation between current occupation and QOL 
 
QOL Domain current occupation 
Sum of 
Squares df Mean Square F P value 
Between Groups 3952.305 7 564.615 
Within Groups 166577.695 237 702.859 PF 
Total 170530.000 244  
.803 
 
 
.585 
 
 
Between Groups 4339.989 7 619.998 
Within Groups 285160.011 237 1203.207 RF 
Total 289500.000 244  
.515 
 
 
.823 
 
 
Between Groups 13373.596 7 1910.514 
Within Groups 393791.937 237 1661.569 RE 
Total 407165.533 244  
1.150 
 
 
.333 
 
 
Between Groups 736.092 7 105.156 
Within Groups 90995.949 237 383.949 EF 
Total 91732.041 244  
.274 
 
 
.964 
 
 
Between Groups 1503.695 7 214.814 
Within Groups 93901.758 237 396.210 EWB 
Total 95405.453 244  
.542 
 
 
.802 
 
 
Between Groups 2799.289 7 399.898 
Within Groups 123733.874 237 522.084 SF 
Total 126533.163 244  
.766 
 
 
.616 
 
 
Between Groups 2222.865 7 317.552 
Within Groups 146044.635 237 616.222 PAIN 
Total 148267.500 244  
.515 
 
 
.823 
 
 
Between Groups 1108.781 7 158.397 
Within Groups 93228.974 237 393.371 GH 
Total 94337.755 244  
.403 
 
 
.900 
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Monthly income:  
One-Way ANOVA comparing relation between family monthly income and QOL 
 
QOL Domain Family monthly income 
Sum of 
Squares df Mean Square F Sig. 
Between Groups 2722.708 3 907.569 
Within Groups 167807.292 241 696.296 PF 
Total 170530.000 244  
1.303 
 
 
.274 
 
 
Between Groups 4458.046 3 1486.015 
Within Groups 285041.954 241 1182.747 RF 
Total 289500.000 244  
1.256 
 
 
.290 
 
 
Between Groups 2654.745 3 884.915 
Within Groups 404510.788 241 1678.468 RE 
Total 407165.533 244  
.527 
 
 
.664 
 
 
Between Groups 574.053 3 191.351 
Within Groups 91157.988 241 378.249 EF 
Total 91732.041 244  
.506 
 
 
.679 
 
 
Between Groups 1046.092 3 348.697 
Within Groups 94359.361 241 391.533 EWB 
Total 95405.453 244  
.891 
 
 
.447 
 
 
Between Groups 1121.095 3 373.698 
Within Groups 125412.069 241 520.382 SF 
Total 126533.163 244  
.718 
 
 
.542 
 
 
Between Groups 960.638 3 320.213 
Within Groups 147306.862 241 611.232 PAIN 
Total 148267.500 244  
.524 
 
 
.666 
 
 
Between Groups 930.136 3 310.045 
Within Groups 93407.619 241 387.583 GH 
Total 94337.755 244  
.800 
 
 
.495 
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Duration of diabetes:  
One-Way ANOVA comparing relation between duration of diabetes mellitus and QOL 
 
QOL Domain duration of diabetes mellitus 
Sum of 
Squares df Mean Square F P value 
Between Groups 1885.374 3 628.458 
 Within Groups 168644.626 241 699.770 
 
PF 
Total 170530.000 244  
.898 
 
 
.443 
 
 
Between Groups 2475.097 3 825.032 
 Within Groups 287024.903 241 1190.975 RF 
Total 289500.000 244  
.693 
 
 
.557 
 
 
Between Groups 4725.537 3 1575.179 
 Within Groups 402439.996 241 1669.876 RE 
Total 407165.533 244  
.943 
 
 
.420 
 
 
Between Groups 267.191 3 89.064 
 Within Groups 91464.850 241 379.522 
 
EF 
Total 91732.041 244  
.235 
 
 
.872 
 
 
Between Groups 371.366 3 123.789 
 Within Groups 95034.087 241 394.332 
 
EWB 
Total 95405.453 244  
.314 
 
 
.815 
 
 
Between Groups 1123.840 3 374.613 
 Within Groups 125409.323 241 520.371 SF 
Total 126533.163 244  
.720 
 
 
.541 
 
 
Between Groups 1891.869 3 630.623 
 Within Groups 146375.631 241 607.368 PAIN 
Total 148267.500 244  
1.038 
 
 
.376 
 
 
Between Groups 1926.369 3 642.123 
 Within Groups 92411.386 241 383.450 
 
GH 
Total 94337.755 244  
1.675 
 
 
.173 
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Appendix E 
Tables and results of the variables with significant Associations with QOL domains 
In the bivariate analysis 
Level of education 
The averages and One-Way ANOVA for the effect of level of education on the 
participants’ QOL 
 
QOL 
domains 
Participants’ 
level of education 
N Mean 
Std. 
Deviation 
F P value 
illiterate 4 90.00 16.83 
Primary 16 75.93 24.16 
Preparatory 61 76.39 26.44 
Secondary 88 74.54 25.99 
University  76 72.03 27.93 
PF 
 
 
 
 
 
Total 245 74.57 26.43 
.594 
 
 
.667 
 
 
illiterate 4 93.75 12.50 
Primary 16 57.81 36.19 
Preparatory 61 70.49 31.46 
Secondary 88 63.35 36.14 
University 76 67.10 34.69 
RF 
 
 
 
 
 
Total 245 66.42 34.44 
1.280 
 
 
.278 
 
 
illiterate 4 100.00 .00 
Primary 16 52.08 40.31 
Preparatory 61 71.58 38.41 
Secondary 88 58.71 42.28 
University 76 62.28 40.85 
RE 
 
 
 
 
 
Total 245 63.26 40.84 
2.060 
 
 
.087 
 
 
illiterate 4 76.25 17.01 
Primary 16 57.18 17.88 
Preparatory 61 59.91 19.56 
Secondary 88 57.67 20.15 
University 76 58.28 18.71 
EF 
 
 
 
 
 
Total 245 58.69 19.38 
.974 
 
 
.422 
 
 
illiterate 4 84.00 16.32 
Primary 16 57.00 17.06 
Preparatory 61 62.09 20.43 
Secondary 88 53.90 19.23 
University 76 60.94 19.07 
EWB 
 
Total 245 58.82 19.77 
3.820 
 
 
.005 
 
 
illiterate 4 87.50 25.00 
Primary 16 62.50 23.71 
Preparatory 61 73.15 23.80 
Secondary 88 73.01 22.49 
University 76 70.72 21.75 
SF 
 
 
 
 
 
Total 245 71.88 22.77 
1.307 
 
 
.268 
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illiterate 4 92.50 9.57 
Primary 16 73.43 23.95 
Preparatory 61 75.77 24.39 
Secondary 88 75.25 24.43 
University 76 75.55 25.94 
PAIN 
Total 245 75.64 24.65 
.502 
 
 
.735 
 
 
illiterate 4 67.50 11.90 
Primary 16 47.50 20.81 
Preparatory 61 56.63 19.70 
Secondary 88 50.34 20.40 
University 76 49.47 18.10 
GH 
 
 
 
 
 
Total 245 51.73 19.66 
2.180 
 
 
.072 
 
 
 
 
LSD test for the differences of EWB of QOL by participants’ level of education 
 
Dependent Variable (I) Level of education you have completed 
(J) Level of education 
you have completed 
Mean Difference 
(I-J) P value 
Primary 27.00000(*) .013 
Preparatory 21.90164(*) .029 
Secondary 30.09091(*) .003 
illiterate 
 
 
 
University 23.05263(*) .021 
illiterate -27.00000(*) .013 
Preparatory -5.09836 .349 
Secondary 3.09091 .557 
Primary 
 
 
 
University -3.94737 .459 
illiterate -21.90164(*) .029 
Primary 5.09836 .349 
Secondary 8.18927(*) .012 
Preparatory 
 
 
 
University 1.15099 .729 
illiterate -30.09091(*) .003 
Primary -3.09091 .557 
Preparatory -8.18927(*) .012 
Secondary 
 
 
 
University -7.03828(*) .021 
illiterate -23.05263(*) .021 
Primary 3.94737 .459 
Preparatory -1.15099 .729 
EWB 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
University 
Secondary 7.03828(*) .021 
 * The mean difference is significant at the .05 level. 
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Additional resources rather than monthly income 
 
Independent T-test testing relation between additional resources rather than monthly 
income and QOL 
  
QOL 
Domain 
Presence of additional sources of 
income 
N 
Mean 
score 
Std. 
Deviation 
t 
P 
value 
 
yes 28 77.14 22.70 
 
PF 
 no 217 74.23 26.90 
 
.546 
 
.585 
 
yes 28 50.00 37.88 
 
RF 
 no 217 68.54 33.48 
 
-2.716 
 
.007 
 
yes 28 36.90 38.85 
 
RE 
 no 217 66.66 39.93 
-3.723 
 
.000 
 
yes 28 56.07 20.42 
 
EF 
 no 217 59.03 19.27 
 
-.760 
 
.448 
 
yes 28 54.28 16.16 
 
EWB 
 no 217 59.41 20.14 
 
-1.292 
 
.197 
 
yes 28 65.62 22.47 
 
SF 
 no 217 72.69 22.73 
 
-1.551 
 
.122 
 
yes 28 66.60 25.25 
 
PAIN 
 no 217 76.80 24.38 
 
-2.075 
 
.039 
 
yes 28 47.85 20.29 
 
GH 
 no 217 52.23 19.57 
 
-1.109 
 
.268 
 
 
 
Smoking status 
 
Independent T-test for relation between smoking status and QOL domains 
  
QOL Domain 
Smoking 
status 
N 
Mean 
score 
Std. 
Deviation 
t 
P 
value 
yes 46 69.4565 26.25152 
 
PF 
 no 199 75.7538 26.40372 
 
-1.459 
 
.146 
 
yes 46 49.4565 37.07692 
 
RF 
 no 199 70.3518 32.66956 
 
-3.809 
 
.000 
 
yes 46 57.2464 38.27325 
 
RE 
 no 199 64.6566 41.38975 
 
-1.109 
 
.268 
 
yes 46 58.9130 16.01780 
 
EF 
 no 199 58.6432 20.12382 
 
.085 
 
.932 
 
yes 46 57.4783 20.95258 
 
EWB 
 no 199 59.1357 19.53336 
 
-.512 
 
.609 
 
yes 46 80.4348 22.68356 
 
SF 
 no 199 69.9121 21.35223 
 
2.866 
 
.005 
 
yes 46 75.7609 29.95770 
 
PAIN 
 no 199 75.6156 23.34208 
 
.036 
 
.971 
 
yes 46 50.0000 20.84333 
 
GH 
 no 199 52.1357 19.41276 
 
-.663 
 
.508 
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Following special diet for diabetics 
 
Independent T-test comparing measures scores of QOL domains between followers of 
special diet for diabetics and non followers 
 
QOL Domain 
following 
special diet for 
diabetics 
N 
Mean 
score 
Std. 
Deviation 
t 
P 
value 
yes 129 72.7132 28.00675 
 
PF 
 no 116 76.6379 24.52839 
 
-1.161 
 
.247 
 
yes 129 76.5504 29.10648 
 
RF 
 no 116 55.1724 36.49259 
 
5.092 
 
.000 
 
yes 129 77.5194 33.63478 
 
RE 
 no 116 47.4138 42.42660 
 
6.184 
 
.000 
 
yes 129 60.8527 21.02941 
 
EF 
 no 116 56.2931 17.15810 
 
1.847 
 
.066 
 
yes 129 59.6279 20.38039 
 
EWB 
 no 116 57.9310 19.12509 
 
.670 
 
.504 
 
yes 129 78.9729 20.06973 
 
SF 
 no 116 64.0086 23.08745 
 
5.427 
 
.000 
 
yes 129 81.6473 22.71489 
 
PAIN 
 no 116 68.9655 25.09129 
 
4.152 
 
.000 
 
yes 129 57.2481 14.55004 
 
GH 
 no 116 45.6034 22.64235 
 
4.836 
 
.000 
 
 
Physical activity 
  
Independent T-test comparing average scores of QOL domains by physical activity and 
exercise: 
QOL 
Domain 
Physical activities 
(walking, running 
swimming) 
N 
Mean 
score 
Std. 
Deviation 
t 
P 
value 
yes 150 77.2667 27.52416 
 
PF 
 no 95 70.3158 24.15388 
 
2.018 
 
.045 
 
yes 150 69.3333 34.77476 
 
RF 
 no 95 61.8421 33.58898 
 
1.665 
 
.097 
 
yes 150 66.0000 40.59035 
 
RE 
 no 95 58.9474 41.09973 
 
1.319 
 
.189 
 
yes 150 63.0000 16.21996 
 
EF 
 no 95 51.8947 21.96684 
 
4.540 
 
.000 
 
yes 150 60.6400 17.26590 
 
EWB 
 no 95 55.9579 22.99672 
 
1.814 
 
.071 
 
yes 150 72.6667 24.20665 
 
SF 
 no 95 70.6579 20.36636 
 
.672 
 
.502 
 
yes 150 77.5000 24.07692 
 
PAIN 
 no 95 72.7105 25.38183 
 
1.485 
 
.139 
 
yes 150 51.7333 21.56609 
 
GH 
 no 95 51.7368 16.32073 
 
-.001 
 
.999 
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BMI of  the participants  
 
ANOVA test comparing averages of QOL domains by BMI  
 
QOL 
domain BMI of the participants N Mean 
Std. 
Deviation F P value 
<19.9(very under weight, 
under weight) 40 73.75 24.35 
20 -25 (healthy weight) 99 77.12 27.62 
>25 (overweight, obese, 
very obese) 106 72.50 26.08 
PF 
Total 245 74.57 26.43 
.804 .449 
<19.9(very under weight, 
under weight) 40 55.00 40.50 
20 -25 (healthy weight) 99 73.73 29.31 
>25 (overweight, obese, 
very obese) 106 63.91 35.20 
RF 
Total 245 66.42 34.44 
4.862 .009 
<19.9(very under weight, 
under weight) 40 61.66 34.21 
20 -25 (healthy weight) 99 74.41 33.61 
>25 (overweight, obese, 
very obese) 106 53.45 46.61 
RE 
Total 245 63.26 40.84 
7.109 .001 
<19.9(very under weight, 
under weight) 40 51.00 24.81 
20 -25 (healthy weight) 99 63.93 16.86 
>25 (overweight, obese, 
very obese) 106 56.69 18.08 
EF 
Total 245 58.69 19.38 
7.739 .001 
<19.9(very under weight, 
under weight) 40 51.90 25.20 
20 -25 (healthy weight) 99 57.01 17.68 
>25 (overweight, obese, 
very obese) 106 63.13 18.45 
EWB 
Total 245 58.82 19.77 
5.587 .004 
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<19.9(very under weight, 
under weight) 40 70.62 19.92 
20 -25 (healthy weight) 99 75.88 19.50  
>25 (overweight, obese, 
very obese) 106 68.63 26.00 
SF 
Total 245 71.88 22.77  
2.706 .069 
<19.9(very under weight, 
under weight) 40 79.56 21.40 
20 -25 (healthy weight) 99 79.44 24.52  
>25 (overweight, obese, 
very obese) 106 70.61 25.20 
PAIN 
Total 245 75.64 24.65  
3.985 .020 
<19.9(very under weight, 
under weight) 40 46.37 21.21 
20 -25 (healthy weight) 99 53.43 17.98  
>25 (overweight, obese, 
very obese) 106 52.16 20.38 
GH 
Total 245 51.73 19.66 
1.896 .152 
 
 
LSD test for the differences of RF, RE, EF, EWB and BP of QOL by BMI 
 
QOL 
domains (I) BMI of the participant (J) BMI of the participant 
Mean 
Difference 
(I-J) 
P 
valve 
20 -25 (healthy weight) -18.73737(*) .003 <19.9(very under weight, under 
weight) >25 (overweight, obese, very 
obese) 
-8.91509 .158 
<19.9(very under weight, under 
weight) 
18.73737(*) .003 
20 -25 (healthy weight) 
>25 (overweight, obese, very 
obese) 
9.82228(*) .039 
<19.9(very under weight, under 
weight) 
8.91509 .158 
RF 
>25 (overweight, obese, very 
obese) 20 -25 (healthy weight) -9.82228(*) .039 
20 -25 (healthy weight) -12.74411 .089 <19.9(very under weight, under 
weight) >25 (overweight, obese, very 
obese) 
8.20755 .268 
<19.9(very under weight, under 
weight) 
12.74411 .089 
 20 -25 (healthy weight) 
>25 (overweight, obese, very 
obese) 
20.95165(*) .000 
<19.9(very under weight, under 
weight) 
-8.20755 .268 
RE 
>25 (overweight, obese, very 
obese) 20 -25 (healthy weight) -20.95165(*) .000 
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20 -25 (healthy weight) -12.93939(*) .000 <19.9(very under weight, under 
weight) >25 (overweight, obese, very 
obese) 
-5.69811 .105 
<19.9(very under weight, under 
weight) 
12.93939(*) .000 
20 -25 (healthy weight) 
>25 (overweight, obese, very 
obese) 
7.24128(*) .007 
<19.9(very under weight, under 
weight) 
5.69811 .105 
EF 
>25 (overweight, obese, very 
obese) 20 -25 (healthy weight) -7.24128(*) .007 
20 -25 (healthy weight) -5.11010 .161 <19.9(very under weight, under 
weight) >25 (overweight, obese, very 
obese) 
-11.23208(*) .002 
<19.9(very under weight, under 
weight) 
5.11010 .161 
20 -25 (healthy weight) 
>25 (overweight, obese, very 
obese) 
-6.12197(*) .025 
<19.9(very under weight, under 
weight) 
11.23208(*) .002 
EWB 
>25 (overweight, obese, very 
obese) 20 -25 (healthy weight) 6.12197(*) .025 
20 -25 (healthy weight) .11806 .979 <19.9(very under weight, under 
weight) >25 (overweight, obese, very 
obese) 
8.94929(*) .049 
<19.9(very under weight, under 
weight) 
-.11806 .979 20 -25 (healthy weight) 
 >25 (overweight, obese, very 
obese) 
8.83124(*) .010 
<19.9(very under weight, under 
weight) 
-8.94929(*) .049 
PAIN 
>25 (overweight, obese, very 
obese) 20 -25 (healthy weight) -8.83124(*) .010 
* The mean difference is significant at the .05 level. 
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HbA1c level 
 
Comparison of the averages of QOL domains by HbA1c level 
  
QOL domains HbA1c levels N 
Mean 
score 
Std. Deviation t p 
<8%(acceptable 
control) 63 75.7937 
31.54881 
 PF 
 
≥ 8%(poor  
control) 182 74.1484 24.50538 
 
.425 
 
 
 
 
.671 
 
 
 
<8%(acceptable 
control 63 70.2381 32.33430 RF 
 
≥ 8%(poor  
control) 182 65.1099 35.13571 
 
1.019 
 
 
 
 
.309 
 
 
 
<8%(acceptable 
control 63 64.0212 36.56466 RE 
 
≥ 8%(poor  
control) 182 63.0037 42.32371 
 
.170 
 
 
 
 
.865 
 
 
 
<8%(acceptable 
control 63 59.7619 16.15022 EF 
 
≥ 8%(poor  
control) 182 58.3242 20.41880 
 
.506 
 
 
 
 
.613 
 
 
 
<8%(acceptable 
control 63 59.0476 21.06475 EWB 
 ≥ 8%(poor  
control) 182 58.7473 19.36711 
 
.104 
 
 
 
 
.917 
 
 
 
<8%(acceptable 
control 63 75.3968 21.76305 SF 
 
≥ 8%(poor  
control) 182 70.6731 23.04497 
 
1.422 
 
 
 
 
.156 
 
 
 
<8%(acceptable 
control 63 83.7302 20.69787 PAIN 
 
≥ 8%(poor  
control) 182 72.8434 25.33312 
 
3.39 
 
 
 
 
.001 
 
 
 
<8%(acceptable 
control 63 59.0476 17.41007 GH 
 ≥ 8%(poor  
control) 182 49.2033 19.80701 
 
3.73 
 
 
 
 
.001 
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Presence of other health problems than diabetes mellitus 
 
Independent T-test comparing relation between presence of other health problems than 
diabetes mellitus and QOL 
 
QOL Domain 
Presence of health 
problems other 
than diabetes 
N 
Mean 
score 
Std. 
Deviation 
t 
P 
value 
yes 65 70.92 25.90 
 
PF 
 no 180 75.88 26.57 
 
-1.300 
 
.195 
 
yes 65 61.92 41.71 
 
RF 
 no 180 68.05 31.38 
 
-1.232 
 
.219 
 
yes 65 57.94 39.20 
 
RE 
 no 180 65.18 41.36 
 
-1.225 
 
.222 
. 
yes 65 48.46 22.16 
 
EF 
 no 180 62.38 16.88 
 
-5.224 
 
.000 
 
yes 65 56.06 18.28 
 
EWB 
 no 180 59.82 20.24 
 
-1.316 
 
.189 
 
yes 65 72.50 20.15 
 
SF 
 no 180 71.66 23.69 
 
.252 
 
.801 
 
yes 65 65.34 24.89 
 
PAIN 
 no 180 79.36 23.54 
 
-4.051 
 
.000 
 
yes 65 39.00 18.89 
 
GH 
 no 180 56.33 17.86 
 
-6.602 
 
.000 
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Presence of chronic diabetic complications  
 
Independent T-test for differences in means of QOL domains by chronic diabetic 
complications  
 
QOL Domain 
presence of one or 
more of chronic 
diabetic 
complications 
N 
Mean 
score 
Std. 
Deviation 
t 
P 
value 
yes 50 72.2000 21.66913 
PF 
no 195 75.1795 27.54272 
-.710 .478 
yes 50 31.5000 29.79950 
RF 
no 195 75.3846 29.54519 
-9.306 .000 
yes 50 28.0000 37.10621 
RE 
no 195 72.3077 36.71938 
-7.549 .000 
yes 50 42.0000 21.18914 
EF 
no 195 62.9744 16.40733 
-6.516 .000 
yes 50 49.4400 16.90811 
EWB 
no 195 61.2308 19.77510 
-4.243 .000 
yes 50 49.0000 19.37150 
SF 
no 195 77.7564 19.69316 
-9.333 .000 
yes 50 58.5500 21.12940 
PAIN 
no 195 80.0256 23.59859 
-6.256 .000 
yes 50 33.2000 21.70677 
GH 
no 195 56.4872 16.00076 
-7.107 .000 
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Presence of hypoglycemic episodes 
 
Independent T-test testing for the effect of presence of hypoglycemic episodes during four 
weeks prior data collection on QOL domains 
 
QOL Domain 
Hypoglycemic 
episodes N 
Mean 
score 
Std. 
Deviation t P 
yes 107 70.5607 29.13313 
 
PF 
 no 138 77.6812 23.78553 
 
-2.106 
 
.036 
 
yes 107 63.3178 37.66751 
 
RF 
 no 138 68.8406 31.65329 
 
-1.246 
 
.214 
 
yes 107 58.2555 39.94059 
 
RE 
 no 138 67.1498 41.26655 
 
-1.697 
 
.091 
 
yes 107 56.7290 22.43547 
 
EF 
 no 138 60.2174 16.57619 
 
-1.399 
 
.163 
 
yes 107 58.5794 21.03906 
 
EWB 
 no 138 59.0145 18.81023 
 
-.170 
 
.865 
 
yes 107 73.2477 20.63615 
 
SF 
 no 138 70.8333 24.32170 
 
.823 
 
.412 
 
yes 107 74.3692 23.00813 
 
PAIN 
 no 138 76.6304 25.89220 
 
-.711 
 
.477 
 
yes 107 48.1776 20.62002 
 
GH 
 no 138 54.4928 18.49531 
 
-2.521 
 
.012 
 
 
Presence of hyperglycemic episodes 
 
Independent T-test for differences in means of QOL domains by hyperglycemic episodes 
during the four weeks prior to data collection  
 
QOL Domain 
Hyperglycemic 
episodes 
N 
Mean 
score 
Std. 
Deviation 
t 
P 
value 
yes 111 74.9550 26.76918 
 
PF 
 no 134 74.2537 26.25430 
 
.206 
 
.837 
 
yes 111 56.9820 40.47603 RF 
 no 134 74.2537 26.18261 
-4.027 
 
.000 
 
yes 111 49.5495 45.36382 
 
RE 
 no 134 74.6269 32.74649 
 
-5.014 
 
.000 
 
yes 111 52.4324 20.13438 
 
EF 
 no 134 63.8806 17.16398 
 
-4.804 
 
.000 
 
yes 111 54.3063 17.09481 
 
EWB 
 no 134 62.5672 21.08288 
 
-3.321 
 
.001 
 
yes 111 66.3288 25.32700 
 
SF 
 no 134 76.4925 19.33120 
 
-3.560 
 
.000 
 
yes 111 66.8694 25.52732 
 
PAIN 
 no 134 82.9104 21.40988 
 
-5.350 
 
.000 
 
yes 111 44.3694 19.96721 
 
GH 
 no 134 57.8358 17.22745 
 
-5.666 
 
.000 
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Appendix F 
 
QOL domains in the univariate analysis 
 
Physical functioning 
 
Physical functioning domain univariate analysis (GLM) 
 
Source 
Type III 
Sum of 
Squares 
df 
Mean 
Square 
F 
P 
value 
Partial 
Eta 
Squared 
N 
Estimated 
marginal 
mean  
Corrected  
Model 
5366.865(b) 2 2683.432 3.932 .021 .031   
Intercept 1241642.765 1 1241642.765 1819.277 .000 .883   
Physical 
activity 
2311.191 1 2311.191 3.386 .067 .014 Yes 150 
No     
76.613 
70.281 
hypoglycemia 2556.724 1 2556.724 3.746 .054 .015 Yes 107 
No   
70.176 
76.718 
Error 165163.135 242 682.492      
Total 1532950.000 245       
Corrected  
Total 
 
170530.000 244        
a Computed using alpha = .05                                                b  R Squared = .031 (Adjusted R Squared = 
.023) 
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RF domain  
 
Associations with RF domain in the Univariate analysis (GLM) 
   
Source 
Type III Sum 
of Squares df Mean Square F 
P 
value 
Partial 
Eta 
Squared 
N 
Estimated 
Marginal 
mean 
Corrected Model 132007.365 10 13200.736 19.613 .000 .456   
Intercept 103219.437 1 103219.437 153.362 .000 .396   
Additional 
sources of income 
2999.808 1 2999.808 4.457 .036 .019 Yes   28 
No    217 
36.39 
47.60 
Smoking 19405.433 1 19405.433 28.832 .000 .110 
Yes    46 
No    199 
28.61 
55.37 
Diet 13435.561 1 13435.561 19.962 .000 .079 
Yes    29 
No    116 
50.33 
33.66 
BMI 2466.214 2 1233.107 1.832 .162 .015 
<19.9 40 
20-25 99 
>25  106 
41.50 
45.98 
38.50 
Number of 
insulin 
injections/day 
15198.738 3 5066.246 7.527 .000 .088 
Once  21 
Twice102 
3 times  92 
>3 times30 
 
58.80 
43.56 
44.53 
21.08 
hyperglycemia 509.286 1 509.286 .757 .385 .003 
Yes    11 
No   134 
40.33 
43.65 
Diabetic 
complications 
40684.829 1 40684.829 60.449 .000 .205 Yes    50 
No   195 
24.00 
59.9 
Error 157492.635 234 673.045      
Total 1370625.000 245     245  
Corrected Total 289500.000 244       
R Squared = .456 (Adjusted R Squared = .433) 
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RE domain 
Associations with the RE domain in univariate analysis (GLM).   
Source 
Type III 
Sum of 
Squares 
df 
Mean 
Square 
F 
P 
value 
Partial 
Eta 
Square
d 
N 
Estimated 
marginal 
mean 
Corrected 
Model 
164418.328 9 18268.703 17.686 .000 .404 
  
 
Intercept 
132665.098 1 132665.098 128.431 .000 .353 
  
 
Additional 
sources of 
income 
13874.525 1 13874.525 13.432 .000 .054 Yes     28 
No     217 
34.329 
58.263 
Diet 
28955.745 1 28955.745 28.032 .000 .107 Yes   129 
No     116 
58.494 
34.098 
BMI 
15799.431 2 7899.715 7.648 .001 .061 <19.9  40 
20-25  99 
>25   106 
55.552 
49.288 
34.048 
Number of 
insulin 
injections/day 
24256.168 3 8085.389 7.827 .000 .091 
Once     21 
Twice   102 
3 times   92 
>3 times30 
 
68.525 
47.060 
48.799 
20.800 
Hyperglycemia 
2136.494 1 2136.494 2.068 .152 .009 Yes       111 
No        134 
42.918 
49.674 
Diabetic 
complications 
31097.906 1 31097.906 30.105 .000 .114 Yes         50 
No        195 
30.564 
62.028 
Error 
242747.205 235 1032.967 
     
 
Total 
1387777.778 245 
    245  
 
Corrected 
Total 
407165.533 244 
      
 
R Squared = .404 (Adjusted R Squared = .381) 
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EF domain 
 
Associations with EF domain of QOL in univariate analysis (GLM).  
 
Source 
Type III Sum 
of Squares 
df Mean Square F 
P 
value 
Partial 
Eta 
Squared 
N 
Estimated 
marginal 
means 
Corrected 
Model 
36338.455 9 4037.606 17.129 .000 .396    
Intercept 249668.868 1 249668.868 1059.187 .000 .818   
Physical 
activity 
4305.290 1 4305.290 18.265 .000 .072 Yes150 
No   95 
56.66 
45.68 
BMI 823.498 2 411.749 1.747 .177 .015 
<19.9  40 
20 -25 99 
>25   106 
48.89 
53.94 
50.67 
Number of 
insulin 
injections/day 
5142.230 3 1714.077 7.272 .000 .085 
Once    21 
Twice 102 
3 times 92 
>3 time30 
59.88 
46.50 
54.53 
43.76 
Health 
problems 
rather than 
diabetes 
4819.735 1 4819.735 20.447 .000 .080 Yes      65 
No     180 
45.27 
57.06 
Hyperglycemia 130.835 1 130.835 .555 .457 .002 
Yes    111 
No    134 
50.30 
52.04 
Diabetic 
complications 
4764.570 1 4764.570 20.213 .000 .079 Yes      50 
No    195 
44.83 
57.50 
Error 55393.586 235 235.717      
Total 935750.000 245       
Corrected 
Total 
91732.041 244       
R Squared = .396 (Adjusted R Squared = .373)        
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EWB domain 
 
Associations with EWB of QOL in univariate analysis (GLM) 
 
Source Type III 
Sum of 
Squares df 
Mean 
Square F 
P 
value 
Partial 
Eta 
Squared N 
Estimated 
marginal 
mean 
Corrected 
Model 
29784.299 11 2707.664 9.614 .000 .312   
 
Intercept 191786.593 1 191786.593 680.974 .000 .745   
 
 
Participants’ 
level of 
education 
 
2858.251 4 714.563 2.537 .041 .042 
Illiterat4 
Prima16 
Prep.  61 
Secon88 
Acad.  76 
73.93 
55.60 
58.31 
51.70 
55.47 
BMI 1315.856 2 657.928 2.336 .099 .020 
<19.9  40 
20 -25 99 
>25   106 
60.30 
55.83 
60.88 
Number of 
insulin 
injections/day 
13290.101 3 4430.034 15.730 .000 .168 
Once       21 
Twice   102 
3 times   92 
>3 times 30 
71.69 
59.95 
64.32 
40.06 
hyperglycemia 403.871 1 403.871 1.434 .232 .006 
Yes   111 
No     134 
57.54 
60.46 
 Diabetic 
complications 
2492.728 1 2492.728 8.851 .003 .037 Yes      50  
No     195 
54.53 
63.48 
Error 65621.155 233 281.636     
 
 
Total 943184.000 245      
 
 
Corrected 
Total 
95405.453 244     245   
R Squared = .312 (Adjusted R Squared = .280) 
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SF domain 
 
Associations with the SF domain of QOL in the univariate analysis (GLM). 
   
Source 
Type III 
Sum of 
Squares 
df 
Mean 
Square 
F P value 
Partial 
Eta 
Squared 
N 
Estimated 
marginal 
mean 
Corrected 
Model 
48627.371 12 4052.281 12.06 .000 .384   
 
Intercept 240506.535 1 240506.535 716.2 .000 .755   
 
Smoking 2724.633 1 2724.633 8.114 .005 .034 
Yes       46 
No       199 
68.53 
58.82 
Diet 8433.883 1 8433.883 25.116 .000 .098 
Yes     129 
No       116 
70.18 
57.17 
Number of 
insulin 
injections/day 
1720.548 3 573.516 1.708 .166 .022 
Once     21 
Twice 102 
3 times 92 
>3 time30 
66.53 
64.80 
66.12 
57.25 
Hyperglycemia 151.290 1 151.290 .451 .503 .002 
Yes     111 
No       134 
64.57 
62.78 
Diabetic 
complications 
17938.348 1 17938.348 53.420 .000 .187 Yes       50 
No       195 
51.65 
75.70 
Error 77905.792 232 335.801      
 Total 1392656.250 245     245  
 Corrected 
Total 
126533.163 244       
 R Squared = .384 (Adjusted R Squared = .352) 
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BP domain 
 
Associations with BP of QOL domain in univariate analysis (GLM) 
 
Source 
Type III 
Sum of 
Squares df 
Mean 
Square F 
P 
value 
Partial 
Eta 
Squared N 
Estimated 
marginal 
mean 
Corrected 
Model 
47419.100(a) 13 3647.623 8.355 .000 .320   
Intercept 244752.654 1 244752.654 560.622 .000 .708   
 
Additional 
sources of 
income 
786.816 1 786.816 1.802 .181 .008 Yes       28 No      217 
67.36 
73.27 
Diet 5658.301 1 5658.301 12.961 .000 .053 
Yes     129 
No      116 
75.55 
65.08 
 
BMI 3027.145 2 1513.573 3.467 .033 .029 
<19.9    40 
20 -25   99 
>25     106 
75.28 
70.35 
65.32 
HbA1c 3658.459 1 3658.459 8.380 .004 .035 
<8         63 
>8       182 
74.94 
65.69 
 
Health 
problems 
rather than 
diabetes 
3909.629 1 3909.629 8.955 .003 .037 Yes       65 No      180 
65.36 
75.27 
Hyperglycemia 1926.759 1 1926.759 4.413 .037 .019 
Yes     111 
No      134 
67.05 
73.58 
Diabetic 
complications 
2924.623 1 2924.623 6.699 .010 .028 Yes       50 No      195 
65.43 
75.202 
Error 100848.400 231 436.573      
 Total 1550118.750 245       
 Corrected 
Total 
148267.500 244       
 a  R Squared = .320 (Adjusted R Squared = .282) 
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GH domain 
 
Associations with GH domain in univariate analysis (GLM) 
 
Source 
Type III Sum 
of Squares df 
Mean 
Square F 
P 
value 
Partial 
Eta 
Squared 
N 
Estimate 
marginal 
mean 
Corrected Model 
40380.993 9 4486.777 19.541 .000 .428 
  
Intercept 
173114.179 1 173114.1 753.971 .000 .762 
  
 
Diet 
6162.112 1 6162.112 26.838 .000 .102 Yes  129 
No    116 
52.95 
41.51 
Number of 
insulin 
injections/day 
1212.722 3 404.241 1.761 .155 .022 
Once  21 
Twice102 
3 times 92 
>3times30 
53.88 
45.11 
45.89 
44.02 
Health problems 
rather than 
diabetes 
5848.816 1 5848.816 25.474 .000 .098 Yes      65 
No     180 
40.61 
53.84 
Hypoglycemia 
198.778 1 198.778 .866 .353 .004 Yes    107 
No      138 
46.23 
48.22 
Hyperglycemia 
1.399 1 1.399 .006 .938 .000 Yes    111 
No      134 
47.13 
47.32 
Diabetic 
complications 
6238.739 1 6238.739 27.172 .000 .104 Yes      50 
No      195 
39.79 
54.67 
HbA1c 
3120.135 1 3120.135 13.589 .000 .055 <8        63 
>8      172 
51.84 
42.61 
Error 
53956.762 235 229.603 
     
 
Total 
750075.000 245 
    245  
 
Corrected Total 
94337.755 244 
      
 
R Squared = .428 (Adjusted R Squared = .406) 
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ﺠﻭﺩﺓ ﺍﻟﺤﻴﺎﺓ ﻭﻤﺤﺩﺩﺍﺘﻬﺎ ﻟﺩﻯ ﻤﺭﻀﻰ ﺍﻟﺴﻜﺭﻱ ﻤﻥ ﺍﻟﻨﻭﻉ ﺍﻷﻭل ﺍﻟﺫﻴﻥ ﻴﺘﻠﻘﻭﻥ ﺍﻟﺭﻋﺎﻴﺔ "
ﺴﻜﺭﻱ ﺍﻟﺘﺎﺒﻌﺔ ﻟﻤﺭﺍﻜﺯ ﺍﻟﺭﻋﺎﻴﺔ ﺍﻟﺼﺤﻴﺔ ﺍﻷﻭﻟﻴﺔ ﺍﻟﺤﻜﻭﻤﻴﺔ ﻓﻲ ﺍﻟﻤﺤﺎﻓﻅﺎﺕ ﻓﻲ ﻋﻴﺎﺩﺍﺕ ﺍﻟ
  "ﺍﻟﺸﻤﺎﻟﻴﺔ ﻤﻥ ﺍﻟﻀﻔﺔ ﺍﻟﻐﺭﺒﻴﺔ
 
  ﺭﺸﺎ ﻋﺒﺩ ﺍﻟﺭﺤﻤﻥ ﺍﻟﻜﺭﻤﻲ: ﺇﻋﺩﺍﺩ
 
  ﺍﻟﺩﻜﺘﻭﺭ ﺨﻠﺩﻭﻥ ﺒﺩﺭ: ﺇﺸﺭﺍﻑ
  ﺍﻟﺩﻜﺘﻭﺭ ﻫﺸﺎﻡ ﺩﺭﻭﻴﺵ: ﻤﺸﺭﻑ ﻤﺴﺎﻋﺩ
 
  ﺍﻟﻤﻠﺨﺹ
  
 ﺍﻷﻁﻔﺎل ﻴﻌﺘﺒﺭ ﻤﺭﺽ ﺍﻟﺴﻜﺭﻱ ﻤﻥ ﺍﻟﻨﻭﻉ ﺍﻷﻭل ﺜﺎﻟﺙ ﺍﻷﻤﺭﺍﺽ ﺍﻟﻤﺯﻤﻨﺔ ﺍﻷﻜﺜﺭ ﺸﻴﻭﻋﺎ ﻓﻲ
ﻭﺍﻟﻤﺭﺍﻫﻘﻴﻥ ﺤﻴﺙ ﺃﻨﻪ ﻴﺴﺒﺏ ﺍﻟﻜﺜﻴﺭ ﻤﻥ ﺍﻻﻀﻁﺭﺍﺒﺎﺕ ﺍﻟﻨﻔﺴﻴﺔ ﻭﺍﻻﺠﺘﻤﺎﻋﻴﺔ ﻓﻲ ﺤﻴﺎﺓ ﺍﻟﻤﺭﻀﻰ ﻭﻜﺫﻟﻙ 
ﻭﻤﻥ ﻫﻨﺎ ﺒﺭﺯﺕ ﺃﻫﻤﻴﺔ ﺩﺭﺍﺴﺔ ﺠﻭﺩﺓ ﺍﻟﺤﻴﺎﺓ ﻭﺍﻟﻌﻭﺍﻤل ﺍﻟﺘﻲ ﺘﺅﺜﺭ ﻋﻠﻴﻬﺎ ﻋﻨﺩ ﻫﺫﺍ ﺍﻟﻨﻭﻉ ﻤﻥ . ﻋﺎﺌﻼﺘﻬﻡ
  .ﺍﻟﻤﺭﻀﻰ
 ﺒﻤﺭﺽ ﺍﻟﺴﻜﺭﻱ ﻤﻥ ﺍﻟﻨﻭﻉ ﻫﺩﻓﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﺇﻟﻰ ﺘﻘﻴﻴﻡ ﺠﻭﺩﺓ ﺍﻟﺤﻴﺎﺓ ﻟﺩﻯ ﺍﻟﻔﻠﺴﻁﻴﻨﻴﻴﻥ ﺍﻟﻤﺼﺎﺒﻴﻥﻭ
ﺍﻷﻭل ﻭﺍﺴﺘﻜﺸﺎﻑ ﺍﻟﻌﻭﺍﻤل ﺍﻻﻗﺘﺼﺎﺩﻴﺔ ﻭﺍﻻﺠﺘﻤﺎﻋﻴﺔ ﺍﻟﺩﻴﻤﻭﻏﺭﺍﻓﻴﺔ ﻭﻨﻤﻁ ﺍﻟﺤﻴﺎﺓ ﻭﻜﺫﻟﻙ ﺍﻟﻤﺘﻐﻴﺭﺍﺕ 
  .ﺍﻟﻤﺭﻀﻴﺔ ﺍﻟﺘﻲ ﺘﺅﺜﺭ ﻋﻠﻴﻬﺎ
  
  ﺇﺠﺭﺍﺀﺍﺕ ﺍﻟﺩﺭﺍﺴﺔ
 
 ﻋﻠـﻰ ﻋﻴﻨـﺔ ﻋـﺸﻭﺍﺌﻴﺔ 1102ﻭﻗﺩ ﺃﺠﺭﻴﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻓﻲ ﺍﻟﻔﺘﺭﺓ ﺍﻟﻭﺍﻗﻌﺔ ﺒﻴﻥ ﻨﻴﺴﺎﻥ ﻭﻜﺎﻨﻭﻥ ﺃﻭل 
 ﻤﺭﻀﻰ ﺍﻟـﺴﻜﺭﻱ  ﻤﻤﺜﻠﺔ( ﻤﻥ ﺍﻟﻤﺠﺘﻤﻊ ﺍﻟﻤﺴﺘﻬﺩﻑ % .435.ﻤﺎ ﻴﻭﺍﺯﻱ  ) ﻤﺭﻴﺽ، 252ﻁﺒﻘﻴﺔ ﺒﻭﺍﻗﻊ 
 ﻭﺍﻟـﺫﻴﻥ ﻴﺘﻠﻘـﻭﻥ (ﻤـﺭﻴﺽ  )827  ﺴﻨﺔ41ﻤﻥ ﺍﻟﻨﻭﻉ ﺍﻷﻭل ﻤﻥ ﺍﻟﺫﻴﻥ ﺃﻋﻤﺎﺭﻫﻡ ﺃﻜﺜﺭ ﺃﻭ ﺘﺴﺎﻭﻱ ﺃﻭ
ﺍﻟﻌﻼﺝ ﻓﻲ ﻋﻴﺎﺩﺍﺕ ﺍﻟﺴﻜﺭﻱ ﺍﻟﺘﺎﺒﻌﺔ ﻟﻤﺭﺍﻜﺯ ﺍﻟﺭﻋﺎﻴﺔ ﺍﻟﺼﺤﻴﺔ ﻓﻲ ﻭﺯﺍﺭﺓ ﺍﻟـﺼﺤﺔ ﻓـﻲ ﺍﻟﻤﺤﺎﻓﻅـﺎﺕ 
ﻫﺩﺍﻓﻬﺎ ﺘﻡ ﺍﺴﺘﺨﺩﺍﻡ ﺍﺴﺘﺒﻴﺎﻥ ﻴﺠﻤﻊ ﻤﻌﻠﻭﻤـﺎﺕ ﻋـﻥ ﺍﻟﻤﺒﺤـﻭﺙ ﻭﻟﺘﺤﻘﻴﻕ ﺃ  .ﺍﻟﺸﻤﺎﻟﻴﺔ ﻤﻥ ﺍﻟﻀﻔﺔ ﺍﻟﻐﺭﺒﻴﺔ 
ﻜﺎﻟﻌﻤﺭ،ﺍﻟﺠﻨﺱ ﻭﺍﻟﻌﻭﺍﻤل ﺍﻟﻤﺭﻀﻴﺔ ﻭﻜﺫﻟﻙ ﻤﺭﺍﺠﻌﺔ ﺍﻟﻤﻠﻔﺎﺕ ﺍﻟﻁﺒﻴﺔ ﻟﻠﻤﺭﻀﻰ ﻜﻤﺎ ﺘﻡ ﺍﺴﺘﺨﺩﺍﻡ ﺍﻟﻨـﺴﺨﺔ 
 ﻭﻗﺩ ﺘﻡ ﺘﺤﻠﻴل ﺍﻟﺒﻴﺎﻨﺎﺕ ﺒﺎﺴﺘﺨﺩﺍﻡ ﺭﺯﻤـﺔ ﺍﻟﺒـﺭﺍﻤﺞ ﺍﻹﺤـﺼﺎﺌﻴﺔ ﺍﻟﻌﺭﺒﻴﺔ ﺍﻟﻤﻭﺠﺯﺓ ﻟﻤﻘﻴﺎﺱ ﺠﻭﺩﺓ ﺍﻟﺤﻴﺎﺓ 
    .ﻟﻠﻌﻠﻭﻡ ﺍﻻﺠﺘﻤﺎﻋﻴﺔ
 401 
   
  ﻟﺩﺭﺍﺴﺔﻨﺘﺎﺌﺞ ﺍ
  
 2.52 ﺴـﻨﺔ ﺒﻤﻌـﺩل 85 ﻭ 41ﻭﺘﻠﺨﺼﺕ ﻨﺘﺎﺌﺞ ﺍﻟﺩﺭﺍﺴﺔ، ﺒﺄﻥ ﺃﻋﻤﺎﺭ ﺍﻟﻤﺒﺤﻭﺜﻴﻥ ﺘﺭﺍﻭﺤﺕ ﺒﻴﻥ ﻋﻤﺭ 
، (92 – 91)ﻜﺎﻨﻭﺍ ﻤﻥ ﺍﻟﻔﺌﺔ ﺍﻟﻌﻤﺭﻴﺔ  %( 7.54)ﺇﻨﺎﺙ، ﻭﺃﻥ % 4.15ﺫﻜﻭﺭ ﻭ  % 6.84ﺴﻨﺔ ﻤﻨﻬﻡ 
%( 92)ﻗﺩ ﺍﻨﻬﻭﺍ ﺍﻟﺘﻌﻠﻴﻡ ﺍﻟﺠﺎﻤﻌﻲ، ﻜﻤـﺎ ﺃﻥ  %( 13)ﻗﺩ ﺍﻨﻬﻭﺍ ﺍﻟﻤﺭﺤﻠﺔ ﺍﻟﺜﺎﻨﻭﻴﺔ ﺒﻴﻨﻤﺎ %( 9.53)ﻭﺃﻥ 
ﻋﻼﻤـﺎﺕ ﺍﻟﻤﺘﻭﺴـﻁﺎﺕ .  ﻤﻥ ﺍﻟﻤﺒﺤﻭﺜﻴﻥ ﻗﺩ ﺘﻡ ﺘﺸﺨﻴﺹ ﺍﻟﻤﺭﺽ ﻟﺩﻴﻬﻡ ﻤﻨﺫ ﺃﻗل ﻤﻥ ﺨﻤﺱ ﺴـﻨﻭﺍﺕ 
 46.57 ﻭ ﻟﻠﻤﺠﺎل ﺍﻟﺫﻱ ﻴﻘﻴﻡ ﺍﻟﺤﺎﻟـﺔ ﺍﻟـﺼﺤﻴﺔ  37.15ﻟﻤﺠﺎﻻﺕ ﺠﻭﺩﺓ ﺍﻟﺤﻴﺎﺓ ﺍﻟﺜﻤﺎﻨﻴﺔ ﺘﺭﺍﻭﺤﺕ ﺒﻴﻥ 
  ﻭﻗﺩ ﻜﺎﻥ ﺃﻜﺜﺭ ﺍﻟﻤﺠﺎﻻﺕ ﺘﺄﺜﺭﺍ ﻫﻭ ﺫﻟﻙ ﺍﻟﻤﺠﺎل ﺍﻟﺫﻱ ﻴﻘﻴﺱ ﺍﻟﻤﺩﻯ ﺍﻟﺫﻱ .ﻟﻠﻤﺠﺎل ﺍﻟﺫﻱ ﻴﻘﻴﺱ ﺸﺩﺓ ﺍﻷﻟﻡ 
ﻤﻥ ﺍﻟﻤﺒﺤﻭﺜﻴﻥ ﻗﺩ % 34ﺘﺘﻌﺎﺭﺽ ﻓﻴﻪ ﺍﻟﻨﺎﺤﻴﺔ ﺍﻟﺼﺤﻴﺔ ﻤﻊ ﺃﺩﺍﺀ ﺍﻷﻋﻤﺎل ﻭﺍﻷﻨﺸﻁﺔ ﺍﻟﻴﻭﻤﻴﺔ، ﺤﻴﺙ ﺃﻥ 
 ﻭﺍﻟﻌﻭﺍﻤل ، ﻨﻤﻁ ﺍﻟﺤﻴﺎﺓ ، ﻭﺍﻻﺠﺘﻤﺎﻋﻴﺔ ﺔﺍﻟﺩﻴﻤﻭﻏﺭﺍﻓﻴﺒﻭﺍﺤﺩ ﺃﻭ ﺃﻜﺜﺭ ﻤﻥ ﺍﻟﻌﻭﺍﻤل ﺘﺄﺜﺭﻭﺍ ﻓﻲ ﻫﺫﺍ ﺍﻟﻤﺠﺎل 
، ﻴﻠﻴﻪ ﺍﻟﻤﺠﺎل ﺍﻟﺫﻱ ﻴﻘﻴﻡ ﻤﻥ ﺨﻼﻟﻪ ﺍﻟﻤﺒﺤﻭﺙ ﺤﺎﻟﺘﻪ ﺍﻟـﺼﺤﻴﺔ، ﺤﻴـﺙ ﺃﻥ ﺤـﻭﺍﻟﻲ ﺍﻟﻤﺘﻌﻠﻘﺔ ﺒﺎﻟﺴﻜﺭﻱ 
ﺒﻴﻨﻤﺎ ﻟﻡ ﻴﺘﺄﺜﺭ ، ﺒﻭﺍﺤﺩ ﺃﻭ ﺃﻜﺜﺭ ﻤﻥ ﺍﻟﻌﻭﺍﻤل ﺍﻟﻤﺩﺭﻭﺴﺔ ﻤﻥ ﺍﻟﻤﺒﺤﻭﺜﻴﻥ ﻓﺩ ﺘﺄﺜﺭﻭﺍ ﻓﻲ ﻫﺫﺍ ﺍﻟﻤﺠﺎل %  14
 ﺍﻟﺘﺯﺍﻡ ﺍﻟﻤﺒﺤﻭﺜﻴﻥ ﺒﻨﻅﺎﻡ ﺍﻟﺤﻤﻴﺔ ﺍﻟﺨـﺎﺹ ﺇﻥ . ﺍﻟﻌﻭﺍﻤل ﻫﺫﻩ ﻤﻥﺒﺄﻱﺍﻟﻤﺠﺎل ﺍﻟﺫﻱ ﻴﻘﻴﻴﻡ ﺍﻟﻨﺸﺎﻁ ﺍﻟﺠﺴﺩﻱ 
 ﺍﻟﺴﻜﺭﻱ ﻭﻜﺫﻟﻙ  ﻭﺠﻭﺩ ﻭﺍﺤﺩ ﺃﻭ ﺃﻜﺜﺭ ﻤﻥ ﻤﻀﺎﻋﻔﺎﺕ ﺍﻟﺴﻜﺭﻱ ﻜﺎﻥ ﻟﻬﻤﺎ ﺍﻷﺜﺭ ﺍﻷﻜﺒﺭ ﻋﻠـﻰ ﻟﻤﺭﻀﻰ
ﺒﻴﻨﻤﺎ ﻜﺎﻥ  ﻟﻭﺠﻭﺩ . ﻤﺠﺎﻻﺕ ﺠﻭﺩﺓ ﺍﻟﺤﻴﺎﺓ،ﺤﻴﺙ ﺃﻥ ﺃﺭﺒﻊ ﻤﺠﺎﻻﺕ ﻋﻠﻰ ﺍﻷﻗل ﻗﺩ ﺘﺄﺜﺭﺕ ﺒﻬﺫﻴﻥ ﺍﻟﻌﺎﻤﻠﻴﻥ 
ﻤﺼﺎﺩﺭ ﺩﺨل ﺇﻀﺎﻓﻴﺔ ﻏﻴﺭ ﺩﺨل ﺍﻷﺴﺭﺓ ﺍﻟﺸﻬﺭﻱ ، ﺍﻟﻤﺴﺘﻭﻯ ﺍﻟﺘﻌﻠﻴﻤﻲ ﺍﻟﺫﻱ ﺃﻨﻬﺎﻩ ﺍﻟﻤﺒﺤﻭﺙ، ﻤﻤﺎﺭﺴـﺔ 
ﺎﻀﺔ ﻭﺍﻟﺘﻤﺎﺭﻴﻥ ﺍﻟﺠﺴﺩﻴﺔ،ﻋﺩﺩ ﺍﻟﻤﺭﺍﺕ ﺍﻟﻴﻭﻤﻴﺔ ﻟﻠﺤﻘﻥ ﺒﺎﻷﻨﺴﻭﻟﻴﻥ ، ﻭﺠﻭﺩ ﺃﻤﺭﺍﺽ ﺃﺨـﺭﻯ ﻏﻴـﺭ ﺍﻟﺭﻴ
ﻤﺭﺽ ﺍﻟﺴﻜﺭﻱ ، ﻤﻌﺩل ﺍﻟﺴﻜﺭ، ﺯﻴﺎﺩﺓ ﻭﺯﻥ ﺍﻟﻤﺒﺤﻭﺙ ﻭﻜﺫﻟﻙ ﺘﻌﺭﺽ ﺍﻟﻤﺒﺤﻭﺙ ﻟﻨﻭﺒﺎﺕ ﻤﺘﻜﺭﺭﺓ ﻤـﻥ  
ﺃﻤﺎ ﺒﺎﻟﻨـﺴﺒﺔ ﻟﻠﻌﻤـﺭ . ﺍﺭﺘﻔﺎﻉ ﻨﺴﺒﺔ ﺍﻟﺴﻜﺭ ﻓﻲ ﺍﻟﺩﻡ  ﺃﺜﺭ ﻋﻠﻰ ﻭﺍﺤﺩ ﺃﻭ ﺃﻜﺜﺭ ﻤﻥ ﻤﺠﺎﻻﺕ ﺠﻭﺩﺓ ﺍﻟﺤﻴﺎﺓ 
 ﺍﻟﺤﺎﻟﺔ ﺍﻻﺠﺘﻤﺎﻋﻴﺔ، ﺍﻟﻤﻬﻨﺔ ﺍﻟﺤﺎﻟﻴﺔ، ﺩﺨل ﺍﻷﺴﺭﺓ ﺍﻟﺸﻬﺭﻱ ﻁﻭل ﻓﺘﺭﺓ ﺍﻟﻤﺭﺽ ﻭﻜﺫﻟﻙ ﻭﺠﻭﺩ ﻭﺍﻟﺠﻨﺱ،
ﻟﻨﻭﺒﺎﺕ ﻤﺘﻜﺭﺭﺓ ﻤﻥ ﺍﻨﺨﻔﺎﺽ ﻨﺴﺒﺔ ﺍﻟﺴﻜﺭ ﻓﻲ ﺍﻟﺩﻡ ﻟﻡ ﻴﻜﻥ ﻟﻬﺎ ﺃﻱ ﺘﺄﺜﻴﺭ ﻋﻠﻰ ﺃﻱ ﻤﻥ ﻤﺠﺎﻻﺕ ﺠـﻭﺩﺓ 
  .ﺍﻟﺤﻴﺎﺓ
  
  ﺍﻻﺴﺘﻨﺘﺎﺠﺎﺕ ﻭﺍﻟﺘﻭﺼﻴﺎﺕ
  
ﺠﻭﺩﺓ ﺤﻴـﺎﺓ ﻤﺘﻭﺴـﻁﺔ ﺇﻟـﻰ ﻭﻤﻥ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻨﺴﺘﻨﺘﺞ ﺃﻥ ﻤﺭﻀﻰ ﺍﻟﺴﻜﺭﻱ ﻤﻥ ﺍﻟﻨﻭﻉ ﺍﻷﻭل ﻟﺩﻴﻬﻡ 
ﻤﺭﺘﻔﻌﺔ ﻨﺴﺒﻴﺎ ﻭﺃﻥ ﻫﻨﺎﻙ ﺒﻌﺽ ﺍﻟﻌﻭﺍﻤل ﺍﻟﺘﻲ ﺘﺅﺜﺭ ﻋﻠﻴﻬﺎ ﺒﺤﻴﺙ ﺨﻔﻀﺕ ﻤﻥ ﻤﻌﺩل ﺠﻭﺩﺓ ﺍﻟﺤﻴﺎﺓ ﻤﺜـل 
  .ﻭﺠﻭﺩ ﻤﻀﺎﻋﻔﺎﺕ ﺍﻟﺴﻜﺭﻱ
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 ﺘﻭﺼﻲ ﺍﻟﺩﺭﺍﺴﺔ ﻤﻘﺩﻤﻲ ﺍﻟﺨﺩﻤﺎﺕ ﺍﻟﺼﺤﻴﺔ ﻭﺼﺎﻨﻌﻲ ﺍﻟﻘﺭﺍﺭ ﺒﺄﺨﺫ ﺘﻠﻙ ﺍﻟﻨﺘﺎﺌﺞ ﺒﻌﻴﻥ ﺍﻻﻋﺘﺒﺎﺭ ﻤﻥ ﺍﺠل 
ﻤﺭﻀﻰ ﺍﻟﺴﻜﺭﻱ ﻤﻥ ﺍﻟﻨﻭﻉ ﺍﻷﻭل ﻤﻥ ﺃﺠل ﺘﺨﻔﻴﻑ ﺍﻟﻤﺴﺎﻫﻤﺔ ﻓﻲ ﺘﻁﻭﻴﺭ ﺍﻟﺨﺩﻤﺎﺕ ﺍﻟﺼﺤﻴﺔ ﺍﻟﻤﻘﺩﻤﺔ ﻟ
     . ﻤﻌﺎﻨﺎﺘﻬﻡ ﻭﺍﻟﺤﻴﻠﻭﻟﺔ  ﺩﻭﻥ ﺤﺩﻭﺙ ﻤﻀﺎﻋﻔﺎﺕ ﻤﺴﺘﻘﺒﻠﻴﺔ ﻤﻤﺎ ﻗﺩ ﻴﺭﺘﻘﻲ ﺒﻬﻡ ﺇﻟﻰ ﺠﻭﺩﺓ ﺤﻴﺎﺓ ﺃﻓﻀل
